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ABSTRACT 
 
The purpose of this study was to develop a framework for provision of essential medicines 
for the district health services. A qualitative descriptive, exploratory and contextual action 
research design was followed. The data collection was conducted through site visits and 
semi structured interviews targeting the responsible pharmacists who were purposively 
selected on the basis of their expert knowledge and experiences from the eight of the 
nine provinces of the Republic of South Africa which is a developing country with limited 
resources for provision of healthcare services. 
 
The study found that there was no standardised framework for provision of essential 
medicines for the District Health Services. Based on the site visits and action research 
findings a proposed Framework covering the selection, procurement, warehousing, 
distribution and management support components for provision of essential medicines 
for district health services was developed and subjected to national pharmaceutical 
experts and district health services managers review and critique which is finally 
presented, after taking into consideration the experts inputs as a proposed framework 
emanating from the study. The proposed framework will contribute towards improving the 
provisioning and availability of essential medicines within the district health services. 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
Pharmaceutical purchases (medicines) are the key cost driver for the health care system 
second only to the compensation of employees for the health budget (Management 
Science for Health [MSH] 2012:18.3). As a result, when the medicines are not available, 
the control and treatment of diseases is negatively affected resulting in the premature 
deaths and morbidity of the citizens. Medicines Sans Frontiers (MSF) (2013:13) reported 
that lack of access to medicines has complex underlying causes ranging from health 
programme implementation to medicine supply system. 
 
A study conducted on pharmaceutical management of tuberculosis in seven of our nine 
provinces found that the availability of ARV and TB medication was at less than 95 % in 
five of the provinces namely the Free State, Eastern Cape, Gauteng, Limpopo, and 
Mpumalanga. The factors contributing to this low availability especially in primary health 
clinic settings included poor stock control and management in nurse-led primary health 
clinics, and a lack of pharmacist’s assistants to take charge of drug supply management. 
Further a lack of electronic stock management systems also played a role in poor 
medicine availability as manual stock cards were found not to be updated at most facilities 
(Pure Health Consulting 2012:97).  
 
Western Cape and North West had above 95% availability for essential medicines. The 
factors that contributed to the better access and availability included electronic stock 
management, maintenance of the 3 month buffer stock, close monitoring and weekly 
reporting on stock availability, active contract  management, and interaction with the 
suppliers over quantification, shortages and forecasting of needs, involvement of all role-
players in medicine stock management including finance, programme managers and 
pharmacists and adjustment of issuing quantities during limited stock period to ensure 
that all patients receive medication whilst waiting for the replenishment stock (Pure Health 
Consulting 2012:129). 
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In terms of policy guidelines, in South Africa the provision of medicines is guided by the 
National Drug Policy (NDP) whose objective is to ensure consistent availability of 
essential drugs (medicine) to all South African citizens (NDOH 1996:3). The essential 
medicines are those medicines required in order to treat the majority of diseases that 
affect the people, these medicines satisfy the priority health care needs of the population 
(WHO 2016). However, in practice there have been several challenges regarding 
medicine supply in South Africa, with various provinces reporting medicine stock outs to 
the extent that the inability to provide the required quantity and quality of medicines was 
identified as a key challenge facing the South African Government (Stock Out 2016:13). 
The challenge of medicine availability and access was confirmed by the Civic 
Organisation called Stop Stock Out Report that revealed that medicine stock out is a 
national crisis affecting all the nine provinces in particular for the HIV and TB medicines, 
with rural provinces being the worst affected at 54% stock out rate and also suffering 
major stock out for the vaccines at 35% in November 2013 (MSF 2013:7-12). The 
prevalent shortage of medicines requires that new approaches and models should be 
explored to ensure that medicines are accessible and affordable to the citizens of the 
country.  
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM  
 
In South Africa provision of medicines is governed by the Medicine and related Substance 
Act of 1965 as amended. The procurement of essential medicines for the public sector is 
done through the national tender system with provinces buying for the facilities falling 
within their areas of governance. South Africa has ten medical depots with Eastern Cape 
having two medical depots, independently run by the nine provinces with an objective to 
ensure consistent supply of the essential medicines.  
 
The medical depots are responsible for coordination the procurement, distribution of the 
essential medicines including antiretroviral, tuberculosis, vaccines and chronic medicines 
and medical consumables namely gloves, syringes, injections and intravenous lines to 
the health facilities. Within these depots there are different procedures and no standard 
model utilised in the procurement and distribution of medicines across the country. 
Provinces including Eastern Cape and Northern Cape procure for all the facilities within 
their provinces whereas Western Cape province procure primarily for the district health 
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services as the larger hospitals are said to be well enabled to manage medicine and 
consumables supply utilising their own resources. 
 
The South African government in 2009 realised the importance of medicine and medical 
supplies as an integral part of the platform for provision of quality health care services to 
an extent that medicine and medical consumables availability has been listed as one of 
the six priorities listed for the South African Department of Health (NDOH 2009a:1). The 
escalation to six priority list of these essential health commodities was adopted in order 
to improve the health profile of all South Africans. Further improving medicine supply and 
management have been identified as key action point in the South African Health 
Programme of Action. The Ten Point Plan of the South African National Department of 
Health places the emphasis on the review of drug policies which may lead to the 
improvement of medicine availability by means of improved procurement of medicines 
and the possible establishment of a state owned pharmaceutical industry (NDOH 
2009b:5). 
 
1.2.1 The source of the research problem  
 
Only 14 percent of the South African health facilities achieved an acceptable level for the 
availability of (essential) medicines and supplies in the baseline health facilities audit 
conducted (Matsoso, Fryatt & Andrews 2015:98).  
 
1.2.2 Background to the research problem 
 
Prior to the effect of South Africa’s democratic government dispensation in 1994, 
medicine policies were also in line with the fragmented provision of the health services 
model. This resulted in differentiated access and varied availability of medicines due to 
lack of standardised essential medicine lists. In 1996 the National Drug Policy (NDP) was 
developed and approved by the new government in line with WHO standard requirements 
of member countries developing and implementing national medicine policies. The 
primary objective for the NDP was that of ensuring the availability of essential medicines 
(medication) to all South African citizens. The NDP is supported by Standard Treatment 
Guidelines and the Essential Medicine List for each level of care to realise the provision 
of affordable essential medicines (South Africa 1996:3).  
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The government is expected to ensure availability of generic essential medicine through 
implementation of incentives that favour generic medicines and their production in the 
country (South Africa 1996:10).  
 
Post 1994, in South Africa the major platform through which citizens’ access basic health 
services and medicines became the primary health care centres which are located within 
the district health services. The provision of medicines in the primary health care context 
has been free for all citizens since 1994 in an attempt to promote healthy living and 
improve life expectancy of the population (South Africa 1996:1). Although the medicine 
policies are in place, medicine availability has not been at acceptable levels. During May 
2010 South Africa experienced a shortage of over 80 medicines in the public health sector 
which included, amongst others, influenza vaccinations, medication for hypertension and 
tuberculosis. The severity of this shortage varied from province to province, as well as 
from hospital to hospital within the provinces, depending on the leadership abilities and 
skills levels of management (Health 24 2010).  
 
The Public Service Commission results of the 2010 citizen survey also indicated that there 
were instances where citizens visited service delivery points and returned without 
receiving what they needed. Of the patient (10,5%) who participated in the survey were 
told to come the following day for their treatment, due to lack of sufficient stock of medicine 
or that it was time for staff to knock off for the day (Public Service Commission 2011:41). 
As the challenges with the health services provision, including medicine availability, 
continued to surface the need to strengthen District Health Services to become well-
functioning was also identified as a core principle of primary health care re-engineering 
processes (Gray, Vawda & Jack 2011:23). The re-engineering process, it is believed, will 
contribute towards the efficiency of district health services in the rendering of required 
essential services and will ensure that health programmes are available. This will include 
the provision of medicines, as well as treatment and care to the population in the areas 
where they live. The South African Department of Health formally recognised that 
medicine availability is cardinal in the provision of quality health care services to the extent 
that medicine availability has been regarded as one of the six Ministerial priorities required 
for compliance in all public health facilities (NDOH 2011a:16).  
 
In further developments over the years the South African Government has also regarded 
Health as one of 12 key outcomes to be prioritised during the 2009-2014 government 
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term of office towards ensuring a better life for all South Africans and the achievement of 
the millennium development goals during the period 2010-2015 (GCIS 2010). In order to 
improve the health profile of all South Africans improved medicine supply and 
management have been identified as key factors in the South African Health Programme 
of Action. However, the negative media coverage on the non-availability and stock out of 
medicines ensured the public health services a poor reputation as service users did not 
receive the expected medications as they visited health facilities (Thom & Langa 2010:7).  
 
In 2011 the Ministry of Health commissioned a baseline audit for all public health facilities 
based on these standards. The purpose was to assess the current state of health services 
as well as the degree of compliance with standards. The results showed that the majority 
of health facilities did not comply with medicine availability standards due to stock out of 
essential medicines (Gray et al 2011:62). In 2012 the South African Ministry of Health, 
responding to the countrywide medicine shortages, adopted what is called non-
negotiables for the public health sectors. The non-negotiables list is a list of items that are 
supposed to be available at all times for the continued provision of safe and quality health 
services. These items include medicine, cleaning materials, as well as equipment and 
laboratory services. The Minister called for provinces to do sufficient budgeting and ring-
fence these funds with the intention to minimise the recurrence of non-availability of 
essential goods and services for basic service delivery (NDOH 2012a:1).  
 
For quality and efficient medicine provision the South African Pharmacy Council 
advocates the availability of pharmacists and pharmacist’s assistants to take charge of 
the provision of medicines in the hospitals, community health centres and primary health 
clinics in an environment compliant with good pharmacy practice (South African 
Pharmacy Council 2010:2). However, in practice there have been several challenges 
regarding availability of pharmacists and pharmacists’ assistants in public health facilities 
with hospitals and community health centres not having permanent pharmacists. In 
primary health clinics nurses are in the main the only available personnel responsible for 
the provision-, ordering-, control of and enabling access to medicines (International 
Council of Nurses 2011:1).  
 
This situation has the potential for the consistent non-replenishment of medicine stock as 
nurses’ primary function is to render nursing care depending on other health workers and 
support services for on-site provision and medicine supply management. Therefore, it will 
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be important that a study on the provision of essential medicines be conducted and 
proposal for a standard framework be developed to improve the availability of medicines. 
 
1.3 STATEMENT OF THE RESEARCH PROBLEM  
 
South Africa does not have a framework approved for use in the country to guide and 
facilitate measurement and provisioning of essential medicines. Each province manage 
the medicine supply differently as evidenced by Free State and Western Cape operating 
as trading entities which handles medicine procurement and provisioning as a business 
transaction meaning that health facilities are only able to procure medicines if they have 
budget available without budget the medicine stock is withheld until budget availability 
proof is confirmed, resulting in avoidable medicine stock outs  whereas the other seven 
provinces utilise an in house state warehouse approach which provide facilities with 
medicine as ordered based on needs submitted servicing either all the three levels of care 
whilst others only serve the district health services. Under the in-house warehouse 
approach medicine budget is shared amongst all cost centres where there is under 
expenditure experienced funds are rearranged to complement the over expenditure 
pressure. The risk occurs when the organisation is unable to pay the suppliers and stock 
is withheld by the suppliers resulting in the medicine stock outs. 
 
The utilisation of the different frameworks and procedures has led in practice to delayed 
delivery of medicines to the facilities as the consignments are routed through the medical 
depots and sub depots before dispatch to the health facilities. The results manifest as the 
medicine stock out that is experienced in the various provinces. This negatively affects 
the cure and treatment of communicable and non-communicable diseases. South African 
health system continues to experience problems with insufficient medicine stock 
availability in eight of the nine provinces. No known formal study has yet been conducted 
nationally to establish the cause of the problem and propose a standard framework for 
better provisioning of essential medicines within the district health services.  
 
With the above mentioned problem the following questions arise: 
 
 Why is there a shortage of medicine in the various provinces? 
 How can these shortages be eliminated? 
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1.4 AIM OF THE STUDY  
 
Develop a standardised framework for provision of essential medicines for the district 
health services in South Africa. 
 
1.4.1 Purpose of the study 
 
The purpose of the study is to determine the various provinces approach to the provision 
of essential medicines in order to develop a standardised framework for the country 
district health services with a view to improve essential medicines availability. 
 
1.4.2 Research objectives 
 
 Explore and describe the different provinces approaches in the provision of 
essential medicines. 
 Make recommendations on a corrective measure to be implemented in order to 
improve the availability of medicine in the various provinces.  
 Identify best practices to be incorporated into the framework for the provision of 
essential medicines for the district health services. 
 Formulate a framework for the provision of essential medicines for the district 
health services. 
 
1.4.3 Research questions 
 
 Has there been adequate provisioning of essential medicines within the district 
health services? 
 How do provinces approach the provision of essential medicines for the district 
health services? 
 How can the South African Department of Health ensure sufficient medicine 
provisioning across the nine provinces district health services? 
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1.5 SIGNIFICANCE OF THE STUDY  
 
On average, WHO Member States spend about half of their total health expenditure on 
medical products and up to 90% of the population in developing countries purchase health 
commodities through out-of-pocket payment. Improving access to and regulation of these 
essential health commodities is a prerequisite for universal health coverage and to the 
achievement of international goals relating to the unfinished agendas for maternal and 
child health, communicable diseases targeted by the Millennium Development Goals, and 
equally crucial in the face of fast growing burdens of non-communicable diseases and a 
rapidly ageing world population (WHO 2014:2). 
 
Medicines are the second highest cost driver after the cost of employees in terms of 
budget allocation and expenditure. There is also high wastage of medicines due to poor 
stock management and expiry in the health facilities which would encourage prioritisation 
of improvement strategies and introduction of better mechanisms to manage medicine 
supply (MSH 2012:1.3). Many reports have alluded to the ineffectiveness of medicine 
depots in ensuring that essential medicines reach the facilities in time and in the required 
quantities. Further the results of the National Core Standards assessment conducted in 
South Africa in the year 2011 reflected that all primary health clinics and community health 
centres were unable to meet the compliance requirements including the availability of 
essential medicines and supplies (Matsoso et al 2015:85). As such it has become 
imperative that attention be focused on key issues including that of provisioning of 
essential medicines 
  
The study will therefore contribute towards design of the framework for the provision of 
medicines within the Republic of South Africa district health services with the intention of 
improving the overall availability of medicine in the various provinces. 
 
1.6 DEFINITION OF KEY CONCEPTS 
 
1.6.1 Medicine 
 
The Medicines and Related Substances Act (Act 101 of 1965, as amended) defines 
medicine as “any substance used in diagnosis, treatment, mitigation, modification or 
prevention of disease” (South Africa 2002). 
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1.6.2 Essential medicines  
 
Essential medicines are defined as those therapeutic substances used in the diagnosis, 
treatment, mitigation, and modification of the majority of the diseases affecting the 
population. These medicines are referred to as essential medicines (World Health 
Organization 2016). 
 
1.6.3 Responsible pharmacist  
 
SAPC defines responsible pharmacist as a natural person who is a pharmacist and who 
shall be responsible to the council for complying with all the provisions of this Act and 
other legislation applicable to services which specially pertain to the scope of practice of 
a pharmacist, and the legislation applicable to the pharmacy which is under his or her 
personal supervision; as a pharmacist registered with council as the pharmacist 
answerable for all matters relating to safekeeping, control and issue of medicines in a 
particular institution (SAPC 2010:201). 
 
For the purpose of this study the Responsible Pharmacist will be defined as the person 
who is in charge of Pharmaceutical Services or medicine provision including Depot 
Managers as well as Pharmaceutical Services Managers.  
 
1.6.4 District health services 
 
In terms of the National Health Act 61 of 2003 a district is a demarcated area within a 
province which may further be divided into sub-districts. For the purpose of this study, 
district health services can be defined as the health services offered within a demarcated 
area ranging from primary health care services up to district hospital level (South Africa 
2003).  
 
1.6.5 Medical depot (medical warehouse) 
 
Medicine and Related Substances Act 101 of 1965 defines the warehouse as the 
institution utilised for storage and distribution of medicines for wholesale purposes. For 
the purpose of this study Medical Depot will be defined as a provincial store of medicine 
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from which the institutions order medicine and other medical consumables (South Africa 
2002).  
 
1.7 THEORETICAL FOUNDATIONS FOR THE STUDY  
 
1.7.1 Research paradigm  
 
In Polit and Beck (2014:6), the research paradigm is defined as the world view or general 
perspective on the complexities of the real world. This worldview can be naturalistic 
paradigm which promotes the belief that the reality is not fixed but constructed by 
individuals within a particular context as such subjective in nature and knowledge 
maximised when the researcher and the participants are interacting closely in the quest 
of knowledge or positivist paradigm which promotes that there is single objective reality 
which can be studied independent of those being researched and researcher not able to 
influence the research findings.  
 
For this study the paradigm chosen is the naturalistic paradigm as the focus is on the 
experiences of the service delivery managers responsible for day-to-day provisioning of 
essential medicines within different settings and experience in order to produce in depth 
data rich understanding towards the development of a framework. 
 
1.7.2 Theoretical framework  
 
Theory is explained as an integrated set of defined concepts and propositions that present 
a view of phenomenon. Theoretical framework is a logical structure of meaning that will 
guide the study and consist of an integrated set of defined concepts and propositions that 
present a view of the phenomenon and can be used to describe, explain the phenomenon 
under study (Grove, Burns & Gray 2013:41).  
 
This study for the provision of medicines is guided by the Pharmaceutical Management 
Framework adopted by the World Health Organization as developed by the Management 
Sciences for Health. The Framework is composed of selection, procurement, distribution 
and use components supported by the legal framework and management support across 
the value chain (MSH 2012:2). 
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1.8 THE RESEARCH DESIGN AND METHOD  
 
1.8.1 Research design  
 
Research design involves a set of decisions regarding what topic is to be studied among 
what population with what research methods and purpose thereof (Barbie 2013:116). 
According to Grove et al (2013:43), the research design is the blue print for maximising 
control over factors that could interfere with the study intended outcomes.  
 
The type of design directs the selection of the population, sampling process, methods of 
measurement as well as the plan for data collection and analysis. The research design 
enables the researcher to obtain research participants and collect information from them 
to reach conclusions about a research problem. This research will be conducted as a 
qualitative exploratory, descriptive study through experiences of the managers 
responsible for provision of medicine.  
 
1.8.2 Qualitative research design  
 
According to Streubert and Carpenter (2011:20), qualitative research design is the design 
based on a belief in multiple realities, commitment to identifying an approach to 
understanding that support the phenomenon under study as well as participant view point 
limiting the disruption of the natural environment under study acknowledging the 
researcher’s participation in the research process and reporting the data in a literary style 
with the participants’ commentaries.  
 
The focus of qualitative studies is on the meaning that the participants attach to their 
social world. Marshall and Rossman (2011:2) also confirm that qualitative research is 
typically enacted in a naturalistic setting focusing on context, is emergent and evolving 
as well as fundamentally interpretative. Savin-Barden and Major (2013:66) confirmed that 
the qualitative research paradigm subscribes to the view that reality is subjective and 
constructed by individuals and groups as such regard knowledge as the meaning 
participants assign to their lives and create reality as a social construct through dialogue 
and negotiation. 
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According to Barbie (2013:90), the purpose of conducting qualitative research can be 
exploration, description and or explanation of a phenomenon. Qualitative research design 
is suitable for the study on the framework for provision of essential medicines as the 
research is intended to explore and describe in an uncontrolled setting the experiences 
of the pharmaceutical managers responsible for provision of medicines towards 
development of a standardised framework for provision of medicines in the district health 
services.  
 
1.8.3 Research approach action research  
 
This study was executed with the involvement of the participants in reviewing and 
improving their practice environment with an intention to promote new strategies to 
ensure consistent medicine availability in the health facilities. The study intention was to 
improve the practice as well as the quality of health care through development of a 
framework to ensure consistent provisioning of essential medicines. Action research is 
useful in circumstances where participatory, democratic processes are required to 
develop practical knowledge and promotion of flourishing of individuals and their 
community’s. Action research is about working towards practical outcomes and creating 
new forms of understanding. The characteristics of action research are participation and 
collaboration, human flourishing, focuses on practical issues, and reflexive in nature with 
intent for action leading to change (Taylor & Francis 2013:154).  
 
Action research is reported to be problem focused, context specific, future oriented 
educative, deals with individual as members of the social groups involving a change 
intervention aimed at improvement and involvement recognising those involved as 
participants in the change process (Koshy, Koshy & Waterman 2011:29). Action research 
is not only concerned with doing things differently but also aspires to make judgement of 
the effectiveness of actions, existing and new (Townsend 2013:109). As such it was found 
to be suitable for studies focusing on development of framework for provisioning of 
essential medicines.  
 
1.8.4 Study population  
 
Barbie (2013:135) defines the study population as the aggregation of elements from 
which the sample is actually selected. Guest and Namey (2015:513) define the (study) 
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target population as the set of elements to which the researcher desire to apply the 
findings of the study.  
 
The population for this study were the responsible pharmacists including provincial 
pharmaceutical services managers and medical depot managers covering various 
provinces of the Republic of South Africa. The core function of the study population is the 
provision of essential medicines.  
 
1.8.5 Sampling 
 
Qualitative studies including action research participants should be obtained through 
purposive sampling with the intention to identify and select key informants who on account 
of their position or experience have more information than regular group members (Barbie 
2013:128). The participants for this study were identified through purposive sampling to 
ensure that they would be able to provide a rich explanation and description of the content 
under study. 
 
1.8.6 Sample 
 
Qualitative researchers aim for information rich data sources for their studies and utilise 
various non probability sampling designs to identify participants as the interest is on 
participants who meet the study needs, knowledgeable, able to articulate and reflective 
on the phenomenon under study (Polit & Beck 2014:284).  
 
According to Neuman (2011:268), purposive sampling is appropriate for selecting unique 
cases that are especially informative in order to gain deeper understanding of the 
phenomenon under study.  
 
For this study South African National Department pharmaceutical services, provincial 
pharmaceutical and medical depot managers were purposively selected as they have the 
knowledge and experience in the provision of medicines. 
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1.8.7 Data collection  
 
Data collection is the process of gathering information relevant to the study using one of 
the following primary methods: participating in the setting, observing directly, interviewing 
in depth, and analysing documents (Marshall & Rossman 2011:137).  
 
The data collection process in qualitative studies aim for rich, narrative accounts of the 
phenomenon under study. As such, the chosen collection method should capture the 
experiences and views of the participant in expressed words format (Streubert & 
Carpenter 2011:38). Conducting action research to understand and change the practice 
has an advantage that there is already data collected to be reviewed. Document analysis, 
observations, interviews, questionnaire completion, site visits and journal reviews are 
applicable as data collection tools (Townsend 2013:85). The view that data collection 
could be done in many forms, including interviews, observation, documents and audio-
visual equipment for qualitative studies is supported by this author (Creswell 2013:177). 
 
For this study data collection was executed through semi structured interview guide which 
was utilised to record field notes as well as participants biographical during interviews 
and site visits to the various provinces. 
 
1.8.8 Data analysis 
 
Qualitative data analysis is a search for general statements about the relationship and 
underlying themes in a study (Marshall & Rossman 2011:207). Data analysis in qualitative 
research consists of preparing and organising the data for analysis then reducing the data 
into themes through a process of coding and condensing the codes, and finally 
representing the data in figures, tables or discussion (Creswell 2013:180). Data analysis 
for qualitative studies progresses through classification of ideas, themes, topics, 
activities, and types of people as well as other categories relevant to the study (Schensul 
& Le Compte 2013:98). The goal of data analysis is to illuminate the experiences of those 
who have lived them by sharing the richness of lived experiences and cultures (Streubert 
& Carpenter 2011:47). Data analysis involves organising the data, preliminarily reading 
through of the database, coding and organising themes, representing the data in a 
meaningful format and forming of an interpretation thereof. These steps are 
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interconnected and form a spiral of activities all related to the analysis and representation 
of the data (Creswell 2013:179). 
 
For this study data were analysed through reading and rereading the collected data to 
make sense of the data and classification of findings using themes categorisation in 
relation to the components of the pharmaceutical management framework towards 
production of the district health services framework for provision of essential medicines. 
 
1.9 SCOPE OF THE STUDY  
 
The study focus was on the provision of the essential medicines for the first level of care 
which is district health services utilising the framework for pharmaceutical services 
components of selection, procurement, storage, distribution and use taking into account 
the legislation and management support elements.  
 
1.10 STRUCTURE OF THE THESIS  
 
The thesis is comprised of seven chapters constituted as following: 
 
Chapter 1: Orientation of the study  
 
The chapter above presented an overview of the research study including the 
background, research problem, research process as well as the thesis structure.  
 
Chapter 2: Theoretical framework  
 
The chapter provide an overview and discussion of the pharmaceutical management 
theoretical framework as developed by management science for health for the provision 
of essential medicines that guided the study.  
 
Chapter 3: Literature review  
 
The chapter will present detailed literature review from an international, African and South 
African context on approaches and experiences with regard to provision of essential 
medicines.  
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Chapter 4: Research design  
 
This chapter will provide an outline of the research design and the methodology followed 
in the research execution.  
 
Chapter 5: Data analysis, presentation of research findings and discussion of 
action areas  
 
The research finding based on the site visits conducted as well as practices observed in 
the provision of essential medicines will be presented utilising the theme approach taking 
into account the pharmaceutical management framework. Further in this chapter the 
action areas and interventions based on the research findings will be discussed. 
 
Chapter 6: Presentation of the proposed framework for provision of essential 
medicines in the district health services  
 
The proposed framework for the provision of essential medicines within the district health 
services will be presented in this chapter. 
 
Chapter 7: Conclusion and recommendation for further studies  
 
The conclusion and recommendations for further studies will be presented in this chapter. 
 
1.11 CONCLUSION  
 
The chapter gave an overview and orientation to the study in relation to the research 
problem of the provision of essential medicines, theoretical framework and the research 
design as well as methodology followed in undertaking the research project. In the next 
chapter the literature review content is presented and explained further. 
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CHAPTER 2  
 
LITERATURE REVIEW  
 
2.1 INTRODUCTION 
 
Pharmaceutical purchases (medicines) are the key cost driver for the health care system, 
being second only to the compensation of employees in terms of the health budget high 
expenditure items (MSH 2012:18.3). It is undisputed fact that medicines are essential for 
the treatment of diseases and illnesses despite this fact, according to World Health 
Organization estimation, 1.7 billion people nearly one third of the world population have 
inadequate or no access to essential medicines. It is therefore; essential that the ability 
of pharmaceuticals to save lives, reduce suffering and improve health is ensured through 
strategies and processes at promotion of the likelihood that medicines are of good quality, 
safe, available, affordable and properly used all the time (WHO 2011a:4). 
 
As part of efforts to improve access to medicines, provision of medicines is included in 
the Sustainable Development Goals under SDG 3: Ensure healthy lives and promote well-
being for all at all ages specifically as target 3.11: Support the research and development 
of vaccines and medicines for the communicable and non-communicable diseases that 
primarily affect developing countries, provide access to affordable essential medicines 
and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and 
Public Health, which affirms the right of developing countries to use to the full the 
provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights 
regarding flexibilities to protect public health, and, in particular, provide access to 
medicines for all (United Nations 2016:1). Access has been defined as having medicines 
continuously available and affordable at public or private health facilities or medicine 
outlets that are within one hour’s walk of the population. The vision of the WHO Essential 
Medicines and Health Products Department (EMP) is closely aligned with SDG 3 by 
striving for a world where every child, man and woman can afford and has access to the 
quality medicines and health products they need to lead a healthy and productive life 
(WHO2014.1). 
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2.2 PROBLEM OF ACCESS AND PROVISION OF MEDICINES  
 
Expenditures on medicines can represent up to 66 percent of total health spending in 
developing countries and could be a major cause of household impoverishment as up to 
90 percent of such expenditures are out-of-pocket expenses. Today, over one-third of the 
world’s population and over one-half of the poorest in Asia and Africa still lack access to 
essential drugs. According to the WHO, such access should cover the therapeutic, 
physical and financial aspects i.e. cover priority health problems, are available within easy 
physical reach and are affordable to all. For the poor in developing countries, availability 
and affordability of essential medicines are both key problems. Some fear that with the 
introduction of strong product patents for medicines through the world-wide uniform 
standards of the World Trade Organization, the Trade and Related Intellectual Property 
Rights Agreement, prices of essential drugs would be even higher and therefore, even 
less affordable for the poor. This is because such patents give their owner the right to 
exclude all others from unauthorised making, using, selling or distributing the product thus 
giving a ‘legal monopoly’ right. Further access to medicines will continue to be poor even 
in the absence of patents due to lack of adequate purchasing power and necessary 
infrastructure (WHO 2014:2). 
 
The implications were reported to be serious for HIV/AIDS in developing countries where 
the access to life saving treatment is limited by cost due to patents and prices. An 
estimated 95 percent of those suffering from this disease live in developing countries 
where the disease is showing no signs of abatement. With over half of such persons 
belonging to the most productive age of below 25 years, this disease is causing serious 
social and economic consequences (WHO 2011a:4).  
 
The fact that medicines are expensive requires that processes used to procure and 
distribute medicines are effective and efficient to maximise the benefits and use of 
medicines however; most health system strengthening interventions have ignored 
interconnections between systems components. In particular complex relationships 
between medicines and health financing, human resources, health information and 
service delivery are not given sufficient consideration.  
 
As a consequence, populations access to medicines (ATM) is addressed mainly through 
fragmented often vertical approaches usually focusing on supply and unrelated to the 
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wider issue of access to health services and interventions (Bigdeli, Jacobs, Tomson, 
Laing, Ghaffar, Dujardin & Van Damme 2012:692). The results have been that medicines 
are often not available when needed. Studies carried out in Brazil have shown that on 
average 40 percent of the medicines prescribed in public primary health care were not 
available when needed (Bertoldi, Helfer, Camargo, Tavares & Kanavos 2012:2). As a 
result, when the medicines are not available and accessible the control and treatment of 
diseases is negatively affected resulting in the premature deaths and morbidity of the 
citizens.  
 
MSF (2013:13) reported that lack of access to medicines has complex underlying factors 
ranging from health programme implementation to medicine supply system challenges. 
A study conducted on Pharmaceutical Management of Tuberculosis in seven of the nine 
provinces in the Republic of South Africa (RSA) found that the provision of essential 
medicines including Anti-Retroviral and Tuberculosis medication was not optimal at less 
than 95 percent in five of the provinces, namely the Free State, Eastern Cape, Gauteng, 
Limpopo, and Mpumalanga. The factors contributing to poor provisioning of medicines 
were especially in clinic settings poor stock control and management in nurse-led primary 
health clinics and a lack of pharmacist’s assistants to take charge of drug supply 
management. Further a lack of electronic stock management systems also played a role 
as manual stock cards were found not to be updated at most facilities (Pure Health 
Consulting 2012:97). 
 
In the Republic of South Africa only two of the nine provinces namely Western Cape and 
North West had adequate provision of above 95 percent availability for essential 
medicines. The factors that contributed to this included electronic stock management, 
maintenance of the 3 month buffer stock, close monitoring and weekly reporting on stock 
availability, active contract management and interaction with the suppliers over 
quantification, shortages and forecasting of needs, involvement of all role-players in 
medicine stock management including finance, programme managers and pharmacists 
as well as adjustment of issuing quantities during limited stock period to ensure that all 
patients receive medication whilst waiting for the replenishment stock (Pure Health 
Consulting 2012:129). 
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The available literature demonstrate that there have been several challenges regarding 
medicine supply in RSA, with various provinces reporting medicine stock outs to the 
extent that the inability to provide the required quantity and quality of medicines was 
identified as a key challenge facing the South African Government. 
 
Although there have been some successes over the past three years, and the South 
African government has undertaken several initiatives to improve the supply chain for 
medicines, stock outs at primary healthcare facilities remain an undeniable threat to the 
health of the people of South Africa. Those most vulnerable to the effects of stock outs 
are usually poor and rural communities who depend on public facilities for health services. 
When these remote facilities experience stock outs, the impact goes beyond health: 
Patients often make repeated, costly trips to health facilities to keep up their prescriptions. 
Pharmacists and nurses spend more time rationing drugs instead of caring for ill patients. 
Babies are not vaccinated at times (Stock Out 2016:6).  
 
This was confirmed by the Civic organisation report that revealed that medicine stock out 
is a national crisis affecting all the nine provinces in particular for the HIV and TB 
medicines, with rural provinces being the worst affected at 54 percent stock out rate and 
also suffering major stock out for the vaccines at 35 percent in November 2013 (MSF 
2013:7-12). Further evidence from South Africa suggest deficiencies with the supply of 
medicines within the state sector as evidenced by medicines intended for use in state 
only facilities being found in the private sector. Such theft of pharmaceuticals in SA has 
been acknowledged by the government (Patel, Norris, Gauld & Rades 2008:547-549).  
 
Internationally medicine provisioning problems have been reported in some states of 
Brazil including challenges in medicines distribution, where supply of public sector 
facilities is often problematic as evidenced by inadequate quantities, problems with 
frequency and time of distribution, and inefficient stock control among others. Further the 
lack of standard operational procedures for medicine stock management, no access 
restrictions to non-authorised personnel, lack of training to those working in the medicine 
store rooms and lack of technical criteria to select the medicines to be available to the 
population were reported (Bertoldi et al 2012:2). The study recommended that in order to 
control the problem of access to essential medicines decision makers need to realise that 
many factors play a role including patent protection, poor living conditions, lack of medical 
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facilities, proper infrastructure, malnutrition and lack of means for distribution and 
administration of medicines.  
 
In the light of the prevalent shortage of medicines it is therefore; necessary that new 
approaches and models should be explored to ensure that medicines are accessible and 
affordable to the citizens of the country. Even in the RSA there are indications that 
medicine provisioning is not optimum in the district health services in particular at 
community health centres and primary health clinics. However; the District hospitals were 
found to have satisfactory medicine availability. The following factors affected negatively 
the availability of medicines: poor medicine stock management, late deliveries from the 
Medical Depot, poor communication amongst the role players, lack of electronic ordering 
systems, duplication of patients, medicine theft, transport and departmental red tape 
(Zuma 2013:91). 
 
2.3 INTERNATIONAL WORLD HEALTH ORGANIZATION CONTEXT ON 
PROVISION OF ESSENTIAL MEDICINES 
 
WHO has since 1978 Declaration of Alma Ata established a department of Essential 
Medicines which is responsible for monitoring member countries initiatives towards 
universal access and availability of medicines. The 2011 WHO Essential Medicine 
Availability report which is based on the standard methodology and focuses on essential 
medicines used in the majority of the member countries indicates that medicine 
availability across the WHO regions was reported at an average of 60 percent. In the 
Eastern Mediterranean region medicine availability scored 32 percent, with 58 percent in 
the European region.  In the African and South Asian regions the average availability was 
less than 60 percent (WHO 2011a:4).  
 
A study conducted in 36 countries reports that in the public sector the provision and 
availability of 15 generic medicines was found to be low, ranging from 9,7 percent in 
Yemen to 79,2 percent in Mongolia. The regional availability ranged from 29, 4 percent 
in Africa and 54, 4 percent in America. In the private sector the availability of generic 
medicine was lower, ranging from 50, 1 percent in the Western Pacific to 75,1 percent in 
South East Asia. The lowest availability of medication was recorded in Chad to be at 14,8 
percent, Kuwait 36,3 percent, Philippines 33,6 percent and China ranging from 34,6 
percent to 38,3 percent.  
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The mean availability of medicines was found to be generally lower in the public sector 
than in the private sector. The factors contributing to low availability of medicines in the 
public sector in particular relate to key processes required for effective provision of 
medicines including inadequate funding, lack of incentives to maintain stocks, inability to 
forecast accurately, inefficient distribution systems or leakage of medicine for private use. 
In the private sector the factors influencing medicine provisioning and access were mainly 
the price. However, the private sector demonstrated a high availability of generic 
medicines, such as recorded in Syria at 97, 5 percent and in Chenai, India, of 91, 8 
percent. Factors contributing to improved access included setting of limits by the state on 
the price mark-up and elimination of taxes on medicinal products (Cameroon, Roubos, 
Ewen, Mantel-Teeuwisse, Leufkens & Laing 2011:416).  
 
The United Nation reported that while the availability of generic essential medicines is 
limited especially in the public sector the situation with regard to medicine for treating 
chronic conditions is particularly worse. This is very disturbing given the fact that chronic 
diseases are the cause of no less than 40 percent of all deaths in low income countries. 
Moreover, only 27 percent of respondents from poor households in low-income countries 
who needed treatment for a chronic condition reported having received the treatment (UN 
2011:52).  
 
Gray and Manasse (2012:158) in recent commentary in a Belgian pharmacy journal 
claims that the problem is global − "from Afghanistan to Zimbabwe" − listing 21 countries 
affected by a variety of medicine supply problems. A shortage of the injectable antibiotic 
Streptomycin was reported in 15 countries in 2010, with 11 more countries predicting their 
stocks would run out before they could be replenished. This report states that there was 
a wide range of causes for medicine supply shortages (provisioning) some of which could 
be dealt with by government agencies. These shortages occur against a clear 
understanding that medicines are a critical commodity for maintaining the health status 
of citizens across the world. It should be free at a point of service for poor communities 
and accessible to all countries at affordable prices. Further, according to Mercurio 
(2007:23), the availability of medicine is also affected by inflated medicine prices due to 
tariffs levied by the production countries on medicine leaving their shores. In the 
Democratic Republic of Congo, the tax levied on medicine is 30 percent. Other countries 
including India, Sierra Leone, Nigeria and Bolivia also impose tariffs on the importation of 
pharmaceuticals, namely 55 percent, 40 percent, 34 percent and 32 percent respectively. 
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The charging of additional sales tax in countries including South Africa (14 percent), 
Argentina (21 percent), Bangladesh (15 percent), The Dominican Republic (28 percent), 
Greece (15 percent) and Turkey (18 percent) is another factor affecting medicine 
availability and access to medicine by individual patients. Due to poor medicine 
provisioning systems in the public health sector patients from lower income countries, 
including South Africa, are forced to buy medicine privately, where original brands are 
sold costing the public a possible four times the price of the generic medicines (WHO 
2011b:7).  
 
The non-availability of medicines in public health facilities and high cost of original brands 
result in patients from poor lower income countries being exposed to the risk of defaulting 
treatment and disease complications, which contributes to reduced life expectancy as 
well as premature mortality and morbidity. WHO further report that lack of access to 
medicines is not the only a problem. Less than one third of the oral contraceptives used 
globally are of the assured quality required in industrialised countries. In one Asian 
country, more than half of the ingredient combinations for malaria are fake. Moreover, 
even when medicines are available and of assured quality, they are not always used 
appropriately. In many countries up to half of all prescriptions are unnecessary or 
incorrect, and half of all patients do not take their medicines as prescribed (WHO 2010:1). 
The WHO made the following recommendations to facilitate lifesaving medicine’s 
availability and access: improve financing and distribution efficiency, promote the use of 
generic products and control supply chain costs by limiting the mark-ups and remove 
duties and taxes on medicine. It is believed that improvement in the availability of 
medicine through these measures will contribute towards improving health outcomes 
including reduction of infant mortality, improving maternal health and combating HIV and 
AIDS, tuberculosis and malaria (WHO 2011a:2). The WHO further proposes a review of 
policies towards improving the availability of medicines, including the components of 
medicine selection, procurement, distribution, and financing. Financing models include 
promotion of the provision of free essential medicines and also the introduction of the 
insurance system, like medical aid and subsidies for different categories of the population 
(WHO 2011b:13).  
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2.4 WHO REGIONAL CONTEXT FOR PROVISION OF THE ESSENTIAL 
MEDICINES 
 
WHO has divided the countries into five regions namely Africa, European, South East 
Asia, America, Eastern Mediterranean, Western Pacific (WHO 2015). In developing 
countries, pharmaceutical expenditures and drug procurements account for 20–50 
percent of public health budgets.  
 
Making essential medicines available for everyone at affordable prices is a key condition 
for improving national health indicators. Inadequate provision of medicine and medical 
supplies has a direct bearing on the performance of the health system. Corruption in 
procurement/distribution of pharmaceutical and medical supplies reduces access to 
essential medicines, particularly for the most vulnerable groups. WHO estimates indicate 
that approximately 2 billion people lack regular access to medicines and that improving 
access to medicines could potentially save the lives of 10 million people every year (WHO 
2014:14). 
 
2.5 WORLD REGIONS MEDICINE PROVISIONING CONTEXT  
 
2.5.1 Essential medicines provision in the American region  
 
2.5.1.1 Brazil 
 
This country has population of at least 200 million as per 2013 census with a high risk of 
non-communicable diseases (WHO 2015). The studies carried out in Brazil have shown 
that on average 40 percent of the medicines prescribed in public primary health care were 
not available when needed. In this country medicine access relates both to affordability 
and availability (available stock of essential medicines in pharmacies). Availability 
particularly in the public sector remained an issue of considerable concern in Brazil, 
recent research found that for 71 percent of medicines the availability of generics was 
below 10 percent. International evidence, using data from 36 low and middle-income 
countries, showed that in the public sector, availability ranged from 29 to 54 percent and 
prices for private patients were 9 to 25 times higher than international reference prices 
for generics and 20 times higher for originator products.  
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In the public sector, a series of different procurement models is used by governments 
from developing countries to purchase medicines and other health products. An 
increasing number of countries have opted to decentralise the procurement process as 
an effort to answer to local needs. The decentralised purchase involves different levels of 
responsibility in the procurement process at the federal, state and city levels (Bertoldi et 
al 2012:2). 
 
2.5.1.2 United States of America 
 
This country has a population of 320 million also having a high prevalence of the non-
communicable diseases including hypertension and cancer (WH0 2015). USA is 
regarded as a developed country, however does also experience poor provisioning and 
non-availability of medicine. Gray and Manasse (2012:158) reported that shortages of 
essential medicines, amongst them generic injectable chemotherapy agents are an 
increasing cause for concern in the country. The problem is said to be far greater, 
affecting other classes of medicines including injectable anaesthetic agents, nutrition and 
electrolyte products, enzyme replacement products and radio pharmaceuticals. Further 
Erin Fox, manager of the drug information centre at the University of Utah, states that the 
reported drug shortages are at its highest in a decade in the United States of America. 
The service is said to have recorded 211 new drug shortages, up from 70 shortages in 
2006 and 166 in 2008. These shortages have an impact on patient safety and care 
standards with more than 1000 near misses and adverse patient outcomes reported 
(Larkin 2011:28).  
 
The lack of some of the most basic medications has caused physicians to advise their 
patients to seek the medicines they need from locations outside the United States of 
America. Manufacturing quality problems have been implicated as one of the contributing 
factors in shortages of medicines produced by a limited number of suppliers, such as the 
influenza vaccine. Overall 43 percent of 127 shortages investigated by the United States 
Food and Drug Administration were attributed to manufacturing quality problems (Nash 
2012:12).  
 
The other factors contributing to the poor provision of medicines in the United States of 
America include medicine manufacturers depending on a small number of facilities for 
medicine production, Changes in procurement practices are also another factor (such as 
  
26 
insistence on the WHO prequalification status or registration with a stringent regulatory 
authority) which may invalidate a previous supplier as in the case of Streptomycin (Gray 
& Manasse 2012:158).  
 
2.5.1.3 Mexico 
 
A country with the population of 122 million whose leading cause of death is diabetic 
mellitus (WHO 2015). According to Wirtz, Russo and Escoban (2009:30) in Mexico, like 
many other developing countries access to and availability of medicines has been 
hampered by various factors including stock outs in the public health sector (especially 
for the uninsured population) as well as the out of pocket expenditure on medicines and 
the fragmentation of the Mexican health system. Access to and availability of medicine 
was further limited by the fact that at least 42 percent of the health services users had to 
pay for their prescribed medicines. Thus if the patient could not pay he will not obtain the 
required medicine. Over the years’ population access does not seem to have improved 
significantly as the patients who had to buy medicines in private pharmacies increased 
from 42 percent in 2000 to 47 percent in 2006.  
 
2.5.2 Eastern Mediterranean region medicines provisioning context  
 
2.5.2.1 Sudan 
 
According to the WHO data, the country has 38 million citizens and spend at least 6,8 
percent of the budget on health. The availability of essential medicines in this country is 
relatively higher with medical stores and private pharmacies reporting the average 
availability at 100 percent, and 82 percent in public facilities (WHO 2015). 
 
The high availability is enhanced by the existence of a central medicines store which is a 
governmental corporation responsible for ensuring that quality medicines are available at 
affordable prices through, amongst other strategies, the creation of dedicated funding for 
medicine, and the implementation of good procurement, storage, transportation and 
distribution practices. Parts of this country reporting lower medicine availability listed 
contributing factors as being the absence of drug (medicine) inventory cards, poor 
financial support for transportation and distribution from the central medicine store to the 
pharmacies (Elamin, Ibrahim & Yousif 2010:36).  
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2.5.3 Western Pacific region  
 
2.5.3.1 China 
 
China has at least 1,3 billion population with an average health expenditure of 5,6 percent 
with drug expenditures comprising up to 40 percent of total health expenditures ranking 
amongst the highest proportions in the world, however, the country experienced 
challenges with essential medicines provisioning. 
 
Yang, Dib, Zhu, Gang and Zhang (2010:224) reported that the availability of low price 
generic medicine in the Hubei province was found to be 38, 9 percent in the public sector 
and 44, 4 percent in the private sector. Further, a field survey conducted in Shandong 
and Gansu provinces in 2007 revealed that the median availability of surveyed medicines 
in hospital pharmacies ranged from 19 to 69 percent. Moreover, the Chinese people have 
suffered from inaccessible and unaffordable health services for decades. By the end of 
2012, there were still eighty thousand five hundred and twelve people, comprising 
approximately 6 percent of the population, who lacked access to health services (Li, Li, 
Zhu Fu, Xu, Wei & Chu 2015:345).  
 
Another survey conducted in 2006 in Shanghai, China, revealed that the overall 
availability of medicine was poor in both the public and private sectors. Generic medicine 
was more readily available in the public sector than the private sector. The average 
availability in the public sector was 13, 3 percent for the innovator (non-generic 
expensive) brand and 33,3 percent for the lower priced generics respectively, whilst in 
private pharmacies the average availability for innovator brands was 10 percent and 15 
percent for lower priced generics. The factors reported to contribute mainly to the poor 
provisioning include prescribers’ preference of branded drugs rather than generic 
medicines in the public sector as evidenced by doctors not prescribing medicines on the 
essential lists resulting in essential medicines not being ordered for utilisation in public 
health facilities (Lu 2006:35).  
 
In 2009 the government of China invested in large-scale health care reform to achieve 
universal health care coverage. One of the major reform components focuses on 
improving access to essential medicines to reduce high out–of–pocket medicines 
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spending. The reform policies were comprehensive, and included systematic selection of 
essential medicines to improve availability, centralised procurement and tendering at 
provincial levels, pricing policies, provision of essential medicines at cost in primary level 
facilities, and stronger quality and safety standards. While challenges remain, China's 
system sets an example of a comprehensive approach that other countries could emulate 
in reforming their health care systems and achieving universal coverage (Barber, Huang, 
Santoso, Laing, Paris & Wu 2013:1). 
 
2.5.3.2 Pakistan  
 
With a population of 182 million and health expenditure of 2,8 percent of the country’s 
gross domestic product (WHO 2015). The country is affected in the provision of essential 
medicines by the lack of standard procurement systems and effective use and 
maintenance of health technologies for the primary health care network posing serious 
limitations to the delivery of quality care to an extent that the insufficient availability of 
medicines has detrimentally affected the use of public health services where a very limited 
proportion of public sector facilities had an uninterrupted flow of essential medicines.  
 
According to the study conducted in 2010, there was insufficient availability of medicines 
which affected the use of public health facilities as there were few health facilities that 
had uninterrupted essential medicine supply. The author proposed that to enhance 
access to life-saving primary health care services, essential medicines should be 
procured in sufficient quantities along with improved efforts to reduce stock outs caused 
by improper procurement and transport, storage and management deficiencies (Sabih, 
Bile, Buehler, Hafeez, Nishtar & Siddiqi 2010:142). 
 
Poor availability and erratic supply of medicines in the Pakistan government sector are 
rooted in several factors such as inadequate management to address the local needs, 
poor distribution at the level of local health facilities, corruption at the level of distributers 
and suppliers and inefficiencies in the supply and distribution chain and insufficient 
availability of medicines in appropriate dosage forms for children as found in other studies 
(Shafiq, Shaik & Kumar 2011:136). 
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2.5.3.3 Philippines 
 
With a population of 98 million and health expenditure of 4,4 percent of the GDP (WHO 
2015). In this country a 2009 study conducted using WHO methodology indicated that 
availability of essential medicines in the public health facilities was 53,3 percent. In the 
private sector it was at 100 percent, and in central district warehouses supplying the 
public sector it was 33,3 percent. The stock out duration for the public facilities was an 
average of 24, 9 days and 43, 8 days in the central districts warehouses respectively. The 
factors contributing to the insufficient provisioning were poor provisioning systems 
including non-centralisation of procurement from the district warehouses, as facilities 
could still bypass the warehouses to obtain medicines elsewhere, as well as high 
medicine prices in the country (Batangan & Juban 2009:34).  
 
2.5.3.4 Malaysia 
 
This country has at least 29 million populations and spends 4 percent of the GDP on 
health (WHO 2015). According to Babar, Ibrahim, Sing and Bukhari (2005:17), in the 
Malaysian public sector only 25 percent of the generic medicines were available in the 20 
facilities surveyed. The factors contributing to the poor provisioning and low availability 
were under-regulation of medicine prices, uncapped mark-ups by health practitioners and 
poor monitoring for the provision and procurement of medicines on the National Essential 
Drug List. The pharmacist’s role in ensuring the availability of medicine was also limited 
as medicine was freely available in private doctors’ consulting rooms. However, stricter 
measures were imposed on medicine control and issuing by pharmacists. The country 
also did not have a national medicine pricing policy. The recommendations included that 
government should control mark-ups on generic brands and ensure that medicines on 
the National Essential Drug List are available in the public sector.  
 
In summary within this region, the factors contributing to poor provisioning and low 
availability of essential medicines were: 
 
 Poor quality of medicine in circulation as the strength of medicine available 
differed from the recommended strength in the WHO survey manual. 
 Lack of supply from the manufacturers due to low government prices. 
 Irrational use of medicine due to financial incentives. 
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 That profit driven prescribing physicians were prescribing more expensive 
medicines. 
 The hospital centred issuing of medicine which led to low medicine availability in 
private pharmacies as patients were encouraged to obtain medication in hospital 
rather than in private pharmacies. 
 That the policy on global budget control on pharmaceutical expenditure limited the 
procurement of innovator non-generic medicines.  
 
2.5.4 Essential medicine provision context in the South East Asia  
 
2.5.4.1 Nepal  
 
Nepal is a low-income country in South Asia located between China and India. It has a 
population of 28.1 million of whom 44.2 percent are living below the poverty line as 
determined by the Multidimensional Poverty Index. A review of the free essential health 
care services programme reported that both the type and quantities of free essential 
medicines were insufficient for PHC facilities and district hospitals, expired medicines 
were present in health facilities and human resources were inadequate. Thus, there is a 
need to improve logistics, human resource capabilities and coverage of the essential 
medicines programme so as to improve access to and quality use of medicines to achieve 
the goals of the free essential health care services programme (Bhuvan, Haydon & Norris 
2015:2). 
 
2.5.4.2 India 
 
A country with 1,252 billion populations spending at least 4 percent of their GDP on health 
(WHO 2015) has also experienced challenges with medicine supply and provisioning. 
Kotwani, Ewen, Dey, Lyer, Lakshmi, Patel, Raman, Singhai, Thawani, Tripathi and Laing 
(2007:645-654) in a study conducted in six sites in India, found that the average 
availability of core medicines in accordance with WHO methodology was low ranging 
between 30 percent in Chennai ,10 percent in Haryana, and 12,5 percent in Kartnataka. 
The factors contributing the low availability and poor provisioning included poor 
consideration and disregard of the state essential medicine list in the prescription patterns 
by the clinicians, limited finances for medicine, inefficient distribution systems and 
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utilisation of different essential medicine lists by pharmacies leading non-availability of 
medicines prescribed by specialists.  
 
It is recommended the following strategies to improve medicine provisioning and 
availability: 
 
 That the country should legalise implementation of one country essential medicine 
lists to reduce the number of available medicine in the country. 
 That the usage of generic medicines rather than the non-generic brands should be 
promoted. 
 That pharmacists should be empowered to issue generic brand equivalents. 
 The introduction of national regulation of medicinal prices.  
 
2.5.4.3 Summary of common factors affecting medicine provision and availability 
in the South East Asia 
 
The common factors identified were lack of national medicine policies, inadequate 
medicine distribution services, pricing, tax levies, use of expensive non-generic brands, 
unsubsidised medicine in state facilities resulting in out of pocket expenses, poor quality 
of medicines not compliant with WHO standards, and irrational prescribing by health 
professionals. 
 
2.6 AFRICAN COUNTRIES’ MEDICINE PROVISIONING CONTEXT  
 
Over the years the African region has also experienced an alarming lack of essential 
medicines in the public sector, driving patients to pay higher prices in the private sector 
or stay without medicine to manage their ailments and diseases. In an attempt to turn 
around the situation, the African Region of WHO hosted a consultative workshop to 
explore ways to improve access to and availability of medicine. During this workshop the 
major contributing factor to medicine shortages was identified as African countries having 
weak or no mechanisms for essential medicine availability monitoring and evaluation 
(WHO AFRICA 2006:38). Reasons for persistently low access to medicines include 
inadequate financing, regulatory problems, lengthy procurement processes, lack of 
incentives for maintaining sufficient stock levels, poor logistics management (e.g., 
forecasting, distribution, information technology (IT) systems); corruption and lack of 
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qualified health workers to manage the medicines supply chain (Lubinga, Larsen-Cooper, 
Crawford, Matemba, Stergachis & Babigumira 2014:2).  
 
The paragraphs below reflect on the medicine provisioning in the African Region: 
 
2.6.1 Ethiopia 
 
The country is amongst the poorest countries with 91 million population and spending 
only 3,8 percent of the budget on health (WHO 2015). In a study conducted by Daniel, 
Tegegnenwork, Demissie and Reithinger (2011:61) provision of continuous access to 
essential medicines, laboratory services and medical supplies was regarded as 
fundamental in addressing the health needs of the population. However, in 10 out of 48 
(21 percent) of the facilities that were surveyed no malaria, tuberculosis or HIV medicines 
were available. The shortage of human resources and weak supply chain processes were 
reported as the main factors contributing to the shortage and poor provision of medicines 
in this country.  
 
2.6.2 Malawi 
 
Malawi has 16 million population spending 8, 3 percent of their Gross Domestic Product 
on health (WHO 2015). Lufesi, Andrew and Aursnes (2007:7) found that medicine 
necessary for treating pneumonia, malaria and sexually transmitted infections were out 
of stock for a period of 42 to 240 days per year. The main factors reported for these 
shortages were poor deliveries from the Regional Medical Store, poor medicine stock 
management practices, delays in the ordering of medicine, as well as lack of training and 
supervision in the facilities and medical stores.  
 
This country is also affected by the shortage of pharmacists and pharmacist assistants in 
the provision of the essential medicines as evidenced by the 2011 Malawi Health Sector 
Strategic Plan report stating that there were only five pharmacists in the country’s public 
health system and only 24 percent of the established positions for pharmacy technicians 
were filled (Lubinga et al 2014:2). 
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2.6.3 Kenya 
 
In this country with the population of 44 million spending at least 4, 5 percent of the budget 
on health services, the public sector drug supply system has been reformed through the 
establishment of the Kenya Medical Supplies Agency (KEMSA) which is a body corporate 
with the mandate of developing and operating a viable commercial service for the 
procurement and sale of medicines and medical supplies to the public health institutions. 
Medicine Procurement and distribution for the Ministry of Health (MOH) is done by MOH 
Procurement and Supply Division through KEMSA an external procurement agency 
which has a drug storage and distribution system with a central warehouse in Nairobi and 
a well-developed network of regional depots and district drug stores (WHO 2015). Further 
a 2008 study by Kangwana, Njogu, Wasunna, Kedenge, Memusi, Goodman, Zurovac 
and Snow (2009:737) investigated the provisioning and availability of malaria medication 
in government facilities. The study showed that 25, 6 percent of the surveyed facilities did 
not have any of the four treatment packs in stock. The factors contributing to this stock 
out were mainly procurement failures and delays due to a shift made away from direct 
procurement towards open tender processes. This shift was intended to achieve value 
for money and increase competition amongst potential suppliers. The open tender system 
implementation was further delayed by difficulty to obtain compliant tender bids from the 
bidders. The recommendation from the study was that procurement processes should be 
strengthened and impact: cost analyses conducted before deciding on international open 
tenders as the processes can be of extended duration leading to medicine stock outs.  
 
The WHO survey recommended that Kenya develop and implement a medicines pricing 
policy to achieve a greater level of transparency, uniformity and predictability in the pricing 
of medicines including the consideration of reference pricing for medicines in the private 
sector, periodically monitor the prices of medicines, as well as aspects of access to 
monitor the effects of interventions, develop and implement pro-poor interventions aimed 
at increasing access to essential medicines and importantly enhance the efficiency of the 
public procurement agency and establish supportive linkages with the mission sector 
procurement system. Wangu and Osunga (2014:441) confirmed that inappropriate 
selection, poor distribution, poor funding and irrational medicine use were the leading 
factors in the poor availability and provision of medicines in Kenya. 
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2.6.4 Uganda  
 
The country has 38 million people and has high poverty prevalence thus dependent on 
government for health care services (WHO 2015). In Uganda the majority of the 
medicines and equipment for government health units are obtained from National Medical 
Stores (NMS) and the medicine budgets have been decentralised, with guidelines to 
protect them at all service delivery levels. However, demand for essential medicines far 
exceeds supply. The survey conducted revealed that not all prescribed medicines were 
obtained due to various reasons including public health pharmacies not having stock 
(WHO AFRICA 2006).  
 
A review of drug management and procurement practices conducted in the period 2006 
to 2007 at the Kilembe Hospital in the Kasese District revealed that there were frequent 
medicine stock outs in the health units ranging between 24 and 94 days on average. In 
addition, large quantities of expired medicine were found in most district level facilities. 
The factors contributing to this situation where the irrational procurement and provision 
of medicines not based on needs and requisition, and poor quantification and donor 
driven supplies without proper coordination with the recipient department to determine 
actual need. These practices led to the non-availability of essential medicines required 
for the treatment of prevailing conditions in the country (Tumwine, Kutyabami, Odoi & 
Kalyango 2010:559).  
 
2.6.5 Nigeria 
 
This country with a population of 173 million (WHO 2015) also faces the challenge of poor 
provisioning, low- and non-availability of medicine as evidenced by the health centres and 
primary health care centres reporting stock out of essential medicines. The factors cited 
for these stock outs include inadequate budgetary allocations for medicines, poor stock 
control in supply chain processes, poor quality medicine not containing the minimum 
required ingredients for effectiveness, poor value for money, uncoordinated government 
action and local non-availability of quality essential medicines. The country has 
developed a Ten Remedies Plan to improve availability, including establishing a 
dedicated fund for primary health care, direct procurement of medicines, and utilisation 
of a drug supply management cycle in the medicine management processes 
(Ohuabunnwa 2010:12).  
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2.6.6 Zimbabwe  
 
This country has a population of 14 million situated within the three regions with more 
than 63 districts which are mostly rural environment. In terms of the systems for provision 
of essential medicines; Zimbabwe has a Central Medical Store at National Level. There 
are six public warehouses in the secondary tier of the public sector distribution. The 
country has two regional warehouses which services the three provinces, two rural and 
one metropolitan province. The other warehouses are in each of the four rural provinces 
and get their supplies form the regional stores. Procurement is done centrally and 
commodities are delivered to the two regional stores where transfers are made to the 
respective branch stores. However; the percentage availability of key medicines at the 
Central Medical Store (CMS) was 38 percent (Zimbabwe 2011:24). 
 
2.6.7 Summary of common factors affecting medicine provisioning in the African 
Region 
 
The pharmaceutical sector data included in country reports indicated that African 
countries generally had limited pharmaceutical production capacity, most depended 
mainly on imports and a diverse distribution chain, with some types of unauthorised 
outlets suggesting the presence of an informal market (WHO 2010:8). Further the 
provision of medicines in developing countries was reported to be undermined by several 
factors including poor medicine supply and distribution systems (Dixit, Jayshree, 
Ubedulla, Manohar & Chandrasekhar 2011:599-600). The unregulated pricing of 
medicines, donor driven availability of medicines with poor coordination with the recipient 
department, poor warehousing (medical depot) practices, lack of skills in quantification 
and medicine supply management, and shortage of skilled human resources to manage 
medicine stock were confirmed to impact on the availability and provisioning of medicines.  
 
The main barriers to access essential medicines in Sub Saharan Africa are summarised 
to be as follows:  
 
 Inadequate national commitment to making healthcare a priority from the national 
to the local levels remains one of the greatest barriers to increasing access to 
existing medicines.  
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 Inadequate human resources for health, including pharmacists and pharmacy 
technicians, is a growing problem that, if unaddressed, threatens to undermine all 
efforts to strengthen health systems and improve healthcare in much of the 
developing world.  
 The international community has not provided adequate finance nor consistently 
fulfilled its existing promises to developing countries.  
 A persistent lack of coordination of international aid reduces access to medicines.  
 The Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement 
may block access to affordable new medicines and vaccines.  
 The current incentive structure is inadequate to promote research and 
development of medicines and vaccines to address priority health problems of 
developing countries (Thompson & Ogbe 2012:2). 
 
2.7 THE REPUBLIC OF SOUTH AFRICA’S NATIONAL CONTEXT OF MEDICINE 
PROVISIONING 
 
South Africa has procured medicines and other pharmaceutical supplies for the public 
sector through the tender system. The public health facilities were hit hard by the 
medicine shortages in over the 2013/2014 and 2014/2015 financial years. Reasons for 
the shortages included failure of provinces to pay suppliers, inability of suppliers to meet 
the tender demands, lack of expertise to monitor activities along supply chain (Stock Out 
2016:13). The problem of medicine supply challenges has been in existence prior to the 
effect of South Africa’s democratic government dispensation in 1994, medicine policies 
were also in line with the fragmented provision of the health services model. This resulted 
in differentiated access and varied availability of medicines due to lack of standardised 
essential medicine lists. In 1996 the National Drug Policy (NDP) was developed and 
approved by the new government in line with WHO standard requirements of member 
countries developing and implementing national medicine policies. The primary objective 
for the NDP was that of ensuring the availability of essential medicines (medication) to all 
South African citizens. The NDP is supported by Standard Treatment Guidelines and the 
Essential Medicine List for each level of care to realise the provision of affordable 
essential medicines (South Africa 1996:3). The government is expected to ensure 
availability of generic essential medicine through implementation of incentives that favour 
generic medicines and their production in the country (South Africa 1996:10).  
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The NDP emphasises that for the consistent availability of medicinal treatment, there 
should be effective management of medicine stock; adequate budget for medicine, 
effective stock control and monitoring as well as the availability of adequately trained 
health professionals capable of issuing medicine to the health services consumers (South 
Africa 1996:28). In South Africa the major platform through which citizens’ access basic 
health services and medicines has been identified as primary health care centres which 
are located within the district health services. The provision of medicines in the primary 
health care context has been free for all citizens since 1994 in an attempt to promote 
healthy living and improve life expectancy of the population (South Africa 1996:1). 
Achieving these objectives requires a comprehensive strategy that not only includes 
improved supply and distribution, but also appropriate and extensive human resource 
development. The implementation of an Essential Drugs Programme (EDP) formed an 
integral part of this strategy, with continued rationalisation of the variety of medicines 
available in the public sector as a first priority (NDOH 2012a:15.).  
 
In practice there has been  limited work done to assess the impact of the National Drug 
Policy although the original policy document committed to conducting regular evaluations 
of the NDP, no official comprehensive review of the South African NDP and its impact 
has been conducted since its adoption in 1996.The limited scope  surveys that were 
carried out in all the nine provinces and six metros of SA in 2003,with the aim of 
determining the impact of the NDP at PHC level demonstrated that the availability of 
medicines was found to be on average of 82 percent of a basket of key medicines.  
 
However significant challenges were noted in terms of stock control (for instance 50 
percent of stock records were inaccurate) and rational medicines use (in 7 percent of 
facilities, 50 percent or fewer patients knew how to take their medicines). A marked 
increase in the proportion of patients prescribed an antibiotic was noted increased from 
an average of 25 percent in the 1996 to 1998 baseline surveys to 47 percent in 2003 
(Padarath & English 2013:178). 
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2.7.1 Graphic representation of the Republic of South African medicines supply 
chain or provisioning  
 
 
Figure 2.1  SA Public Sector Medicine Supply Chain   
(SPS 2009) 
 
In South Africa provision of medicines is governed by the Medicine and related Substance 
Act of 1965 as amended. The procurement of essential medicines for the public sector is 
done through the national tender system with provinces buying for the facilities falling 
within their areas of governance. The National Treasury has been responsible for 
awarding all contracts.  
 
However, following reports of deterioration in medicines availability across the country, a 
Ministerial Task Team was established in 2009 to assess the state of medicines 
procurement in the public sector and make recommendations for procurement reforms 
(Padarath & English 2013:181) 
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The delivery of health care services in South Africa is a provincial government 
competence. This country has ten medical depots with Eastern Cape having two medical 
depots independently run by the nine provinces with an objective to ensure consistent 
supply of the essential medicines. These medical depots coordinate the procurement, 
distribution of the essential medicines including antiretroviral, tuberculosis, vaccines and 
chronic medicines and medical consumables namely gloves, syringes, injections and 
intravenous lines to the health facilities. There are different procedures and no standard 
model utilised in the procurement and distribution of medicines across the country. 
Provinces including Eastern Cape and Northern Cape procure for all the facilities within 
their provinces whereas Western Cape province procure primarily for the district health 
services as the larger hospitals are said to be well enabled to manage medicine and 
consumables supply utilising their own resources It is likely that  the imposition of any 
reform that includes central control of the pharmaceutical budget and of the medicines 
distribution chain is bound to be met with resistance (Padarath & English 2013:182). The 
government in 2009 realised the importance of medicine and medical supplies as an 
integral part of the provision of quality health care services to an extent that Medicine and 
medical consumables availability has been listed as one of the six priorities listed for the 
South African Department of Health (NDOH 2009a:1). This was done in order to improve 
the health profile of all South Africans.  
 
Further improving medicine supply and management have been identified as key action 
point in the South African Health Programme of Action (NDOH 2009b:5).The Ten Point 
Plan of the National Department of Health further placed the emphasis on the review of 
drug policies which may lead to the improvement of medicine availability by means of 
improved procurement of medicines and the possible establishment of a state owned 
pharmaceutical industry (NDOH 2009b): Although the medicine policies are in place as 
reported by Padarath and  English (2013:178)  medicine availability has not been at an 
acceptable levels  
 
During May 2010 South Africa experienced a shortage of over 80 medicines in the public 
health sector which included, amongst others, influenza vaccinations, medication for 
hypertension and tuberculosis. The severity of this shortage varied from province to 
province, as well as from hospital to hospital within the provinces, depending on the 
leadership abilities and skills levels of management (Health 24 2010).  
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The Public Service Commission results of the 2010 Citizen Survey also indicated that 
there were instances where citizens visited service delivery points and returned without 
receiving what they needed. Of the patient (10,5 percent) who participated in the survey 
were told to come the following day for their treatment, due to lack of sufficient stock of 
medicine or that it was time for staff to knock off for the day (Public Service Commission 
2011:41). As the challenges with the health services provision, including medicine 
availability, continued to surface the need to strengthen District Health Services to 
become well-functioning was also identified as a core principle of primary health care re-
engineering processes (Gray et al 2011:23). The re-engineering process, it is believed, 
will contribute towards the efficiency of district health services in the rendering of required 
essential services and will ensure that health programmes are available. This will include 
the provision of medicines, as well as treatment and care to the population in the areas 
where they live. The National Department of Health formally recognised that medicine 
availability is cardinal in the provision of quality health care services to the extent that 
medicine availability has been regarded as one of the six ministerial priorities required for 
compliance in all public health facilities (NDOH 2011a:16).  
 
In further developments over the years the South African Government has also regarded 
Health as one of 12 key outcomes to be prioritised during the 2009-2014 government 
term of office towards ensuring a better life for all South Africans and the achievement of 
the Millennium Development Goals during the period 2010-2015 (GCIS 2010). In order to 
improve the health profile of all South Africans improved medicine supply and 
management have been identified as key factors in the South African Health Programme 
of Action. However, despite these developments; the negative media coverage on the 
non-availability and stock out of medicines gave the public health services a poor 
reputation as service users did not receive the expected medications as they visited 
health facilities (Thom & Langa 2010:7).  
 
In 2011 the Ministry of Health commissioned a baseline audit for all public health facilities 
based on these standards. The purpose was to assess the current state of health services 
as well as the degree of compliance with standards. The results showed that the majority 
of health facilities did not comply with medicine availability standards due to stock out of 
essential medicines (Gray et al 2011:62).  
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Subsequent to the baseline audits in 2012, the Ministry of Health, responding to the 
countrywide medicine shortages, adopted what is called non-negotiables for the public 
health sectors. The non-negotiables list is a list of items that are supposed to be available 
at all times for the continued provision of safe and quality health services. These items 
include medicine, cleaning materials, as well as equipment and laboratory services. The 
Minister called for provinces to ensure sufficient budgeting and ring-fence these funds 
with the intention to minimise the recurrence of non-availability of essential goods and 
services for basic service delivery (NDOH 2012a:1).  
 
For quality and efficient medicine provision the South African Pharmacy Council 
advocates the availability of pharmacists and pharmacist’s assistants to take charge of 
the provision of medicines in the hospitals, community health centres and primary health 
clinics in an environment compliant with Good Pharmacy Practice (South African 
Pharmacy Council 2010:2).However, in practice there have been several challenges 
regarding availability of pharmacists and pharmacists’ assistants in public health facilities 
with hospitals and Community Health Centres not having permanent pharmacists. In 
primary health clinics nurses are in the main the only available personnel responsible for 
the provision, ordering, control of and enabling access to medicines (International Council 
of Nurses 2011).  
 
This situation has the potential for the consistent non-replenishment of medicine stock as 
nurses’ primary function is to render nursing care depending on other health workers and 
support services for on-site provision and medicine supply management. Strengthening 
Pharmaceutical Services 2009:12) also reported that medicine stock outs were due partly 
to the little knowledge concerning management of medicines by the nurses who were 
responsible for the health centres including keeping of stock cards, ordering based on 
real consumption and also to the difficulties in procurement due to unavailability at the 
source and or lack of financial resources.  
 
Matsoso et al (2015:198) advocate for a more effective role of the District Pharmacist as 
various studies suggest medicine stock outs at facility level. The authors believed district 
pharmacists could play a more influential role in medicine provisioning provided they are 
adequately resourced and recognised as key partners in district health services.  
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2.8 PROVINCES OF THE REPUBLIC OF SOUTH AFRICA’S SITUATION ON 
MEDICINE PROVISIONING 
 
When assessing the number of provinces publishing availability details in their annual 
performance plans it becomes clear that not all nine provinces have readily available 
information on medicine shortages. Information regarding the medicine shortages usually 
emerges through the media when there are challenges with stock outs and as reaction to 
criticism by civil society lobby groups including Treatment Action Campaign and Section 
27. The South African health system promotes the utilisation of the primary health care 
facilities as a first point of contact with the broader health system. However; numerous 
reports have highlighted the limited availability of essential medicines in particular at the 
primary health care settings which are located within district health services level across 
all the countries provinces. In the National Health Facilities Baseline Audit at least 86 
percent of the health facilities were reported to be without the full package of the essential 
medicines including treatment for HIV and AIDS. Vaccines, Chronic Conditions and 
Tuberculosis (NDOH 2012a:57). The report published in December 2013 further 
highlighted the shortage of medicines across the country and cited the reasons as being 
lack of the uniform, standardised framework for the provision of medicines in South Africa 
especially for the district health services (SECTION 27 2012:14). 
 
The Free State, Limpopo, Eastern Cape, Gauteng and Mpumalanga all experienced the 
medicine shortages during the 2013/2014 and 2014/15 calendar years (Stock Out 
2016:8). A study conducted on Pharmaceutical Management of Tuberculosis in seven of 
our nine provinces found that provision of essential medicines was not optimal as the 
availability of ARV and TB medication was at less than 95 percent in five of the provinces, 
namely the Free State, Eastern Cape, Gauteng, Limpopo, and Mpumalanga.  
 
The factors contributing to this low availability, especially in clinic settings, include poor 
stock control and management in nurse-led primary health clinics, and a lack of 
pharmacist’s assistants to take charge of drug supply management. A lack of electronic 
stock management systems also plays a role as manual stock cards were found not to 
be updated at most facilities (Pure Health Consulting 2012:97).  
 
Western Cape and North West were reported to have achieved above 95 percent 
availability. The factors that contributed to the better availability of essential medicines 
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include good systems for provision of medicines including electronic stock management, 
maintenance of the three  month buffer stock, close monitoring and weekly reporting on 
stock availability, active contract management, and interaction with the suppliers over 
quantification, shortages and forecasting of needs, involvement of all role-players in 
medicine stock management including finance, programme managers and pharmacists 
and adjustment of issuing quantities during limited stock period to ensure that all patients 
receive medication whilst waiting for the replenishment stock (Pure Health Consulting 
2012:129). 
 
Between July 2012 and June 2013, the KwaZulu-Natal Provincial Pharmacy and 
Therapeutics Committee also faced a number of medicines shortages. The reasons for 
each shortage varied considerably, but each provides insight into the problem in a middle-
income country with some local pharmaceutical manufacturing capacity (Gray 2014:209).  
 
Further a study conducted in the Free State province demonstrated that there is 
inadequate availability of medicine in district health services due to various factors, 
including a shortage of pharmacists and pharmacists’ assistants in the primary health 
setting, lack of delegation, red tape in the procurement of medicines, and lack of an 
electronic medicine procurement and monitoring system. Medicine Availability and 
provisioning thereof has been listed as a non-negotiable item and a priority for the South 
African Health sector requiring that consistent medicine availability is ensured at all times. 
It has been proposed that innovative plans and model should be developed to promote 
consistent medicine availability especially for the District Health System in which the 
majority of the citizens’ access health services in a primary health clinic setting (Zuma 
2013:99).  
 
Further, Kheirandish, Rashidian, Kebriaeezade, Cheraghali and Soleymani (2015:119) 
submit that ensuring a reliable health care and supply systems for provision of medicines 
is critical and can be realised through “Market monitoring enhancement” which is 
implemented in different countries by various methods in order to identify more rapidly 
and accurately the market needs and medicine shortages in the country. The approaches 
include monthly collections of medicine consumption or distribution data , establishing an 
immediate warning system to detect the shortages, expanding the data collection network 
to all parts of the country, establishing an information centre for medicine shortages, 
developing working groups to review the country drug list appropriate to market needs, 
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increasing interactions with the pharmaceutical manufacturers and importers, for example 
via formal meetings and executing programs to receive customer complaints about 
medicine availability. 
 
2.9 CONCLUSION  
 
MSH (2012:8.5) suggests that at the district level the most relevant areas of strengthening 
within the pharmaceutical management cycle are distribution including storage and stock 
management as well as use. Matsoso et al (2015:198) reported that many reports have 
alluded to the ineffectiveness of medicine depots in ensuring that essential medicines 
reach the facilities in time and in the required quantities. As such it has become imperative 
that attention be focused on key issues including that of provisioning of essential 
medicines.  
 
Therefore; it will be important that review of the systems for provision of essential 
medicines be conducted and proposal for a standard framework be developed to improve 
the availability of medicines especially in the district health services. 
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CHAPTER 3 
 
THEORETICAL FRAMEWORK FOR PROVISION OF ESSENTIAL 
MEDICINES  
 
3.1 INTRODUCTION  
 
Research studies have to be based on some form of a framework to guide the study. The 
framework is defined as an abstract, logical structure of meaning that guides the 
development of the study and enables the researcher to link the findings to the body of 
knowledge (Grove et al 2013:41). The framework can be conceptual or theoretical 
depending on the purpose and design followed. Conceptual Framework is defined as 
logical grouping of related concepts that is usually created to draw together several 
different aspects that are relevant to a complex situation whereas the theoretical 
framework is a knowledge form within the empirical form which is created to draw together 
several different aspects that are relevant to a complex situation (Chinn & Kramer 
2011:246, 257). In this study the situation is the provision of essential medicines. 
 
For this study a theoretical framework chosen was the Pharmaceutical Framework as 
developed and further refined by Management Science for Health in 2012 which comprise 
of the following aspects: Selection, Procurement, Distribution and Use of the provision of 
essential medicines guided by the legal framework. 
 
3.2 THEORETICAL FRAMEWORK FOR DRUG (MEDICINE) SUPPLY 
MANAGEMENT 
 
Management Science for Health in 2010 conducted extensive studies on medicine 
provision and availability across the world and after which the member states and regional 
consultations adopted a Medicine Supply Management Framework which is based on a 
four step framework which include activities for the selection, procurement, distribution 
and use as developed by the Management Sciences for Health.  
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At the centre of these processes are management systems, finance, human resources 
management, information management and policy governance functions (MSH 
2012:1.8). This framework guides the provision of the medicines across the member 
countries in a holistic approach through clearly outlined processes for selection, 
procurement, storage, distribution and usage of medicine. When implemented properly 
the possibility of ensuring continuous access and provision of medicine is likely to be 
successful.  
 
There has been further developments within medicine supply management sector 
towards refinement of the framework to guide medicine supply provisioning the 
development was facilitated by the MSH as the main organisation internationally lobbying 
for the medicine provisioning reforms and strongly advocating for the promotion of 
equitable access to quality medicine as both a key development challenge and an 
essential component of strengthening the health systems and primary health care reform 
in the world The framework was finally adopted by World Health Organization in 2011. 
The purpose of the framework was to standardise processes within member countries for 
the medicine provisioning systems with an intention to ensure consistent medicine 
availability at all levels. WHO believed that to preserve lives it is a key principle that the 
provision and continuous availability of medicines be placed as an important priority that 
countries should design and implement the National Medicine Policies to guide selection, 
procurement, distribution and use of medicines. As a core component of the framework, 
the National Medicine Policy is regarded as an indication for political commitment and a 
guide for action that can demonstrate how the government will ensure that efficacious 
and safe medicine of good quality are affordable, accessible, available and rationally used 
(MSH 2012:1.9).  
 
To this end the majority of WHO member countries including South Africa have approved 
national medicine policies. 
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Figure 3.1  The pharmaceutical management framework 
(Management Sciences for Health [MSH] 2012) 
 
According to MSH (2012:1.10), pharmaceutical management framework comprises four 
basic functions: selection, procurement, distribution, and use. Selection involves 
reviewing the prevalent health problems, identifying treatments of choice, choosing 
individual medicines and dosage forms and deciding which medicines will be available at 
each level of the health system. Procurement Includes quantifying medicine 
requirements, selecting procurement methods, managing tenders, establishing contract 
terms, and ensuring pharmaceutical quality adherence to contract terms. Distribution 
includes clearing customs, stock control, store management, and delivery to depots, 
pharmacies, and health facilities. Use includes diagnosing, prescribing, dispensing, and 
proper consumption by the patient. In the pharmaceutical management cycle, each major 
function builds on the previous function and leads logically to the next. Selection should 
be based on actual experience with health needs and medicine use; procurement 
requirements follow from selection decisions, and so forth.  
 
At the centre of the pharmaceutical management cycle is the core of related management 
support systems, including the planning and organisation of services, financing and 
financial management, information management, and human resource management. 
These management support systems hold the pharmaceutical management framework 
together. 
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 Although individual parts of the framework may function independently for a short time, 
the cycle as a whole will soon cease to operate and patient care will suffer without 
effective leadership, a functional organisational structure, adequate and sustainable 
financing, reliable management information, and motivated staff. The entire framework 
rests on a policy and legal components that establishes and supports the public 
commitment to essential medicine supply. The WHO member states subscribe to the 
above framework to manage provision of essential medicines .The paragraphs below will 
discuss each component and reflect key requirements for consistent provision of essential 
medicines.  
 
3.2.1 Selection component  
 
The framework for medicines has to provide for the selection process of essential 
medicines. Selection should be based on thorough discussions and acceptance by a 
multidisciplinary committee of experts who has the ability to interprete data and evaluate 
safety and eficacy of medicines within their area of expertise. The selection of the  
medicines depend on many factors including the prevalent diseases, treatment facilities, 
training and experience of the available personnel, financial resources, population genetic 
,demographic and environmental factors. The outcome of selection component is the 
essential medicines lists (EMLs) which support the systematic delivery of medicines in 
the health-care system (MSH 2012:16.2). 
 
The selection process of the WHO Model List of Essential Medicines has evolved since 
1977 from expert evaluation to evidence-based selection that includes: systematic review 
of evidence of efficacy and safety; consideration of public health needs, availability and 
costs; and a transparent process.The Model List and its supporting documents serve as 
a valuable resource for advocacy, selection, purchasing and supply at the country level. 
In 2016, according to the World Health Organization report, all 194 countries had a 
national EML and the majority had been updated in the previous five years (WHO 2016:1). 
The model list has been expanded to include the WHO Model List of Essential Medicines 
List for Children (EMLc), to address the priority health-care needs of children (WHO 
2016:1).  
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WHO member countries have developed what is referred to as national lists of essential 
medicines.The lists are commonly used in public sector procurement across all countries 
and in high-income countries for public insurance reimbursement. However, only a small 
fraction of countries use the EML for  reimbursement for private insurance. All  responding 
countries reported having a committee for the selection of medicines for the national EML. 
It is important that the EML is regularly updated to ensure that it is relevant to the health 
needs of the population, adapted to changes in therapeutic modalities, concordant with 
local treatment guidelines, and aligned with the logistics and budget of the health system.  
 
The WHO survey showed that 69 percent of  responding countries had updated their list 
within the previous five years. 81 percent of low-income countries had revised the EML 
within the past five years.The production of a national EML can help countries make the 
best use of limited resources to procure and make available the most appropriate 
treatments for the priority diseases and conditions. However, regular revision is essential 
to ensure that the selection remains current and credible (WHO 2011a:6). The concept 
of essential medicines provides the parameters as to which medicines should be included 
in the country list. These should be the medicines to treat the major diseases and 
conditions that affect the population and those that the health system can afford.  
 
3.2.1.1 Benefits and impact of the cordinated selection of medicines  
 
MSH (2012:16.4) highlights the benefits and advantages of limited selection of essential 
medicines can be categorised into the following categories supply, prescribing 
,organisational and patiet use.  
 
3.2.1.1.1 Supply  
 
Easier procurement, storage and distribution, lower stock levels better quality assurance 
and easier dispensing. 
 
3.2.1.1.2 Prescribing  
 
Training of the prescribers will be more focused and simpler with the limited basket of 
medicines for use to an extent that professionals will gain more experience with fewer 
medicines.There will be non availability of irrational treatment alternatives, reduced anti 
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microbial resistance as well as focused medicine education and information and better 
identification of adverse medicine reaction. 
 
3.2.1.1.3 Organisational benefits  
 
The selection and specifying the type and number of pharmaceutical to be purchased will 
lead to an improved quantification process.There will be lower costs due to more 
competition to provide the limited medicine lists.  
 
3.2.1.1.4 Patient use  
 
The limited essential medicine selection and lists will promote medicine availability and 
reduction in the treatment confusion and further improve adherence to treatment as 
patients will have fewer medicines to comphrehend as well as patient education will 
improve with focused education efforts and limited guidelines.  
 
3.2.2 Procurement component  
 
Effective procurement process is meant to ensure the availability of right medicine in the 
right quantities at reasonable prices and in compliance with the recognised quality 
standardsThe procurement process is an integral part of the supply chain and 
pharmaceutical cycle. Good procurement is dependent on selection of the appropriate 
medicines. It is also important to ensure that the medicinal needs of the country are based 
on a strong quantification system.  
 
A reliable supply chain system makes it possible to track the status of deliveries, stock, 
and consumption.It is important that the data from the users and adherence to standard 
treatment guidelines (STGs) is utilised as a measure of consumption data to be used for 
the next round of forecasting and selection (Van der Walt 2014:8). 
 
The process of purchasing supplies utilises National,Multinational,private or public 
suppliers,global agencies depending on availability and costs.Purchasing through global 
agencies require that mechanisms are put in place to ensure that the quality assurance 
and control requirements are met to protect the service users and countries through 
  
51 
procurement planning, purchasing inventory control traffic, receiving,incoming inspection 
and salvage operations (MSH 2012:18.6).  
 
3.2.2.1 Procurement cycle  
 
The procurement cycle involve the following 10 steps: 
 
1. Review medicine selections to determine quantities needed 
2. Reconcile needs and funds 
3. Choose procurement method 
4. Locate and select suppliers 
5. Specify procurement/contract terms 
6. Monitor order status 
7. Receive and check medicines 
8. Make payment 
9. Distribute medicines 
10. Collect consumption information 
 
Where the procurement cycle is followed the outcome is likely to be an effective 
procurement process for medicines which will ensures that: 
 
 the right medicines in the right quantities are sourced 
 the buyer-seller relationship are managed in a transparent and ethical manner  
 the lowest practical purchase price are sourced  
 all pharmaceuticals procured meet recognised standards of quality  
 there are timely delivery to avoid shortages and stock-outs  
 there is supplier reliability with respect to service and quality 
 the purchasing schedule, formulas for order quantities of purchasing are set at 
each level of the system  
 there is efficiency in the procurement processes 
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3.2.2.2 Medicine sourcing – procurement strategies  
 
Sourcing of medicines could be done through open tender,restricted tender, competitive 
negotiation or direct procurement as explained below: 
 
3.2.2.2.1 Open tender 
 
A formal procedure by which quotes are invited from any supplier’s representative on 
national or international, subject to the terms and conditions specified in the tender 
invitation. 
 
3.2.2.2.2 Restricted tender 
 
In a restricted tender, interested suppliers must be approved in advance, often through a 
formal prequalification process that considers adherence to good manufacturing 
practices, past supply performance, financial viability, and related factors.  
 
3.2.2.2.3 Competitive negotiation 
 
In competitive negotiation, the buyer approaches a limited number of selected suppliers 
(typically at least three) for price quotations. Buyers may also bargain with these suppliers 
to achieve specific price or service arrangements. For example, global organisations such 
as UNICEF, the Clinton Foundation, and supply chain management systems (SCMS) 
have successfully negotiated reduced prices of antiretroviral (ARV) medicines with 
manufacturersctors.  
 
3.2.2.2.4 Direct procurement 
 
Involve direct purchase from a single supplier, either at the quoted list price or at an 
agreed standard discount off the list price. For single-source medicines (generally those 
under patent with no licensing agreements that allow other firms to manufacture the 
medicine), the buyer basically has two choices namely direct procurement or selection of 
an alternative drug product (MSH 2012:18.6). 
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3.2.3 Distribution component 
 
Distribution is meant to ensure a consistent of medicines and supplies to the facilities 
where they are needed whilst ensuring that resources are used in the most effective 
manner. Distribution system or framework has four elements which are system, 
information, storage and delivery elements (MSH 2012:22.2).  
 
The decision of which distribution system will be utilised has to  take into account the 
geographic coverage ,land type and distance, population coverage in terms of persons 
numbers as well as level of the health systems.  
 
The distribution system has four major elements:  
 
 System type which refer to a geographic and population coverage number of 
levels within the health system and situation analysis of whether processes are 
centralised or decentralised. 
 Information systems. The information systems should be able to capture, 
generate data to demonstrate inventory or stock control to enable production of 
consumption reports and as far as possible have linkage between the warehouse 
systems and that of the health facilities.  
 Storage systems. The environment under which the medicines are stored whilst 
awaiting distribution has to ensure that the medicines are protected from 
breakages,extreme heat or cold temperature and exposure to the external 
elements.The storage system should take into account selection of appropiate 
sites for storage, building design and layout for optimum temperature and 
movement of stock as well as the material handling systems for effective order 
picking and processing.  
 Delivery systems. These should be developed taking into account the whether 
medicines will be collected by facilities or delivered by the warehouse utilising 
organisational resources or outsourced to the third party as well as the routes and 
scheduling of deliveries. The decision whether to utilise in house or third party 
should consider type of vehicle, mode of transport required whether road or air, 
need for vehicles procurement and maintanance which the health department may 
not necessarily have a skilled resource to manage.  
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3.2.3.1 Distribution system options  
 
There are two options for distribution it can either be a push or pull systems (MSH 
2012:22.9). 
 
3.2.3.1.1 Push system 
 
Push system is achieved by procuring and distributing standard pre-defined quantities of 
essential medicines for routine use .In the push system operational units are expected to 
supply certain stock and consumption information to the supply source so that issuing 
officers can plan allocations when supplying areas with limited access, limited 
management information system, and/or diversion and theft. Delivery plan is made at the 
beginning of a planning period (usually a year) and supplies are delivered according to 
the plan.  
 
Conditions 
 
 Staff members at the lower level of the distribution system are not (yet) competent 
in inventory control. 
 Demand greatly exceeds supply, making rationing necessary. 
 A limited number of products are being handled. 
 Disaster or epidemic relief is needed, or the situation calls for short-term supply. 
 
Transition from a push system to a pull system is recommended once management 
capacity and record-keeping improve. 
 
3.2.3.1.2 Pull system 
 
Pull system is a system through which facilities placed orders from a central warehouse 
based on the minimum and maximum ordering quantities at regular intervals. 
 
Preconditions for success of the pull system  
 
To be effective this system requires that field staff members are regularly supervised and 
performance monitored,good data should be available to decision makers,Staff members 
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at the lower level of the distribution system should be competent in quantifying and 
forecasting needs and managing inventory, sufficient supplies are available at supply 
sources to meet all programme needs and there must be capacity to handle large range 
of products.  
 
3.2.4 Distribution cycle  
 
According to MSH (2012:2.5), distribution cycle is a continous process comprising of the 
following processes: 
 
 Procurement of medicines and commodities to facilitate availability for delivery to 
the health facilities. 
 Port clearing include identification of shipments as soon as they arrive in port 
,processing of all importation documents, completing any customs 
requirements,storage of medicines properly until they leave the port, assessment 
of the shipment for losses or signs of damage and after clearance has been issued 
medicines can then be collected.  
 Reception and  Inspection the new shipment should be kept separate from other 
stock until inspection has been completed to check for damaged and missing items 
further the assessment for compliance with contract conditions regarding medicine 
type, quantity, presentation, packaging, labeling is also executed. 
 Inventory control processes facilitate coordination of the flow of pharmaceuticals 
through the distribution system with key objectives of ensuring protection against 
theft and corruption and facilitate, requisitioning and issuing of medicines, financial 
accounting and preparing consumption and stock balance reports.  
 Storage promotes proper location, construction, organisation, and maintenance of 
storage facilities in order to maintain medication quality, minimise theft and loss 
through damage and maintain regular supply to health facilities. 
 Requisition utilise either a push or pull system through forms and procedures which 
are key components of the inventory control system and provide audit trail for 
tracing the flow of medicines.  
 Delivery options can be warehouse staff or collected by health facility staff 
depending on the cost effective choice made by the entity. 
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 Dispensing the distribution process achieves its purpose when medicines reach 
hospital wards, outpatient clinics, health centers, or community health workers and 
are appropriately prescribed and dispensed to patients. 
 Consumption reporting is a closing link in the distribution cycle enabling flow of 
information on consumption and stock balances back through the distribution 
system to the procurement office for use in quantifying procurement needs.  
 
3.2.4.1 Good distribution practices  
 
Engelbeen and Makhado (2014:20) recommend that In order to ensure that medicines 
reach the end users, the following needs to be implemented:  
 
 Maintain a constant supply of medicines. 
 Conserve medicine quality throughout the distribution process by ensuring that the 
cold chain is maintain and medicines are protected from the external elements and 
adverse weather conditions.  
 Minimise loss of medicines through implementation of controls and tracking of the 
stock movements as well as prevention of theft in transit as well as in the facilities 
and warehouse and maintain accurate inventory records by full documentation at 
every stage and rationalise storage points for medicines. 
 Provide information for forecasting medicine needs. 
 Incorporate a quality assurance programme distribution costs are a significant 
component of the expense of running a public health supply system. 
 Distribution costs below 5 percent of the medicines price are generally considered 
acceptable for essential medicines in public sector systems. 
 
3.2.5 Rational medicine use component  
 
According to WHO (2016:1), the rational use of drugs requires that patients receive 
medications appropriate to their clinical needs, in doses that meet their own individual 
requirements, for an adequate period of time, and at the lowest cost to them and their 
community. 
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WHO (2016:1) further advocates for 12 key interventions to promote more rational use: 
 
 Establishment of a multidisciplinary national body to coordinate policies on 
medicine use 
 Use of clinical guidelines 
 Development and use of national essential medicines list 
 Establishment of drug and therapeutics committees in districts and hospitals 
 Inclusion of problem-based pharmacotherapy training in undergraduate curricula 
 Continuing in-service medical education as a licensure requirement 
 Supervision, audit and feedback 
 Use of independent information on medicines 
 Public education about medicines 
 Avoidance of perverse financial incentives 
 Use of appropriate and enforced regulation 
 Sufficient government expenditure to ensure availability of medicines and staff. 
 
Further, according to Bradley and Mogano (2014:26), pharmaceutical management 
elements of rational medicine use include the following processes: 
 
 A clinician making a diagnosis of a patient’s sickness based on presenting 
complaints, history taken, physical examinations and other investigations 
conducted. 
 Choosing appropriate medicine(s) for the diagnosed condition, and writing this as 
a prescription. 
 A dispenser (pharmacist or nurse) interpreting the prescription, selecting the 
appropriate medicines and packing and labelling them, and counseling the patient 
on correct use. 
 The patient taking the medicines as instructed.  
 
Many factors influence rational use, and it is essential to formulate an overall policy for 
rational use of medicines and detailed procedures to address each of the component 
areas.  
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MSH (2012:27.2) identified the following criteria to be complied to promote rational 
medicine use:  
 
 Prescription is based on sound medical considerations.  
 Due consideration for safety,efficacy suitability for the patient and cost factors.  
 The dosage, duration and the administration route should be appropiate for that 
particular medicine. 
 Patients should be assessed for contra indications to avoid and minimise adverse 
drug reactions.  
 There should be correct dispensing of medicines meaning treatment for the right 
patient for the right condition and appropiate information given to the patient with 
regard to the prescribed medicines.  
 Patients should adhere to the prescribed treatment instructions.  
 
3.2.5.1 Proposed strategies to promote rational medicine use  
 
There are mechanisms and strategies to promote rational medicine use (MSH 2012:27.5) 
including the following:  
 
 There must be a national multi-disciplinary structure to coordinate medicine use 
policies to serve as advisory structure as well as monitor the medicine use 
practices to promote rational medicine use. 
 There must be standard treatment guidelines developed and implemented to 
ensure that the prescribers are guided to make sound and cost effective decision 
with regard to specific conditions. 
 Clear mechanism for developing and revising essential medicine lists based on 
the treatment of choice. 
 Establishment of Pharmaceutical and Therapeutic Committee in the districts and 
hospitals with clear responsibilities for promoting and monitoring rational use of 
medicines. 
 Use problem based training in Pharmaco therapy based on national standard 
treatment guidelines starting with the undergraduate levels. 
 Mandatory continuous professional development for all health professionals 
licensing requirements to include rational medicine use content.  
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 Develop mechanisms to regulate prescribing patterns in the private sector through 
regulation and collaboration with professional societies.  
 Supportive rather than punitive supervision, monitoring and evaluation 
mechanisms including prescription audit and feedback, peer reviews and 
professional syndicate groups engaging in self-identification of medicine problems 
and solutions in a group should promote rational medicine use.  
 
3.2.6 Legal framework component  
 
To protect the public from harmful health practices government, need to approve 
comprehensive law and regulations and establish national regulatory authorities to 
ensure that the manufacturing, trade and use of medicines is regulated appropriately and 
that public has access to safe medicines and accurate medicine information. World Health 
Organization standards require that countries develop and implement national policies 
and standards for the provision of medicines in order to ensure safety of the population. 
All 194 member countries had medicine policies of varying quality (WHO 2016:1). 
 
Makhado (2014:13) reported that the medicine policy has to consist of the following 
components:  
 
 Legislation and regulations inclusive of country medicine control acts, 
establishment of statutory bodies, licensing procedures for medicines and 
practitioners, medicine quality control, quality assurance and trade regulations. 
 Medicine selection for each level of care namely primary health care, district 
hospital services and tertiary hospital services.  
 Pricing taking into account options of non-tax levies for medicines and use of 
generic versus brands utilisation.  
 Human resource development in terms of categories of staff responsible for 
management and supply of medicines. 
 Research incorporating medicine patent rights and production of new medicines. 
 International cooperation guidelines with other countries in terms of trade and 
medicine movement between countries and levy tariffs. 
 Rational medicine use, procurement, distribution.  
 Monitoring and evaluation mechanism. 
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In the South African context there is Medicine and Related Substance Act of 1965 
governing the manufacturing, licensing and sale of medicines in the country supported by 
various professional acts including Pharmacy, Nursing and other health related 
occupations. The National Drug Policy for South Africa was approved in 1996 to 
strengthen provision of medicines in the country and emphasised that the legal framework 
has to provide for establishment of the regulatory bodies with the functions of defining 
role of various parties, licensing, inspection and quality control, pharmaco vigilance 
monitoring and management of adverse medicine reactions, advertisement and 
promotions, sanctions (South Africa 1996:6-7). 
 
3.2.7 Management support component  
 
This component is concerned with management support systems including the planning 
and organisation of services, financing and financial management, information 
management, and human resource management. These management support systems 
hold the pharmaceutical management framework together (MSH 2012:38.2) further 
explained below. 
 
3.2.7.1 Planning and organisation of pharmaceutical services  
 
The management support component should address the planning, implementation and 
monitoring and evaluation elements to be effective. Planning is the process of analysing 
the current situation, assessing the needs, establishing the goals, setting the objectives 
and measurable targets, determining the strategies, responsibilities and resources 
needed to achieve the results in this study which is to ensure availability of medicines. 
Planning is addressed at three levels namely: strategic, programme and work levels 
looking at pharmaceutical supply systems assessment to understand the as is situation 
in order to identify strengths and weakness of the current medicine provisioning system, 
pharmaceutical management programmes, planning for pharmaceutical management, 
contracting pharmaceutical service providers, analysis and control of medicines 
expenditure, financial planning and management and infrastructure in terms of building 
storage facilities (MSH 2012:38.2). 
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3.2.7.1.1 Strategic planning  
 
This component is concerned with the long-term future of the organisation and its overall 
effectiveness in the light of changing internal and external environments usually executed 
when current strategies are not working and possibly when there is a crisis in service 
delivery platform the outcome may be production of new policy.  
 
3.2.7.1.2 Programme planning 
 
Programme planning follows strategic planning focusing on medium term planning 
detailing expected outcomes, responsibilities, time frame, and budget. 
 
3.2.7.1.3 Work planning 
 
Work planning is a short-term looking and involves more the operational staff who is 
responsible for the programme or intervention implementation. The work plan has limited 
set of objectives with indicators for monitoring and measuring progress and results.  
 
The planning process enables the organisation to ensure that the medicine supplies 
required are available, limit the crisis management and minimise the occurrence of 
medicine stock outs due to poor planning.  
 
3.2.7.2 Contracting pharmaceutical service providers  
 
Contracting should always be based on carefully prepared specifications and 
enforcement of contract terms to result in effective and efficient procurement. Further for 
day to day services the arranging contract especially for non-core services such as 
warehousing and transport functions.  
 
The contracts for consideration is supply agency where all warehousing and transport 
functions are performed by private organisation on behalf of the company, direct delivery 
warehouse procures but goods are delivered directly to the hospital or district ,primary 
distribution is utilised when facilities order directly from the approved distributor paying 
the manufacturers and distributions fees directly without going via the warehouse and 
pharmaceutical benefit programme is the provision of prescribed services to designated 
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beneficiaries directly or by appointing agents utilising the mail or courier services (MSH 
2012:39.2). 
 
3.2.7.2.1 Contracting process  
 
The process has four stages: 
 
 Identification of service that could be provided by contract providers and 
undertaking a feasibility study for contracting out. 
 Prepare clear tender specifications and contract terms. 
 Shortlist suitable qualified suppliers, invite formal tenders and appoint service 
providers following due processes. 
 Monitor the contracted provider and health system performance. 
 
3.2.7.3 Organisation management  
 
This component focuses on security, medical stores (warehouse), hospital pharmacy and 
broader health pharmaceutical management (MSH 2012:43). 
 
3.2.7.4 Security management  
 
This component is meant to prevent theft bribery and fraud and require that security 
assessment be conducted to identify sources of security breaches, decide on methods to 
improve security, analyse cost implications and potential savings and monitor the 
implementation of the chosen security measures.  
 
3.2.7.5 Warehouse management  
 
This component is meant to ensure that the flow and reliability of supplies from source to 
the end user is economical and consistent with minimal theft, compromised quality and 
wastage. 
 
According to MSH (2012:44.2), good practices in warehouse management should include 
the following: 
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 There should be full management structure for management of the warehouse 
operations. 
 The staff should be appropriately qualified, well skilled, exposed to continuous 
development, well disciplined and appropriately rewarded. 
 There should be concise and well written standard operational procedures and 
guidelines. 
 The work environment should be well structured to promote easy movement of 
stock whilst ensuring security. 
 Warehouse demarcation to provide for environmental compliance and stock 
security. 
 Stock should be kept in orderly traceable system compliant with First in First Out 
or First Expiry First Out. 
 Periodic stock count. 
 Housekeeping should be well maintained through regular cleaning, pest control, 
controlled disposal of damaged and expired stock, recording of stock movement 
and tight security measures. 
 Stock should be kept in compliance with the manufacturer instructions including 
kept off the floor using pallets, pallet racks, shelves and cold chain maintained.  
 
3.2.7.6 Hospital pharmaceutical management  
 
The medicines in the hospital setting is managed through the Pharmaceutical and 
Therapeutic Committee whose responsibility is to develop policies and procedures for 
rationale medicine use which should be chaired by a senior clinician. The PTC should 
comprise of the multidisciplinary team members including pharmacist administrators, 
quality assurance coordinators and nursing and medical health professionals. The 
hospital pharmacy should be managed by a pharmacist who is responsible for 
procurement, storage and distribution of medicines within the hospital (MSH 2012:45.2). 
 
3.2.7.7 General principles for managing pharmaceutical management in health 
facilities  
 
At every health facility the following should be complied with: 
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 There should be proper security and storage of the medicines. 
 Compliance with the environmental storage requirement. 
 Accurate record keeping for stock movement. 
 Proper systems for facilitating reordering mechanisms. 
 Systems for effective stock rotation and expiry monitoring. 
 Mechanisms for prevention of theft and fire hazards (MSH 2012:46.2). 
 
3.2.8 Information management  
 
Medicine provision should be based on consumption information to promote proper 
procurement and consistent medicine availability. The strategies used for information 
management include monitoring and evaluations, use of pharmaceutical management 
information systems and computer technology (MSH 2012:48).  
 
3.2.8.1 Monitoring and evaluation  
 
This activity is a continuous process utilising the following approaches: 
 
 Supervisory visits for monitoring of progress in the implementation of medicine 
supply work plans. 
 Routine reporting on key data through the pharmaceutical information systems. 
 Sentinel sites for more detailed reporting on new initiatives for. 
 Conduct special studies when indicated by variance availability of medicines or 
eruption of problems.  
 
3.2.8.2 Pharmaceutical management information system  
 
Pharmaceutical management information system is an organised system for collecting 
processing, reporting and using information for decision making (MSH 2012:49.2).  
 
The system should comply with the following processes: 
 
 The record keeping documents should be a combination of registers, ledgers and 
filing systems. 
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 Information reporting forms including periodic status reporting used for 
transmission of data to relevant departments for management decision making. 
 Feedback mechanisms to the information generating units. 
 The system should be able to integrate with other systems to ensure efficiency and 
facilitate data utilisations. 
 
3.2.8.2.1 Computers in pharmaceutical management  
 
Personal computers can be used in all aspect of pharmaceutical cycle When used 
effectively computers save money, promote efficiency and improve the quality of service 
however if poorly planned or implemented the results are wastage of resources, 
decreased efficiencies and limited improvements in management processes  
 
3.2.8.2.2 Guidelines towards successful computerisation 
 
MSH (2012:50.4) advises that the following should be considered and undertaken to 
ensure successful computerisation: 
 
 An assessment should be conducted to determine required software before 
purchasing hardware to ensure suitability and prevent wastage due to 
incompatibility. 
 There should be locally available support for both hardware and software in order 
to reduce downtime due to system failures.  
 Back up manual system should be available to enable uninterrupted service 
delivery in case of unforeseen downtimes.  
 Capacitate staff through training on the computer system and involve the team in 
the development and migration of the computer systems Implement in phases to 
allow for staff adjustment in the computerisation process. 
 Mechanisms should be put in place to ensure back up of files, data, equipment as 
wells as virus protection. 
 There should be funding available for supplies replenishment, system hardware, 
and software upgrades and staff development on latest technologies. 
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3.2.9 Human resource management and capacity development  
 
3.2.9.1 Human resource management  
 
Human resources play a critical role in medicine provisioning across the whole chain from 
manufacturing to the utilisation. In the pharmaceutical sector the goal of human resources 
management is to develop and sustain adequate supply of skilled and motivated 
employees to provide quality service (MSH 2012:51.2). 
 
The strategies used for effective HRM include:  
 
 Empowered supervisors able to manage day-to-day operations and develop staff 
to better efficiency levels. 
 Standard operation procedures for performance management and career 
progression leading to job satisfaction  
 Standard job descriptions and post requirements per level of care  
 Clear labour relations management procedures to manage discipline, dealing with 
grievances and handle conflicts.  
 Standing engagement meeting and communication procedures.  
 
3.2.9.2 Designing and implementing training programme  
 
Training programmes are essential component of human resource management as 
change in procedure occur consistently owing to technology and new treatment 
innovations.  
 
The need for training could be indicated due to need for continuous professional 
development to maintain professional registration and changing circumstances or 
protocols. Training programme design should be preceded by needs assessment taking 
into account the following three steps:  
 
First step: observation of staff in action, seeking the staff and service users or clients’ 
opinion on the work processes allowing submission of innovation proposals for 
consideration, identifying work performance problems and analysis of job descriptions 
and performance reviews reports.  
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Second step: Training learning objectives need to be designed stating clearly what skills 
should the participants demonstrates on training programme completion.  
 
Third and final step result in the training programme design completion and 
implementation to improve performance (MSH 2012:52.2). 
 
3.3 CONCLUSION  
 
The theoretical framework for provision of pharmaceutical services as developed by 
management sciences for health will be used in presenting the research findings as well 
as basis for developing the framework for the provision of medicines within the district 
health services.  
 
  
  
68 
CHAPTER 4 
 
RESEARCH METHODOLOGY 
 
4.1 INTRODUCTION  
 
The previous chapters one to three provided the orientation of the study, literature review 
as well as the theoretical framework of the study. This chapter will present the 
methodology utilised in the conduct of the study including research design, population, 
sampling as well as the data collection, analysis strategies and ethical considerations.  
 
4.2 RESEARCH DESIGN 
 
Research design involve a set of decisions regarding what topic is to be studied, among 
what population, which research methods will be utilised in the execution of the study and 
purpose thereof (Barbie 2013:116). The research design is the overall plan according to 
which researchers obtain answers to the research questions and handling challenges that 
can undermine the study evidence. The research design is the architectural backbone of 
the study indicating aspects of the study including data collection and the setting for the 
study (Polit & Beck 2014:51). The research design, according to Grove et al (2013:43), is 
a blue print for conducting a study that maximise control over factors that could interfere 
with the validity of the findings. This study project was conducted as a qualitative 
exploratory, descriptive study through experiences of the managers responsible for 
provision of essential medicine across eight of the nine provinces of South Africa in an 
attempt to obtain data rich explanations and details of approaches used in order to 
develop a framework for the developing countries.  
 
4.2.1 Philosophical assumptions  
 
Grove et al (2013:10) define philosophy as means that provide a broad, global 
explanation of the world and believes that meaning is produced by perceptually putting 
the pieces together to make the whole and confirmed that because perception varies with 
individuals, many meanings are possible. Philosophical assumptions refer to the view of 
reality and knowledge that in turn inform researcher perspectives, approaches and 
methods as well clarify the reason the researcher choose a particular research design 
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(Savin-Barden & Major 2013:54). The researcher believe in that the experience of the 
frontline practitioners should develop the practice  further as such an approach as defined 
by Streubert and Carpenter (2011:20) that promote multiple realities, accepting that the 
researcher is part of the discovery process , valuing the subjective views of participants , 
with special interest in the description and data rich narratives as well as the various 
context under which the research phenomenon is experienced was preferred for the 
study. 
 
The researcher intended to reflect on the practice of provision of essential medicines 
within the district health services utilising the experiences of the managers on the coal 
face in order to develop new knowledge with regard to the phenomenon under study as 
such a research paradigm promoting interpretive insights and thick description as well as 
reflective practice and interaction between theory and practice towards transforming 
practice was favoured for this study. The research paradigm identified was qualitative 
research. The researcher in the conduct of the study was an active participant engaging 
with the participants in unpacking and creating the social reality. The researcher believed 
that the knowledge developed through mutual engagement of interdependent individuals 
interested in improving practice would have bigger impact on the service delivery 
platform.  
 
4.2.2 Qualitative research design 
 
According to Streubert and Carpenter (2011:20), qualitative research design is the design 
based on a belief in multiple realities, commitment to identifying an approach to 
understanding that support the phenomenon under study as well as participant view point 
limiting the disruption of the natural environment under study acknowledging the 
researcher’s participation in the research process and reporting the data in a literary style 
with the participants’ commentaries. The focus of qualitative studies is on the meaning 
that the participants attach to their social world. Marshall and Rossman (2011:2) also 
confirmed that qualitative research is typically enacted in a naturalistic setting focusing 
on context, is emergent and evolving as well as fundamentally interpretative. According 
to Barbie (2013:90), the purpose of conducting social (qualitative) research can be 
exploration, description and or explanation of a phenomenon.  
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Qualitative research designs have the ability to generate richly nuanced, personal or 
public level data through selection of knowledgeable informants, open ended questioning 
about their attitudes and experiences and inductive probing of their experiences (Guest 
& Namey 2015:444). Qualitative research design is a naturalistic enquiry which is usually 
less obstructive than quantitative investigations and does not manipulate the research 
setting.  
 
4.2.3 Qualitative exploratory, descriptive and design 
 
Qualitative research designs in health enable the exploration of health and illness as they 
are perceived and experienced by the people themselves. Qualitative research is used to 
expose emotions, perspectives, beliefs and values as well as action and behaviours to 
understand the participant’s response and meaning to the phenomenon under study 
(Morse 2012:21). Descriptive research studies involve identifying and understanding the 
nature of phenomenon as well as relationships in a narrative style (Grove et al 2013:12). 
 
As this research was conducted through experiences of the managers responsible for 
provision of medicines. The design used should provide for in depth narrative and content 
rich data. Qualitative research design was found suitable for the study on the framework 
for provision of essential medicines as the research was intended to explore and describe 
in an uncontrolled setting the experiences of the managers responsible for provision of 
medicines towards development of a standardised framework for provision of medicines 
in the district health services. Further the qualitative research design was utilised as it 
allowed for the respondents to share first-hand experiences of the subject under 
investigation to produce narrative rich data.  
 
4.3 RESEARCH APPROACH ACTION RESEARCH  
 
The study intended to improve the practice as well as the quality of health care through 
development of a framework to ensure consistent provisioning of essential medicines. 
Action research was found useful in circumstances where participatory, democratic 
processes are required to develop practical knowledge and promotion of flourishing of 
individuals and their communities with an intention for action that lead to change (Taylor 
& Francis 2013:154). In its pure definition action research can be explained as a 
qualitative research method whose purpose is to engage in a problem solving through a 
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cyclical process of thinking, acting, data gathering and reflection requiring participants to 
be empowered and emphasis is on leading a social change (Savin-Baden & Major 
2013:255). McNiff and Whitehead (2009:11) define action research as a systematic 
enquiry undertaken to improve a social situation utilising processes of improvements and 
making claims that something has improved and then made public. Action research is 
characterised by the intention to produce change in practice with the involvement of the 
stakeholders within a specific context working together towards practical outcomes and 
creating new forms of understanding.  
 
The characteristics of action research are participation and democracy, human 
flourishing, focus on practical issues, knowledge in action and emergent development 
form (Reason & Bradbury 2011:2). Action research is reported to be problem focused, 
context specific, future oriented, educative and deals with individual as members of the 
social groups involving a change intervention aimed at improvement and involvement 
recognising those involved as participants in the change process (Koshy et al 2011:29). 
The principle of collaboration feature prominently in the conduct of action research in that 
those who have a stake in the problem under study must actively participate in developing 
action plan to improve the practice (Herr & Anderson 2015:4). Action Research is suitable 
as an approach employed by practitioners for improving practice as part of the process 
for change enabling the researcher to learn and share newly generated knowledge with 
those who may benefit from this knowledge (Koshy et al 2011:9).  
 
This study was conducted with the involvement of the participants in reviewing and 
improving their practice environment with an intention to promote new strategies to 
ensure consistent medicine availability in the health facilities. Action research is not only 
concerned with doing things differently but also aspire to make judgement of the 
effectiveness of actions, existing and new (Townsend 2013:109). Further action research 
can be useful in developing innovation, improving health care, developing and 
understanding in practitioners as well as involving of users and staff (Reason & Bradbury 
2011:390). As such it would be applicable in studies focusing on development of 
framework for provisioning of essential medicines.  
 
For this research the best results were obtained through action research in order to 
promote active involvement of the informants in the process of the development of the 
  
72 
model for provision of essential medicines so that the improvement in the practice 
environment can be sustained and implemented by the end users. 
 
4.3.1 Action research sub-types  
 
Action research can be categorised to the following: 
 
Insider action research is the kind of action research conducted by a member of that 
community with the participants from within. Usually prompted by the frustration or 
contradiction within the workplace which the practitioners have been thinking about for 
some time (Herr & Anderson 2015:92).  
 
Outsider action research is executed by an external person from a particular community 
together with those community members in order to generate knowledge and make 
contribution to the community or setting under study (Herr & Anderson 2015:95). 
 
4.3.2 Action research stages or cycles  
 
Action research has six stages not necessarily progressing in a linear approach including 
refining a focus, conducting reconnaissance (a stage during which the researcher attempt 
to understand the issue of interest in more depth to be able to develop comprehensive 
plans for the project execution), reflecting on progress, planning for action, implementing 
and observing action, reflecting and evaluating change (Townsend 2013:19). The cycle 
for action research include Identification of the issue of concern, reflection, planning for 
the action reflect, decide on the action, implement the action, discuss the action with those 
involved, reflect and evaluate the impact of change, interpret processes involved in the 
whole cycle and plan next action (Savin-Baden & Major 2013:252).  
 
According to Francis and Taylor (2013:154), the following observable actions should be 
experienced. During planning a plan is developed that will inform action to improve current 
practice; this plan should be flexible and be adaptable to unforeseen effects or constrains. 
The action resulting from the research should be deliberate and controlled promoting 
future development. The researcher is expected to observe the effects and constraints of 
the action. There should also be reflection on the processes, decisions and outcomes 
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achieved as well as the problems encountered and implications thereof for future 
practices. 
 
Koshy et al (2011:79) has condensed the stages of action research into four phases 
namely Identification of an issue and setting up a project, reflection, planning stage and 
evaluation stage as explained below: 
 
4.3.2.1 Identification and setting up a project 
 
Herr and Anderson (2015:86) identify the following activities to be executed in a pilot study 
format testing of the research question, methodologies conduct initial data gathering and 
analysis the content of this face can form part of the final research report and enables the 
researcher to establish relationships with the participants for the study. During this stage 
the problem is identified for possible change implementation, introductory literature 
review and reflection is carried out. In this phase the researcher will conduct literature 
review, obtain ethical and research site approvals as well as prepare for the entry and 
rapport development to the research site. Baseline data collection, analysis and site visits 
will also be done during this period. As an outcome of the identification phase for this 
study a research proposal was developed, finalised and submitted for approval based on 
the literature review. Ethical clearance was granted by the university and the research 
sites which were followed by a pilot study and mini research conducted to further refine 
the research questions and tools to be used for data gathering.  
 
4.3.2.2 Reflection stage  
 
Reflection is a continuous process of identifying the problem aspects of practice, review 
the practice and find constructive ways to deal with the practice problem identified. Action 
researchers are judged on whether they reflected on what was researched, testing own 
judgement against the critical feedback of others thus enabling self-learning from the 
participants (McNiff & Whitehead 2009:14). For this study the researcher and the 
participants worked together to identify practice challenges through joint discussion and 
review of the collected data obtained through the interview and site visits towards 
developing new ways of providing essential medicines for the district health services. The 
reflection process was undertaken continuously during the research project lifespan.  
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4.3.2.3 Planning and implementation stage 
 
This stage involves drawing up a conceptual map of the action research. A research 
proposal is usually developed during this stage. Further entry will be negotiated with the 
settings in which the research would be conducted to ensure that the problem under study 
is essential to the community as well as to establish collaborations for the improvement 
of practice (Herr & Anderson 2015:4). For the purpose of this study the researcher 
conducted in depth interviews and site visits with the provincial depot responsible 
pharmacists/managers and heads of pharmaceutical services (HOPS) in the health 
services setting focusing on the provision of medicines across the eight provinces in the 
Republic of South Africa with an intention to identify best practices to be incorporated into 
the framework. As reflected in the phases of action research, interviewing, reflection and 
focus group discussions are key methods for data collection suitable for this study.  
 
Marshall and Rossman (2011:93) state that although interviewing is often supplemented 
with other data collection methods, the primary objective is to capture the deep meaning 
of experience in the participant’s own words. Herr and Anderson (2015:5) submit that 
action research take the form of an intervention process utilising a spiral of action cycle 
involving development of an action plan to improve practice, implement the action plan, 
observe the effects of the action in the context in which the action occur and continuous 
reflection on the effects as a basis for further planning, subsequent action through a 
succession of cycles. 
 
4.3.2.4 Evaluation stage 
 
During this stage the group evaluate the project in terms of the implementation of the 
activities that were planned. Townsend (2013:109) submitted that this stage contributes 
towards understanding what effect the particular practice or initiative has had. The 
participants were engaged at least twice during the research project lifespan to assess 
whether there have been developments on the practice improvement initiatives that were 
identified with the participants. This process enabled execution of member checking 
which is the practice of verifying the data collected with the participants of the study. 
Braun and Clarke (2013:284) submit that this process contribute to enhance the 
trustworthiness of the research process as well as data collection. 
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During the evaluation stage, the data obtained from the site visits and interviews across 
the provinces of the Republic of South Africa was analysed to identify common themes 
and best practices towards developing a framework for provision of essential medicines 
for district health services. 
 
4.4 STUDY POPULATION AND SAMPLING  
 
4.4.1 Study population  
 
Barbie (2013:135) defines the study population as the aggregation of elements from 
which the sample is actually selected. Guest and Namey (2015:513) define the (study) 
target population as the set of elements to which the researcher desire to apply the 
findings of the study. The population for this study was the responsible pharmacists 
including the provincial pharmaceutical services managers and medical depot 
responsible pharmacists. The core function of the study population is management of the 
provision of essential medicines activities and operations.  
 
4.4.2 Sampling framing  
 
A sampling frame is a list of units composing a population from which a sample is selected 
(Barbie 2013:144). Guest and Namey (2015:513) also define the sampling frame as the 
listing of the entire target population.  
 
The subjects in the qualitative research are called participants or informants for the 
purposes of the study. Qualitative studies including action research participants should 
be obtained through purposive sampling with the intention to identify and select key 
informants who on account of their position or experience have more information than 
regular group members (Barbie 2013:128). The participants for this study were identified 
through purposive sampling to ensure that they would be able to provide a rich 
explanation and description of the content under study. 
 
4.4.3 Purposive sample selection  
 
Purposive sampling is a non-probability sampling procedure in which elements are 
selected from the target population on the basis of their fit with a specific set of inclusion 
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or exclusion criteria (Guest & Namey 2015:522). Purposive sampling was used to identify 
and select the individuals that have more information than the regular group members. 
The selected subjects should present information rich cases from which the researcher 
can learn a lot about the central focus of the study. Barbie (2013:128) defines purposive 
sampling as the selection of the sample on the basis of knowledge of the population, its 
elements and the purpose of the study. According to Neuman (2011:268), purposive 
sampling is appropriate for selecting unique cases that are especially informative in order 
to gain deeper understanding of the phenomenon under study.  
 
For this study, provincial pharmaceutical and medical depot managers were purposively 
selected as they have the knowledge and experience in the provision of essential 
medicines. 
 
4.4.4 Research setting  
 
The research was conducted in the eight of the nine provinces of the Republic of South 
Africa as sites responsible for provision of essential medicines. The depots and 
pharmaceutical services offices in these provinces were found suitable as they are the 
platform under which medicine provisioning is implemented as such provided the best 
sites, data and the practices to inform the development of the framework.  
 
This setting provided a suitable environment for the conduct of the study and allowed for 
observation and an in-depth understanding of the problems faced by the participants 
regarding medicine provisioning. 
 
4.5 DATA COLLECTION 
 
Data collection is the process of gathering information relevant to the study using one of 
the following primary methods: participating in the setting, observing directly, interviewing 
in depth, and analysing documents (Marshall & Rossman 2011:137). The data collection 
process in qualitative studies aims for rich, narrative accounts of the phenomenon under 
study. As such, the chosen collection method should capture the experiences and views 
of the participant in expressed words format (Streubert & Carpenter 2011:38). Conducting 
action research to understand and change the practice has an advantage that there is 
already data collected to be reviewed. Document analysis, observations, interviews, 
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questionnaire completion, site visits and journal reviews are applicable as data collection 
tools (Townsend 2013:85). 
 
For this study, data collection was executed through individual managers’ interviews 
using an interview guide to collect the biographic data and responses to key discussion 
points as well as site visits to various provinces to review and observe the processes 
involved in the provision of essential medicine. The face to face interviews were chosen 
because of the possibility for full range of communication including response to non-
verbal signs observed (Harding 2013:33). Creswell (2013:177) also support the view that 
data collection could be done in many forms, including interviews, observation, 
documents and audio-visual equipment for qualitative studies.  
 
4.5.1 Site visits  
 
The researcher submitted the request to all nine provincial pharmaceutical services and 
medical depots managers for participation and permission to conduct site visits to 
observe, analyse practices on essential medicine provisioning and also engage in 
discussion and interviews with the managers to explore and develop a framework for the 
district health services, however eight out nine provinces responded positively towards 
participation with one province non response despite numerous requests and follow ups.  
 
4.5.2 Interview guide  
 
Despite the flexibility that is a hall mark of qualitative data collection, there is still a need 
to prepare an interview guide to guide the interview which could be developed with full 
questions or reminder of topics to be discussed during the interviews (Harding 2013:36). 
The researcher usually has a list of topics or broad questions that must be covered in an 
interview as such the interview or topic guide is used to ensure that all question areas are 
addressed for semi structured interviews (Polit & Beck 2014:290).  
 
For this study, the interview guide attached as Annexure D was developed based on the 
Pharmaceutical Framework components namely: selection, procurement, distribution, 
use, legal framework and management support covering the hospital, community health 
centres and primary health care clinics within the district health services context. The 
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questions and the data collection process as well as the site visits were based on these 
components. 
 
4.5.3 Semi-structured interviews  
 
Marshall and Rossman (2011:93) recommend that, in order to capture the individuals’ 
lived experiences, an in depth interview should be used to capture the deep meaning of 
experience in the participant’s own words indicate that qualitative research uses a flexible 
questioning approach. Although a basic set of questions is designed to start the project, 
the researcher can change questions or ask follow-up questions at any time as flexibility 
is the special strength of field research (Barbie 2013:347). The interviews were conducted 
using the semi structured interview approach in order to explore the experiences of the 
participants.  
 
The process was expounded by providing the respondents with an interview guide to 
capture demographic details, as well as to record responses to certain predetermined 
questions. The interviews for this study were conducted in the environment in which the 
participants work utilising audio recording facilities.  
 
There were various advantages to face to face in depth interviews namely that the 
researcher could view behaviour in a natural setting, excluding the artificiality that 
sometimes surround experimental research, and fostering of social support networks as 
the participants engage and reflect on the research topic under discussion (Marshall & 
Rossman 2011:150). Furthermore, this approach was believed to have potential to 
increase the depth of understanding that the researcher could gain from the experience. 
 
4.6 DATA ANALYSIS  
 
Qualitative data analysis is a search for general statements about the relationship and 
underlying themes in a study (Marshall & Rossman 2011:207). Data analysis in qualitative 
research consists of preparing and organising the data for analysis then reducing the data 
into themes through a process of coding and condensing the codes, and finally 
representing the data in figures, tables or discussion (Creswell 2013:180). Data analysis 
for qualitative studies progresses through classification of ideas, themes, topics, 
activities, and types of people as well as other categories relevant to the study (Schensul 
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& Le Compte 2013:98). The stages involved in qualitative data analysis are the following 
reading, rereading the data and comparing aspects to understand the content, taking into 
account the research aim and questions underline key segments and provide descriptive 
comments, matching the identified segments across the database, attach labels and 
identification of sub groups and finally assess the grouping against the current literature 
and theory towards presentation of the research findings (Grbich 2013:261). 
 
The goal of data analysis is to illuminate the experiences of those who have lived them 
by sharing the richness of lived experiences and cultures (Streubert & Carpenter 
2011:47). Data analysis involves organising the data, preliminarily reading through of the 
database, coding and organising themes, representing the data in a meaningful format 
and forming of an interpretation thereof. These steps are interconnected and form a spiral 
of activities all related to the analysis and representation of the data (Creswell 2013:179). 
The aim of data analysis is the discovery of patterns among the data including trends or 
changes over time or possible causal links amongst variables (Barbie 2013:411). These 
patterns would point the researcher to theoretical understanding of phenomenon under 
study. 
 
4.6.1 Study data analysis processing  
 
The process of data analysis in qualitative research moves from description to 
interpretation through some identified process (Grbich 2013:259). For this study the data 
analysis was executed through the review of data collected and reflection on the practices 
observed and recorded during the site visits and clustering in accordance with the 
components of the Pharmaceutical Management Cycle to identify common themes and 
best practices towards the development of the framework for the provision of essential 
medicines for the district health services. The data collected were then transcribed from 
the transcripts made of digital recordings and notes that were collected. The data were 
then organised and analysed by means of an inductive model in order to ensure that the 
data that is relevant and related to a particular theme was grouped into appropriate and 
meaningful categories. Coding was then used to classify elements in text data into 
categories that were related to the study topic and useful for analysis (Schensul & Le 
Compte 2013:98). The data analysis process for this study was enhanced by referral to 
professional transcriber and coding specialist using the computer packages where 
indicated (Koshy et al 2011:128). 
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4.7 TRUSTWORTHINESS 
 
Trustworthiness is the extent to which the study can be regarded as reliable and produced 
credible findings. Lincoln and Guba (1985) in Creswell (2013:246) suggest that credibility, 
transferability, authenticity, and confirmability should be demonstrated in a qualitative 
study. The trustworthiness and validity of qualitative studies is concerned with the 
truthfulness of the data collected with special emphasis on conveying the insider view 
and providing a detailed account of how the people we are studying understand the 
phenomenon (Neuman 2011:214). 
 
Trustworthiness is the degree of confidence qualitative researchers have in their data 
assessing using the criteria of credibility, transferability, dependability, confirmability and 
authenticity (Polit & Beck 2014:323). Trustworthiness demonstrates the extent to which 
the study has the potential to produce credible findings and interpretation of the 
phenomenon under study. The test of trustworthiness can thus be described as whether 
or not the study investigates the proposed research questions.  
All the necessary precautions were taken to ensure trustworthiness through identification 
and selection of appropriate informants as well as conduct of the research site visits and 
interviews within the research sites. Furthermore, the design and refinement of the 
interview guide ensured that the research questions are addressed.  
 
The elements of credibility, confirmability, authenticity and transferability were promoted 
in the conduct of the study as discussed below:  
 
4.7.1 Credibility 
 
According to Lincoln and Guba (1985), credibility includes activities that increase the 
probability that credible findings will be produced. Credibility can also be enhanced by 
returning to the participants to assess whether they recognise the findings (Streubert & 
Carpenter 2011:48).  
 
The study was undertaken over time with approval from the university’s ethics committee 
and allowing for prolonged engagement with the participants in a familiar environment 
under the guidance of the supervisors who are seasoned, qualified, and experienced 
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researchers as mentors throughout the lifespan of research project. Cross checking of 
data with the participants ensured that what are reported are the views of the participants. 
Furthermore, the researcher underwent preparation in advanced research methodology 
as part of the studies for the Master’s Degree in Health Studies.  
 
4.7.2 Confirmability 
 
Confirmability is the extent to which the research findings can be verified or confirmed by 
another person (Marshall & Rossman 2011:253). Polit and Beck (2014:323) submit that 
for confirmability to be achieved, the findings must reflect the participants’ voice and the 
conditions of inquiry not the researcher’s biases, motivations or perspectives. 
Confirmability was achieved by keeping an audit trail, namely the written and audio 
records of information collected over time, to enable other researchers to verify the 
findings of the conducted research. A reference list could also be beneficial in facilitating 
the identification of reference material used in doing the research. For this study the audio 
and written notes and reference materials are available for verification purposes. 
 
4.7.3 Transferability  
 
According to Polit and Beck (2014:323), transferability is the extent to which the research 
finding can be applicable to other similar situations. Qualitative researchers as indicated 
in Lincoln and Guba 1985:316 promote transferability through provision of rich descriptive 
information about the context of the studies and leave the decision of transferability to 
those interested in making a transfer to reach a conclusion about whether transfer can 
be contemplated as a possibility.  
 
Streubert and Carpenter (2011:49) define transferability as the probability that the study 
findings have meaning to others in similar situations and submit that the transferability 
possibility rests with potential users of the findings and not the researchers.  
 
Transferability is the level to which the results can be generalised to the population. McNiff 
and Whitehead (2009:13) reported that action research is about improving knowledge 
about existing situations each of which is unique to the people in the situation therefore 
action research findings cannot be generalised or applied but shared with an aim that 
knowledge and learning would result from the knowledge creation and sharing.  
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For this study the quality, credibility, confirmability, and dependability of work produced 
will assist in determining transferability. Transferability will be determined by the readers 
of the research report and not by the researcher, as in this study the purpose is to develop 
the framework for provision of essential medicines based on the experiences and 
assessment of the pharmaceutical operations within seven of the nine provinces the 
transferability will be up to the countries reading the report. 
 
4.7.4 Authenticity  
 
Authenticity is the extent to which researchers fairly and faithfully show a range of different 
realities. In the research report authenticity was realised when the report conveys the 
feeling tone of participants’ lives as they are lived (Polit & Beck 2014:323). 
 
 
For this study authenticity was promoted through the presentation of the findings that 
reflected the expressions of the participants as they knew or experienced the provision of 
essential medicines in their own settings making their opinions known on what strategies 
could be used to further enhance the provision of essential medicines  
 
4.8 ETHICAL CONSIDERATIONS FOR THE RESEARCHER  
 
According to Barbie (2013:32), anyone involved in social research need to be aware what 
is proper or improper conduct of social inquiry (research) including informed consent, 
voluntary participation protection from harm and confidentiality. Therefore; it is important 
to guard against unethical behaviour which may have an adverse effect on the 
participants, and reflect poorly on the profession.  
 
In a clinical or health environment the researcher will come into contact with health 
professionals and their patients, possibly invading their work space, which is normally 
managed by authorities. Streubert and Carpenter (2011:60) present the following general 
ethical principles which the researcher should consider. The first is autonomy which has 
its roots in the categorical imperative and demands the researchers respect the rights, 
values and decisions of other people. The second is non maleficence which is the 
avoidance of intentional harm to respondents and beneficence, which stipulates that a 
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positive obligation to remove existing harm can be identified. Lastly, the principle of justice 
holds that people who are equal in relevant respects should be treated equally. The 
research conduct process should not cause harm to the participants and organisations, 
thereby supporting the principle of beneficence. 
 
For the conduct of action research there are three applicable ethical frameworks namely 
personal, research and the practice itself. Emphasis is placed on the respect for the 
individual’s autonomy, informed participation, protection from harm, data storage and 
utilisation (Townsend 2013:94). The researcher ensured compliance with principles of 
ethical research throughout the study period by implementing the measures required for 
conformance with the principles of autonomy, beneficence, justice and informed consent 
as explained below. 
 
4.8.1 Ethical clearance 
 
Ethical clearance for this study was obtained from the University of South Africa 
(Annexure A) and approval to conduct the study was obtained from the research 
committees of the eight Provincial Departments of Health (Annexure B) which is the 
permission letters from the provinces which were sites in which the research was 
conducted. 
 
4.8.2 Human rights and principles of justice  
 
Human rights include the right to self-determination, privacy, anonymity, and protection 
from harm. The principle of justice is concerned with fair treatment, right to privacy, and 
anonymity (Streubert & Carpenter 2011:65). 
 
4.8.3 Right to self-determination (autonomy)  
 
The prospective participants should have the opportunity to choose whether or not to 
participate in the study (De Vos, Strydom, Fouché & Delport 2011:116). It is accepted 
that as the researcher provides participants a choice to participate or not certain types 
would decline. For this study the potential respondents were not forced or coerced into 
being part of the research by being promised rewards, but did so with the full 
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understanding that their contribution might build knowledge for effective health services 
through improving essential medicine provisioning.  
 
The participants were informed of their right to withdraw at any time or reserve their 
comments and inputs without being penalised.  
 
4.8.4 Informed consent  
 
According to Polit and Beck (2014:87), informed consent require the researcher obtain 
the people voluntary participation enabling the power of free choice to decline or consent 
voluntarily in the study after informing them of potential benefits and risks. This is done to 
ensure that participants have adequate information regarding the research and are 
capable of comprehending the information. Grove et al (2013:177) indicate that the 
potential participants should be informed amongst the critical points about the research 
purpose, methods, risks and procedures, duration of the study and the manner in which 
the confidentiality and privacy will be ensured.  
 
For this study, the reasons, benefits, impact, and content of the research, as well as the 
criteria for being chosen were provided to the potential participants prior to commencing 
the study. This enabled the participants to decide whether or not to take part in the 
research. All participants in this study were above the consenting age of 18 years and 
have basic understanding of the research. The participants also received written requests 
to voluntarily participate in the research and signed a voluntary consent form for 
participation in the study on acceptance (Annexure D). 
 
4.8.5 Privacy and confidentiality 
 
Researchers need to consider and provide clear strategies to protect the participants’ 
privacy and keep the information provided confidential as far as possible (Guest & Namey 
2015:76). The participants’ names and personal identifying information will not be used 
in the records. Instead symbols will be used as codes and personal details will only be 
accessed by the researcher and the supervisors. Should personal information be 
necessary for reporting purposes the permission of the affected participant will be sought. 
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4.8.6 Respect 
 
The participants were not judged for their responses or experiences. All inputs were 
regarded as valuable; contributing to realising the purpose of the research. 
 
4.8.7 Rights of the institution  
 
The institutional routine and integrity should be respected during the research process 
(Creswell 2013:58). Integrity was maintained during the conduct of the study through 
proper arrangements for conducting the research site visits and interviews such that there 
was no interference with the participants’ routine and the supervisor’s permission was 
sought. 
 
4.8.8 Permission to conduct research  
 
Ethical clearance for this study was obtained from the University of South Africa and 
applications to the research committees of the nine provinces were submitted indicating 
the duration and nature of research to be conducted and was approved in writing by eight 
of the nine provinces prior to the commencement of the research. 
 
4.8.9 Confidentiality 
 
A research project guarantees the confidentiality when the researcher can identify a given 
person response but pledges not to divulge the personal details publicly (Barbie 2013:36).  
 
In this study there was no direct mention of the facilities or names of any member of the 
health care facilities management in order to maintain the integrity, privacy, and image of 
the district facilities involved. 
 
4.8.10 Integrity 
 
The institutional routine and integrity should be respected during the research process 
(Creswell 2013:58). Integrity will be maintained during the conduct of the study through 
proper arrangements for conducting the research interviews, such as that there was no 
interference with the participants’ routine.  
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4.9 SCIENTIFIC HONESTY OF THE RESEARCHER   
 
While conducting the study the researcher should not falsify authorship, evidence, data, 
findings, or conclusions, and should neither plagiarise nor disclose information that will 
harm the participants (Creswell 2013:59). 
 
The researcher submits that the following was complied with during the research process: 
 
 Accurate recording and reporting of study findings. 
 Reporting only the truth without distorting the acquired information to meet the 
needs and beliefs of the researcher. 
 Acknowledged all sources ideas and processes and words used or obtained from 
other authors’ work. 
 Utilised the tested means in obtaining data and conducting the research. 
 Did not coerce or manipulate participants into taking part in the research. 
 
4.10 ENSURING RIGOR OF ACTION RESEARCH DATA  
 
Action Research is assessed for rigor meaning criteria for the quality of research through 
the following validity criterions including dialogue, democracy, outcome, catalytic and 
process components as explained below based on Herr and Anderson (2015:67-72). 
 
Dialogue validity  
 
This element require that action research is conducted in a collaborative approach to 
ensure that the research findings resonate or make sense to the community of the 
practice being studied.  
 
Democratic validity  
 
The generation of new knowledge should demonstrate that the process was democratic 
and dialogue in nature enabling both the researcher and the community to engage in the 
execution of the research project action research will be conducted as a collaborative 
inquiry resulting.  
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Outcome validity  
 
The research outcomes should be action oriented demonstrating that there were activities 
aimed at improving practice or the problem that led to the study.  
 
Catalytic validity  
 
The researcher and the participants must have learned something through being 
engaged in the research project, parties involved should experience reorientation of their 
reality and moved to some action to change the environment for better practice. 
Participants can keep a journal to record their experiences of growth during the project.  
 
Process validity  
 
Process validity will be ensured through triangulation of data, site visits, interview and 
document analysis use of multiple methods to confirm your research findings thus 
ensuring that research is not only based on one kind of data source. 
 
As mentioned in the preceding pages all the necessary precautions and steps were 
implemented to ensure collaboration and methodology compliance and emphasis made 
for the improvement to be realised as well as collaboration in the execution of this study 
as action research project. 
 
4.11 SIGNIFICANCE OF THE STUDY  
 
 Medicines are the second highest cost driver after the cost of employees in terms of 
budget allocation and expenditure. There is also high wastage of medicines due to poor 
stock management and expiry in the health facilities which would encourage prioritisation 
of improvement strategies and introduction of better mechanisms to manage medicine 
supply (MSH 2012:1.3).  
 
Matsoso et al (2015:198) reported that many reports have alluded to the ineffectiveness 
of medicine depots in ensuring that essential medicines reach the facilities in time and in 
the required quantities. As such it has become imperative that attention be focused on 
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key issues including that of provisioning of essential medicines. The results of the 
National Core Standards assessment conducted in South Africa in the year 2011 reflected 
that all primary health clinics and community health centres were unable to meet the 
compliance requirements including the availability of essential medicines and supplies. 
 
The study will therefore contribute towards design of the framework for the provision of 
essential medicines within the Republic of South Africa District Health Services with the 
intention of improving the overall availability of medicine in the various provinces which 
would in turn promote access to much needed treatment for the prevailing diseases 
affecting the population. 
 
4.12 SCOPE AND LIMITATIONS  
 
The study focused on the district health services which is the first level of care in the 
health system targeting mainly the provision of essential medicines as per the National 
Department of Health lists as issued in the National Core Standards as such the resultant 
framework will be limited to the first level of care  
 
4.13 CONCLUSION  
 
Conducting a study towards development of the framework for provision of essential 
medicines for the country contributed towards improved access to treatment and care of 
the population and a long healthy life for the community. 
 
The next chapter will present the data collection and findings from the provincial site visits 
and interviews. 
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CHAPTER 5  
 
DATA ANALYSIS, PRESENTATION, DESCRIPTION OF THE 
RESEARCH FINDINGS AND EFFECTS OF THE ACTION AREAS  
 
5.1 INTRODUCTION  
 
The research objectives for this study were:  
 
 Explore and describe the different provinces approach in the provision of essential 
medicines. 
 Make recommendations on a corrective measure to be implemented in order to 
improve the availability of medicine in the various provinces.  
 Formulate a framework for the provision of essential medicines for the district 
health services.  
 Identify best practices to be incorporated into the framework for the provision of 
essential medicines for the district health services.  
 
The findings for this action research study were based on the site visits and interaction 
with the participants identified through purposeful sampling.  
 
According to Savin-Baden and Major (2013:252), action research involve the following 
phases which were executed to arrive at the data presented below:  
 
1. Working collaboratively with practitioners to improve practice  
2. Identifying concerns and themes related to phenomenon under study  
3. Prioritisation and identification of thematic concerns related to practice  
4. Developing an action plan to improve practice  
5. Observe the effects of action  
6. Finally reflection on and evaluation of the improvement action effects 
 
The data were collected through site visits to the seven provinces and telephonic 
interviews for one province due to participants’ request for their organisation privacy rules 
purposes. 
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5.2 DATA MANAGEMENT AND ANALYSIS  
 
De Vos et al (2011:333) define data analysis as the process of bringing order, structure, 
and meaning to the mass of collected data. It is aimed at searching for general statements 
about relationships among the categories of data. Data analysis involves organising the 
data, conducting a preliminary reading through of the database, coding and organising 
themes, representing the data, and forming of an interpretation thereof. These steps are 
interconnected and form a spiral of activities all related to the analysis and representation 
of the data (Creswell 2013:179).  
 
The data for this study were recorded in writing using the interview guide (Annexure D) 
and also audio recorded for reference and audit trail purposes (Annexure C). The 
collected information was then analysed and categorised using open coding to arrive at 
the themes in order to identify common trends as well as unique best practices from the 
various contexts. The process followed in this research data analysis and presentation 
mirrors the steps for qualitative research data analysis and open coding namely: 
managing or organising the data, reading and writing memos, generating categories, 
themes and patterns, coding the data, testing the emergent understandings, searching 
for alternative explanations and representing the collected data in a report format (De Vos 
et al 2011:334). The qualitative data analysis facilitates non-numerical examination and 
interpretation of observations for the purpose of discovering underlying meanings and 
patterns of relationships (Barbie 2013:390). 
 
Data analysis for this study utilised the spiral model as proposed by Creswell (2013:182-
188) as follows. 
 
5.2.1 Data organisation 
 
The data were audio recorded and then transcribed to produce a mind map and narrative 
written data. 
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5.2.2 Reading and memoing 
 
The transcribed data were read comprehensively to make sense of the collected facts 
before clustering the data in line with the research questions and the emergent themes.  
 
5.2.3 Description, classifying and Interpretation into codes and themes 
 
During this process the researcher compiled detailed descriptions of the experiences of 
the informants, highlighting the emerging themes and contrasting the collected data with 
the current literature and the researchers’ experience and views. The outcome was 
coding, which entails the clustering of data into small categories of information and 
labelling it. Barbie (2013:402) defines coding as the classification of individual pieces of 
data. Coding can be categorised into three classes, namely the initial classification and 
labelling of concepts, axial reanalysis of the results of open coding, and selective coding 
which seeks to identify the central code in the study. The data were then labelled into 
general themes, which are broad units of information that consist of several codes 
aggregated to form a common idea. 
 
5.2.4 Data interpretation  
 
Based on the developed codes and themes the researcher made sense of data through 
interpretation, reflecting and contrasting the findings with the current literature available. 
 
5.2.5 Data representation  
 
The data were then presented in a clustered theme approach reflecting the findings and 
identifying trends and practices affecting medicine provisioning. The collected information 
was then shared with the informants for validation as a true reflection of the discussions 
held. 
 
5.2.6 List of themes identified 
 
The following themes were identified and will be discussed further in this chapter:   
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Essential medicines concept standardisation, role of the pharmacist in relation to the 
district health services scope, key processes involved in medicine provisioning, selection, 
procurement, rational medicine use, distribution, legal framework, management support, 
role of the National Department of Health, key strategies used in provisioning, special 
considerations, existing framework. 
 
These themes will be discussed in the light of the participants expressed views and 
highlight the action areas requiring interventions to improve the provisioning of essential 
medicines.  
 
5.3 DESCRIPTIVE STUDY POPULATION DATA  
 
The study population comprised of the managers responsible for pharmaceutical services 
and medical depots across various provinces. The request for participation was emailed 
to all prospective participants followed up with a telephone call. Eight of the nine provinces 
in South Africa responded and accepted to participate in the study. The data was 
collected using the interview guide and coupled with audio recordings.  One province did 
not respond despite numerous follow ups and emails requesting their participation on the 
study.  
 
5.3.1 Participants professional profile  
 
There were fourteen participants for this study, all of them were qualified Pharmacists 
nine were operating within a medical depot setting which is responsible for procurement, 
warehousing and distribution components and the remaining five were from the 
directorates of pharmaceutical services which are generally responsible for overall  
administration of the medicine supply management chain from the depots right to the 
primary health facilities  as the provision of medicines is generally managed by persons 
trained as pharmacists as per profiles detailed below: 
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Table 5.1: Participants’ professional profile 
 
RESEARCH 
SITE  
POSITION  QUALIFICATIONS RELEVANT 
WORK 
EXPERIENCE 
DISTRICT HEALTH 
EXPERIENCE 
A 1 Depot Manager  B. Pharm 18 6 
A2   Depot Responsible 
Pharmacist  
B. Pharm 20 8 
B1  Head of 
Pharmaceutical 
Services 
B. Pharm 19 13 
B2 Depot Manager  B. Pharm 25 6 
C 1  Head of 
Pharmaceutical 
Services 
B. Pharm 14 6 
C2 Depot Manager  B. Pharm 21 7 
D1  Pharmacy Policy 
Specialist  
B. Pharm 02 02 
D2 Depot Manager  B. Pharm 11 05 
E1  Head of 
Pharmaceutical 
Services 
B. Pharm 30 6 
E2 Depot Manager  B. Pharm MBA 24 12 
F1 Depot Manager  B. Pharm 16 12 
G1 Head of 
Pharmaceutical 
Services 
B. Pharm 15 8 
G2 Depot Manager  B. Pharm 11 8 
I2  Depot Manager  B. Pharm 10 6 
 
5.4 PRESENTATION OF FINDINGS AND ACTION AREAS  
 
The findings are presented below in a theme approach highlighting the common and best 
practices identifies in each province. The theme findings were then analysed for action 
areas to be addresses and considered in the development of the framework.  
 
5.4.1 Different understanding of the essential medicine concept 
 
WHO 2011a (2) define essential medicines are defined as those therapeutic substances 
used in the diagnosis, treatment, mitigation, and modification of the majority of the 
diseases affecting the population.  
 
Participants defined the concept of essential medicines utilising their own situation and 
interpretation of the concept based on WHO definition as depicted below: 
  
 
 
 
Table 5.2: Essential medicines concept 
 
SITE A   SITE B   SITE C  SITE D  SITE E   SITE F   SITE G  SITE I  
The basic 
medicine 
necessary in 
the clinics, 
CHC and 
hospitals.  
The list of 
medications 
that will 
address the 
most common 
prevalent 
diseases 
affecting the 
population of 
South Africa. 
 
 
Those 
medicines that 
cover the 
majority of the 
populations of 
South Africa 
and majority 
of diseases 
and those 
have been 
agreed upon 
by National.  
The medicine 
that is used for 
the majority of 
patients for 
the majority 
illness.  
Understood as 
defined by 
World Health 
Organization 
Medicines that 
should be 
available at all 
times required 
to treat majority 
of prevalent 
diseases.  
Medicine that 
treat the 
majority of the 
diseases 
condition for 
the defined 
population.  
Essential medicine 
is the medication 
that must be 
available at all 
times for the 
maintain and also 
prevent any 
disease of patients.  
Essential 
medicines, are 
medicines that you 
can’t do without, 
that you need to 
have available 
optimally at facility 
level for patients.  
 
 
9
4
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5.4.1.1 Aggregate participants understanding of the concept essential medicines  
 
The participants from all sites explained the concept essential medicines in their own 
understanding however appreciated the general definition as defined by the WHO 
indicating a common base for the undertaking of work processes towards the provisioning 
of essential medicines. Essential medicine were defined from the participants view as “ 
those medicines that covers the majority of the populations of South Africa and covers 
majority of diseases and those have been agreed upon by the National EML Committee 
and classified as such, One participant further simplified the definition of essential 
medicines as following: 
 
“Basic medicines necessary in the clinics, Community Health Centres and 
Hospitals to treat basic ailments and should be on national tenders to ensure 
continuous availability”. 
 
During the discussions all participants agreed there is no formally accepted standard to 
measure against the availability at all times of the essential medicines in South Africa. 
Not all provinces had indicators for measurement of medicine availability and provisioning 
provinces differed in the indicator values between 95 and 100 percent targets.  
 
5.4.1.1.1 Thematic action point on essential medicine concept  
 
There is a need of a nationally agreed standard against which to measure the availability 
of essential medicines as all times is not achievable across all provinces as evidenced by 
reported stock outs within the health facilities. There was unanimous recommendation for 
the National Department of Health to set benchmark against which all provinces would 
be assessed on the extent of acceptable provisioning and availability of essential 
medicines.  
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5.4.2 Different understanding of the role of the pharmacist in relation to the district 
health service scope 
 
According to NDoH (2013:12), WHO has recognised the District Health System as the 
best vehicle for the implementation of primary health care and defined it in the following 
way “A district health system based on primary care is a more or less self-contained 
segment of the national health system. It comprises first and foremost a well-defined 
population living within a clearly delineated administrative and geographical area. It 
includes all the relevant health care activities in the area whether governmental or 
otherwise It therefore consist of a large variety of interrelated elements that contribute to 
health in homes, schools, workplaces, communities, the health sector and related social 
and economic sectors. It includes self-care and all health care personnel and facilities 
whether government or non-governmental up to and including the hospital at the first 
referral level and the appropriate support services such as diagnostic, laboratory and 
logistic support. It will be most effective if coordinated by an appropriately trained health 
officer working to ensure as comprehensive a range as possible of promotive, preventive, 
curative and rehabilitative health activities. 
 
The participants had an operational understanding of the district health system 
highlighting the components of the health care environment in which the frontline service 
delivery is offered by mostly the professional health care provider as depicted above. The 
participants identified their perceived role in relation to the district health services in the 
following manner.  
  
 
Table 5.3: Participants’ role within the District Health Services 
 
SITE A  SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I 
I am 
responsible for 
the supply of 
medicine to all 
PHC, CHC and 
hospital in the 
Western 
region. 
 
  
I am 
responsible for 
development of 
policies for 
medicine use. 
And putting up 
systems for 
monitoring 
medicine 
availability in 
the districts to 
ensure that the 
pipeline in 
terms of 
availability at 
depot level and 
also the 
distribution of 
medication 
from the depot 
to the facility 
level. 
My 
responsibility 
is to ensure 
the 
availability of 
medicines 
within the 
province and 
the depot in 
particular. 
We provide 
medicine to the 
whole province 
up until C we 
deliver directly 
to them and they 
order directly 
from us the 
availability of 
medicines lies 
with me to 
ensure we’ve 
got stock what I 
do is update the 
formulary, the 
provincial 
formulary and 
circulate that to 
facilities. 
I am 
responsible for 
procurement, 
Warehousing 
and distribute 
medicines to 
Hospitals and 
Community 
Health centres. 
I have to 
ensure 
consistent 
supply of 
essential 
medicines 
through 
implementation 
of efficient 
pharmaceutical 
procurement 
and 
distribution 
systems. 
My role is 
overall 
management. 
I’m managing 
all the 
activities that 
include the 
procurement, 
distribution 
and 
development. 
As a manager, 
I have to look 
at all facets of 
provision of 
medicines 
starting from 
the budget, 
demand clinic 
and then 
procurement. 
My role is to ensure 
optimal medicine 
availability to all our 
facilities in the 
province.  That 
includes the finance 
aspects, it includes the 
procurement, it 
includes distribution, 
and the support. 
 
9
7
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5.4.2.1 Aggregate interpretation of the role of the participants within the district 
health system  
 
During the discussions the district health system was understood to be limited to the 
district health facilities not inclusive of regional, tertiary and central hospitals. All 
participants whether located within urban or rural setting understood or mentioned the 
mobile clinic as a standing component of the district health system. The unique finding 
was in one province in which the district health services concept was extended to include 
a health post which is a location within the community which is generally manned by local 
volunteers remotely supported by the primary health clinic within the catchment area. 
 
The pharmacists saw their role as cutting across “primarily district hospitals, community 
health centres, and clinics.  So where there is a need identified by patients attending 
those institutions, that need is then consolidated into an order, an order for medication, 
and that order for medication is then presented to the depot for picking, packing, and 
delivery.  So that’s where my role primarily comes in to ensure that the pipeline in terms 
of availability at depot level and also the distribution of medication from the depot to the 
facility level happens within a timeframe so that the five Rs are met: right quantity, right 
place, right time, and all the right.  So that’s a big part of my role and I play an additional 
role also in terms of procurement from suppliers where we’ve got a procurement unit at 
the depot, we’ll then procure medicines on contract or sometimes on quotation basis to 
fill up the pipeline of available medicines at the depot. Obviously, as responsible 
pharmacist, I have to authorise all those purchases to ensure that the amounts being 
ordered are not excessive and also not too little so that we can maximise availability.”  
 
5.4.2.2 Thematic action point on the understanding of pharmacist role within a 
district health services scope 
 
There is a need to develop clear key result areas and job descriptions for standardised 
functioning and role of the pharmacists within the district health system to maximise their 
role and contribution towards improved provisioning of medicines within the district health 
system. 
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5.4.3 Common understanding of the key processes in medicine provisioning 
 
According to MSH (2012:1.10), pharmaceutical management framework comprises four 
basic functions: selection, procurement, distribution, and use. Selection involves 
reviewing the prevalent health problems, identifying treatments of choice, choosing 
individual medicines and dosage forms and deciding which medicines will be available at 
each level of the health system. Procurement Includes quantifying medicine 
requirements, selecting procurement methods, managing tenders, establishing contract 
terms, and ensuring pharmaceutical quality adherence to contract terms. Distribution 
includes clearing customs, stock control, store management, and delivery to depots, 
pharmacies, and health facilities. Use includes diagnosing, prescribing, dispensing, and 
proper consumption by the patient. In the pharmaceutical management cycle, each major 
function builds on the previous function and leads logically to the next. Selection should 
be based on actual experience with health needs and medicine use; procurement 
requirements follow from selection decisions, and so forth.  
 
At the centre of the pharmaceutical management cycle is the core of related management 
support systems, including the planning and organisation of services, financing and 
financial management, information management, and human resource management: The 
participants understanding was in line with the framework for pharmaceutical 
management.  
  
 
 
Table 5.4: Key processes involved in medicine supply 
 
SITE A  SITE B  SITE C   SITE D  SITE E  SITE F  SITE G  SITE I 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework and 
Management 
Support in line 
with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework and 
Management 
Support in line 
with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework and 
Management 
Support in line 
with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework and 
Management 
Support in line 
with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework and 
Management 
Support in line 
with the 
Medicine Supply 
Framework 
 
 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework 
and 
Management 
Support in line 
with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, 
Rational Use, 
Legal 
Framework 
and 
Management 
Support in 
line with the 
Medicine 
Supply 
Framework 
Selection, 
Procurement, 
Distribution, Rational 
Use, Legal 
Framework and 
Management Support 
in line with the 
Medicine Supply 
Framework 
 
1
0
0
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5.4.3.1 Aggregate Interpretation of the participants understanding of key 
processes involved in the provisioning of essential medicines  
 
All participants supported the concept that the above processes are all essential in the 
provision of essential medicines and highlighted that these should occur in a cyclical 
approach with no separation of functions to avoid interruption and resultant medicine 
stock outs the Pharmaceutical Supply Framework as developed by Management Science 
for Health with the above component was unanimously accepted as the basis for the 
provisioning of medicines in South Africa. The understanding from all participants was 
that all the processes are essential to ensure consistent medicine supply and 
provisioning.  
 
The majority view was that poor performance and non-execution of one or more process 
would result in inadequacy of medicine supply and provisioning which would be 
experienced as stock outs within health facilities. Across provinces, the key processes 
were found to be implemented differently with one province services outsourced and 
managed by a non-governmental organisation and other deport either operating a trading 
account billing facilities for the services and medicines issued or issue medicines as 
required for the services without taking into account whether the facility can afford or has 
budget for the delivery of medicines.  
 
5.4.3.2 Thematic action point on the key processes involved in medicine 
provisioning  
 
The required action is to ensure that any framework developed should encompass all key 
processes required for effective medicine supply management.  
 
5.4.4 Varied approach in selection of essential medicines  
 
The selection of the medicines depends on many factors including the prevalent diseases, 
treatment facilities, training and experience of the available personnel, financial 
resources, and population genetic demographic and environmental factors. The outcome 
of selection component is the essential medicines lists (EMLs) which support the 
systematic delivery of medicines in the health-care system (MSH 2012:16.2). 
  
 
 
Table 5.5: Selection processes 
 
SITE A  SITE B   SITE C   SITE D  SITE E  SITE F  SITE G  SITE I 
All essential 
drugs must 
be on 
national 
tenders. 
We have a 
provincial 
PTC, the 
base 
document we 
work from will 
be your 
essential 
drugs list or 
essential 
medicine 
encourage 
facilities to 
have PTCs, 
they 
encourage 
district PTCs 
to use EML 
as a guide. 
Based on the 
guidelines for 
our PTC where 
there is a 
process. 
 
 
 
PTC approves 
all medicines 
The NPC of 
National 
catalogue, we 
use that and 
then…then if 
the PPTC 
agrees on 
those 
motivations, 
then we will 
add it. 
Essential 
Medicine Lists 
and 
Pharmaceutical 
Therapeutic 
Committee. 
Essential 
Medicine Lists 
and 
Pharmaceutical 
Therapeutic 
Committee. 
Selection is 
done by 
provincial 
PTC  
Essential 
Medicine Lists 
and 
Pharmaceutical 
Therapeutic 
Committee. 
 
 
1
0
2
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5.4.4.1 State of functionality of the PTC as governance structure for selection of 
essential medicines  
 
All provinces indicated utilisation of national essential medicine lists and pharmaceutical 
therapeutic committees as mechanisms for facilitating selection of medicines for use in 
that particular province taking into account the affordability and efficacy of the medicines 
All provinces reported existence of provincial governance committee for medicines 
pharmaceutical therapeutics committee which is responsible for the approval of a list of 
medicines to be used in the particular provinces with pharmaceutical services units 
providing technical support . 
 
One participant put it: 
 
“The process in terms of the selection is based on the guidelines for our PTC where 
there is a process in terms of how do we select a particular drug that should be, 
where there is a process that outlines that it must start from downwards upwards. 
So at district level they will have their district PTC and such as items are they want 
them to be put onto the EML and then forward them to the provincial PTC. Then 
they are discussed at that level. Once the item is approved by the provincial PTC 
it’s escalated to the National EML committee where it is going to be discussed 
based on evidence.” 
 
However, three of the seven provinces indicated that pharmacists are also responsible to 
preside over the PTC meetings due to clinicians’ lack of interest or non-availability to take 
a lead in the governance function. This practice is not supported as non-active 
participation of clinicians contribute to irrational medicine use and poor prescribing 
patterns. Further at least half of the provinces indicated limited or non-existence of district 
and institutional PTCs to execute an oversight role within the health facilities thus 
promoting upward inputs into the systems and processes of medicine selection.  
 
5.4.4.2 Thematic action point on selection of essential medicines  
 
There must be mechanism and systems to ensure that the pharmaceutical and 
therapeutic committees are functional and chaired by clinicians at all times to ensure that 
selection of medicines address the needs of the communities. Clear terms of reference 
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should be available to guide provinces on how to formulate and sustain functionality of 
the PTCs.  
 
5.4.5 National contracts − procurement of essential medicine  
 
The process of purchasing supplies utilises national, multinational, private or public 
suppliers, global agencies depending on availability and costs Purchasing through global 
agencies require that mechanisms are put in place to ensure that the quality assurance 
and control requirements are met to protect the service users and countries through 
procurement planning, purchasing inventory control traffic, receiving, incoming inspection 
and salvage operations (MSH 2012:18.6). 
 
  
 
 
 
Table 5.6: Procurement processes 
 
 
SITE A  SITE B  SITE C  SITE D  SITE E SITE F  SITE G  SITE I  
National 
Contracts and 
use quotations 
for those items 
not on contract. 
There will be 
those who are on 
contract and then 
those who are on 
our non-awards 
where there is no 
contract…we will 
procure through 
the tendering 
process. We’ve 
strengthened 
DDVs. 
There are 
different 
procurement 
models that 
we are 
using. 
District 
hospitals 
they order 
directly from 
us. 
National 
Contracts 
and use 
quotations for 
those items 
not on 
contract. 
Depot 
procures from 
pharmaceutical 
companies on 
behalf of 
hospitals and 
CHC. The 
hospitals in 
turn supplies 
the clinics.  
National 
Contracts and 
use quotations 
for those items 
not on 
contract. 
 
Hospitals on 
using direct 
deliveries and 
depot to 
source 
medicines. 
We are using 
national contracts. 
We don’t have 
provincial 
contracts for 
those items not on 
tender we buy 
them on 
quotation. 
National Contracts 
and use quotations 
for those items not 
on contract. 
 
 
 
 
 
1
0
5
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5.4.5.1 Impact of national contract procurement of essential medicines  
 
Based on the interaction there was no single province that was solely dependent on the 
national contracts as not all items contracts were successfully concluded due to variety 
of reason including supplier capacity and uncompetitive prices and tender submissions. 
One participant explained: 
 
“Then there will be those items that are on contract and then those who are on our 
non-awards where there’s no contract. So with the ones on contract obviously we’ll 
procure through the tendering process. We’ve strengthened direct delivery 
approach as well to improve procurement’’. 
 
There was one unique situation of an outsourced depot: 
 
“When it comes to procurement, we procure what is on essential medicine list. We 
don’t procure anything outside the EML, we have a contracted service provider for 
all the district hospitals and clinics, but larger hospitals procure directly according 
to their SOP from the depot. So we have one depot that is centralised managed by 
a contracted service provider which manages the procurement, the warehousing 
and the distribution”. 
 
All procurement for medicines was done through national tenders and dependent on 
tenders being available and in case of suppliers failing to deliver provinces implemented 
buy outs with the approval of the national department to ensure continuous stock 
availability. Procurement through the national contract promote cost-effectiveness 
through bulk purchases and price negotiations. Provinces are implementing supply chain 
reforms of direct delivery of medicines to health facilities rather than medicine stock being 
delivered via the depot first before being delivered to health facilities as an attempt to 
reduce delays and effective utilisation of space within the depot warehouse. One 
participant stated that: 
 
“There will be those who are on contract and then those who are on our non-
awards where there is no contract, we will procure through the tendering process. 
We have strengthened direct deliveries.” 
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5.4.5.2 Thematic action point on procurement  
 
The procurement processes of medicines should allow for direct delivery to hospitals and 
community health centres to allow the depots to focus and improve procurement and 
supply turnaround times for the primary health clinics thus increasing the medicine 
availability at the lowest level.  
 
5.4.6 Different modes for distribution of essential medicines  
 
Distribution is meant to ensure a consistent of medicines and supplies to the facilities 
where they are needed whilst ensuring that resources are used in the most effective 
manner. Distribution system or framework has four elements which are system, 
information, storage and delivery elements (MSH 2012:22.2). 
  
 
Table 5.7: Distribution options 
 
 
SITE A  SITE B  SITE C   SITE D  SITE E  SITE F  SITE G  SITE I 
Outsourced 
from depot 
to the PHC. 
Distribution is 
still 
outsourced. 
We have a 
predefined 
ordering and 
delivery 
schedule. The 
only one 
exception is 
we have 
Central 
Dispensing 
Unit.  They 
then sub-
distribute to 
different 
clinics. 
 
Outsourced from 
depot to the 
District Sub Depot 
and hospital level. 
 
Districts have their 
own vehicles for 
distribution. 
In sourced. 
 
 
Distribution from 
depot to the 
hospitals and 
from hospitals to 
clinics is 
outsourced. 
Mixed approach 
Hospitals, CHCs and 
larger PHC clinics on 
direct delivery using 
an outsourced service 
with a limited number 
of clinics receive their 
orders via the hospital 
pharmaceutical stores 
using facilities state 
pool vehicles. 
Outsourced 
from depot 
to the District 
Depots. 
Outsourced 
from Depot to 
PHC facility and 
Sub Depot for 
one Sub-
district.  
1
0
8
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5.4.6.1 Different approach in the distribution of medicines  
 
Distribution approach varied in all provinces with medicine stock being ordered and 
received by the depots in large quantities and dismantled and packed in accordance with 
health facilities orders. Only two provinces distributed directly from the depot to the 
primary health clinics.  
 
The remaining provinces distributed to the hospitals and district depots which in turn 
distributed to their catchment clinics. The practice of multiple points of medicine stock 
delivery rather than directly to the health facilities requiring the stock has an impact on 
the stock turnaround times and creates an opportunity for medicine stock loss in transit. 
Further the distribution contract was based on varied specifications for all provinces with 
the five provinces being unable to confirm whether the medicines being distributed is 
protected from high temperature and sealed vehicles whilst in transit. 
 
The participants presented the following arguments for outsourced distribution versus 
insourced distribution: 
 
“Distribution from here we use a courier, a contracted-out courier. The main reason 
for that is because we reduce the risk and that’s the first reason and the second 
reason is we actually hand over risk on our premises to our courier and then they 
are responsible for the transport to the facility. The private is reliable distribution 
with efficient distribution. So if I was going to take internal distribution currently with 
our government then what is happening with their vehicles as they are not serviced 
regularly, they can stop on the road and you cannot have that with medicines. So 
you’ve got the motivation factors that you can outsource.” There was also some 
acceptance for an internal distribution service as explained by one participant 
“We’ve got the closed vans with fridge compartments in it. So it’s cooled. It’s got 
the air-conditioning system in it.”  
 
5.4.6.2 Thematic action point on distribution  
 
The distribution of medicines should be direct to health facilities instead of being from the 
depots to the hospitals or district warehouses before being sent to primary health Clinic 
to ensure timeous availability at the health facility level. There also should be standard 
1
0
7
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distribution contract specifications across provinces to ensure preservation of medicine 
quality and timeous delivery to the health facilities. 
 
5.4.7 Rational use of essential medicine  
 
According to WHO (2016:1), the rational use of drugs requires that patients receive 
medications appropriate to their clinical needs, in doses that meet their own individual 
requirements, for an adequate period of time, and at the lowest cost to them and their 
community. 
 
There are mechanisms and strategies to promote rational medicine use (MSH 2012:27.5) 
including the following:  
 
 There must be a national multi-disciplinary structure to coordinate medicine use 
policies to serve as advisory structure as well as monitor the medicine use 
practices to promote rational medicine use. 
 There must be standard treatment guidelines developed and implemented to 
ensure that the prescribers are guided to make sound and cost effective decision 
with regard to specific conditions. 
 Clear mechanism for developing and revising essential medicine lists based on 
the treatment of choice. 
 Establishment of pharmaceutical therapeutic committees in the districts and 
hospitals with clear responsibilities for promoting and monitoring rational use of 
medicines. 
 Use problem based training in pharmacy therapy based on national standard 
treatment guidelines starting with the undergraduate levels. 
 Mandatory continuous professional development for all health professionals 
licensing requirements to include rational medicine use content.  
 Develop mechanisms to regulate prescribing patterns in the private sector through 
regulation and collaboration with professional societies.  
 Supportive rather than punitive supervision, monitoring and evaluation 
mechanisms including prescription audit and feedback, peer reviews and 
professional syndicate groups engaging in self-identification of medicine problems 
and solutions in a group should promote rational medicine use.  
 
  
 
Table 5.8: Rational medicine use 
 
SITE A  SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I  
Limited to PTC 
meetings and 
Demander 
forums. 
We are 
monitoring 
through the 
ABC 
analysis. 
 
The 
screening 
of the 
demand is 
something 
that needs 
to happen 
at district 
level 
because 
this has 
been the 
practice at 
the depot. 
District 
Pharmacist 
responsible 
for the 
function. 
The district 
pharmacists 
control the 
min/max of 
facilities depot 
side also 
min/max, on 
our provincial 
PTC is the 
ABC analysis 
that we point 
out if there’s 
any irrational 
use. 
 
Promoted 
through 
capacity 
building in 
PTC sessions. 
 
Medicine 
Supply 
training for 
users done 
by District 
Pharmacists.  
Promote 
compliance to 
National Standard 
Treatment 
Guidelines 
through 
provincially 
planned trainings 
and support.  
Through PTC 
because it is 
the PTC that 
must ensure 
compliance to 
rational use 
PTC serve as 
a gate keeper 
and use of 
motivation for 
off code 
items. 
Promoted through PTC and 
Demand Management Gate 
keeping on unusual order 
quantities and Items. There 
is also weekly stock 
management meeting with 
pharmacists from Districts 
and Hospitals to promote 
rational ordering and 
medicine use. 1
1
1
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5.4.7.1 Different approach for promotion of rational medicine Use  
 
As can be seen above there was varied approach to rational medicine use capacity 
building in some instances the pharmaceutical services units took responsibility for 
rational medicine use.  
 
“We pharmaceutical services really does that and we’ve got a dedicated person 
who’s the driver of that they have workshops, they have training sessions, they 
have all sorts of activities that they do to promote rational medicine use and the 
engagement with the PPTC is very close as well.”  
 
In the majority of provinces, however, lack of capacity was sighted as a reason for 
inconsistent rational medicine use capacity building interventions. There are no people, 
nobody covers that aspect.  
 
“It is purely done by pharmaceutical services to offer support to those clinics to 
make sure that every clinic has got the correct stuff here, in terms of making sure 
that orders are done on time and done correctly and in the right quantities.”  
 
Leave the district hospital out of it, because the responsible pharmacists at a district 
hospital does not see the need to be managed by district pharmacists. 
 
“Also with us, because provincially there’s only me and the other person that is 
working with me is doing traditional medicine meaning that I’m alone in the whole 
province at the provincial level and then the other one is strictly doing cold chain, 
it’s not under our section also, and then there’s one for pharmacovigilance also 
under ARVs. So it means that I am alone for all those things and the depot’s also 
working with minimal staff as we are all experiencing staff shortage but we are 
expected to provide all the services that are requested”. 
 
5.4.7.2 Thematic action point on the rational medicine use  
 
All participants reported limited capacity building for rational medicine use. This area 
require improvement through development of provincial and district training schedules 
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and programmes targeting the health professionals in order to promote cost effective and 
efficient medicine provision and availability.  
 
5.4.8 Existing legal framework 
 
The National Drug Policy for South Africa was approved in 1996 to strengthen provision 
of medicines in the country and emphasised that the legal framework has to provide for 
establishment of the regulatory bodies with the functions of defining role of various 
parties, licensing, inspection and quality control, pharmaco vigilance – monitoring and 
management of adverse medicine reactions, advertisement and promotions, sanctions 
(South Africa 1996:6-7).In later developments Makhado (2014:13) reported that the 
medicine policy has to consist of the following components: Legislation and Regulations 
inclusive of country medicine control acts, establishment of statutory bodies, licensing 
procedures for medicines and practitioners, medicine quality control, quality assurance 
and trade regulations. 
 
The participants highlighted the following as the current legal framework under which 
provision of essential medicine within the health system: 
 
  
 
Table 5.9: Legal framework 
 
SITE A SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I  
National Drug 
Policy, 
Medicine and 
Related 
Substances Act 
and Pharmacy 
Act. 
 
  
What governs 
us here is 
obviously the 
Medicines 
and Related 
Substances 
Act which 
governs the 
functions of 
pharmacists 
and the Good 
Warehousing 
and pharmacy 
laws, 
pharmacy act, 
medicine act, 
PFMA. 
That is 
basically, the 
NDP…and it’s 
your 
guidelines to 
PTC. 
Definitely the 
pharmacy 
laws, 
pharmacy act, 
medicine act, 
PFMA 
National Drug 
Policy, 
Medicine and 
Related 
Substances 
Act and 
Pharmacy 
Act.  
National Drug 
Policy, 
Medicine and 
Related 
Substances 
Act and 
Pharmacy 
Act.  
National Drug 
Policy. 
We’ve got 
Pharmacy Practice 
document, the 
Pharmacy Act and 
then we have our 
own provincial 
Standard Operating 
Procedures for 
hospitals. 
National Drug Policy, 
Medicine and Related 
Substances Act and 
Pharmacy Act. 
 
 
 
 
 
 
 
1
1
4
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5.4.8.1 Common understanding of the legal framework governing provision of 
essential medicines 
 
There was generally common understanding of the key legislative framework as almost 
all participants had indicated the National Drug Policy as well as the Medicine and Related 
Substances Act. One participant summarised it as following: 
 
“The legal framework that governs us here is obviously the Medicines and Related 
Substances Act which governs the functions of pharmacists, the good warehousing 
and distribution practice and good pharmacy practice is a pharmacy council 
document so that’s linked to the medicine and related substances. Obviously good 
warehousing and distribution practice would be paramount as this piece of legal 
framework has more to do with the regulations that govern the Medicine Control 
Council, the regulator, and then obviously the Hazardous Substances Act.” The 
other participant reported that “we have got pharmacy practice document, the 
Pharmacy Act, and then we have our own provincial standard operating 
procedures”. 
 
5.4.8.2 Thematic action point for legal framework  
 
Majority of the participants submitted that The National Drug Policy which was developed 
in 1996 and has never been reviewed in the light of the new development including 
primary health care and nurse initiated anti-retroviral treatment programmes which 
expanded scope of nurses and prescription privileges.  
 
There is a need to review and develop new frameworks and policies to respond to the 
current health sector reforms including new Nursing Act 33 of 2005 and the shortage of 
pharmacy personnel to manage medicine supply in the district health services in particular 
the primary health setting as well as the rural areas. 
 
5.4.9 Management support 
 
Management support systems include the following components: the planning and 
organisation of services, financing and financial management, information management, 
and human resource management. These management support systems hold the 
pharmaceutical management framework together (MSH 2012:38.2). 
  
 
Table 5.10: Management support functions 
 
SITE A  SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I  
The province has 
no District 
Pharmacist. 
 
Health facilities 
have Pharmacy 
Managers posts 
filled partially to 
provide 
management 
support and 
guidance.  
 
 
Information 
management 
systems used 
include  
Rx Solutions and 
Remote 
Demander 
Modules. 
 
 
 
 
 
We have 
what is called 
a Service 
Level 
Agreement 
which 
governs the 
relationship 
between the 
medical 
depot and all 
demanders.  
 
 
 
Every three 
months we 
have what we 
call DSM The 
province has 
district and 
facility 
pharmacists 
posts partially 
filled  
District 
Pharmacists 
It is purely 
done by 
pharmaceutical 
services to 
offer support to 
those clinics to 
make sure that 
every clinic 
has got the 
correct stuff 
here. 
 
 
 
Information 
management 
systems used 
include  
Rx Solutions 
and Remote 
Demander 
Modules 
We have 
quarterly 
meetings. We 
call it a 
Pharmaceutical 
Management 
forum…they 
monthly 
meetings. 
 
 
 
 
 
The district and 
facility 
pharmacists’ 
posts are 
partially filled to 
provide 
management 
support 
 
 
 
 
 
The district 
and facility 
pharmacists’ 
posts are 
partially filled 
to provide 
management 
support. 
 
 
 
 
 
 
Information 
management 
systems 
used include  
Rx Solutions 
and Remote 
Demander 
Modules 
Training and 
ensuring 
compliance with 
standards set. 
 
 
 
 
 
 
 
 
 
 
Information 
management 
systems used 
include  
Rx Solutions 
and in house 
developed 
medicine stock 
management  
We have a dedicated 
person who goes to 
facilities to support 
them up to PHC level 
we also assisted by 
district pharmacists. 
 
We have the district 
pharmacist and the 
hospital pharmacists 
that are responsible for 
the…and the 
community service 
pharmacist 
 
Management support is 
in terms of information 
management, HR and 
finance 
 
The district and facility 
pharmacists’ posts are 
partially filled to provide 
management support  
 
 
 
The district 
and facility 
pharmacists’ 
posts are 
partially filled 
to provide 
management 
support 
 
 
 
 
 
 
Information 
management 
systems used 
include 
Remote 
Demander 
Module  
and 
provincially 
developed 
medicine 
stock 
management 
1
1
6
 
  
 
SITE A  SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I  
 
 
 
Pharmacy 
Management  
Demander forums 
exist for guidance. 
The unique 
situation is the 
existence of  
Sub-district 
Pharmacists. 
 
  
 
to provide 
management 
support. 
 
Information 
management 
systems used 
include  
Rx Solutions 
and Remote 
Demander 
Modules 
 
 
 
Information 
system used 
include Rx 
Solution as 
well as in 
house 
developed 
order 
management 
system is used.  
 
 
 
 
Information 
management systems 
used include  
Rx Solutions and 
provincially developed 
medicine stock 
management.  
 
 
 
 
 
 
 
 
1
1
7
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5.4.9.1 Diverse management support activities for the provisioning of essential 
medicines  
 
The provinces have varied management support in terms of information management, 
HR, and finance for managing medicine supply in areas where there are district 
pharmacists there is better coordination of medicine provisioning than in those without as 
evidenced by higher expiry of medicines as well as poor stock management and 
increased stock outs.  
 
The provinces with the district pharmacist had a challenge of having non-standardised 
job descriptions and blurred reporting lines with some heads of Pharmaceutical Services 
suggesting: 
 
“The district pharmacists should report directly to the head of pharmaceutical 
services”. 
 
Other view was: 
 
“The district pharmacist report to the district manager as such the district managers 
should manage their job description and performance the district pharmacist 
should be responsible for the pharmaceutical services, even in the hospitals, 
because in that way it means myself as a head of pharmaceutical services with a 
district pharmacist with that professional knowledge in charge of the hospitals. So 
what would happen is he or she will be responsible for the whole platform and that 
also makes rotation or filling up of gaps even possible because you had a 
pharmacist but that pharmacist is not only for this hospital can be deployed 
anywhere there is a need within the district. So, for me, that would work because 
you found even just movement of medicines from the hospital to the clinics is not 
a problem because everybody reports to the same and they even assist in 
management of the district budget where you see one district is under spending, 
another district is overspending.” 
 
5.4.9.2 Thematic action point for management support  
 
The proposed action area on this theme is the development and standardisation of the 
job description of district pharmacist positions through collaboration between the heads 
of pharmaceutical services and district managers. Another action area is the development 
and implementation of a common medicine information management system in all 
provinces to ensure stock visibility to all decision makers to be able to maintain minimum 
and maximum stock levels as well as stock movement between facilities to avoid essential 
medicine stock outs.  
  
 
 
5.4.10 No existing medicine provisioning framework for district health services  
 
Table 5.11: Current provinces provisioning framework 
 
SITE A  SITE B  SITE C  SITE D  SITE E  SITE F  SITE G  SITE I 
No. The province 
have different 
systems and 
methods. 
No The 
province has 
Service Level 
Agreements 
with the 
demanders. 
No We use 
National Drug 
Policy and PTC 
guidelines 
because it gives 
you a guideline 
onto how do you 
procure. 
No. Our 
Service Level 
Agreement is 
currently not 
signed. 
No we have 
SOPs they just 
describe the 
process.  Who will 
order, how regular 
will we order, and 
what if there is an 
order or whatever.  
That’s the only 
guidance there is. 
No No we’ve got 
Pharmacy 
Practice 
document, the 
Pharmacy Act, 
and then we 
have our own 
provincial 
Standard 
Operating 
Procedures for 
hospitals. 
No. We use the 
Medicine Control 
Council and 
Pharmacy Council 
rules. 
 
 
1
1
9
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5.4.10.1 None existence of the framework for provision of essential medicines for 
district health services 
 
None of the sites visited indicated availability of a framework for provisioning of medicines 
covering the key elements of selection, procurement, distribution, rational use and 
management support for the district health services. The provisioning appeared to be 
managed generally despite the different resource and infrastructure availability between 
districts and hospital platforms, they indicated that their provision of essential medicines 
is guided by the standard operating procedures. Participants presented different inputs 
on the framework existence.  
 
“We have our standard operating procedures. On our SOPs for primary health care 
services everything is indicated, the procedures from the depot down to the facility, 
how the medicine is ordered, how they can store it, and the distribution, up to the 
issuing to the patient”. Another participant stated the following “No, it does not 
cover all areas it reaches a certain portion of selection because we’ve only, I think, 
entered that few lines about selection but when it goes at higher level, national 
level, it’s not documented. It’s not reflected. It does not indicate process and we 
didn’t put that in”. 
 
5.4.10.2 Thematic action area for the framework of medicine provision within the 
district health services  
 
Three provinces indicated existence of service level agreement with the end users as 
means to guide the health facilities and clarification of roles in the provision of medicines. 
However, there is a need to develop a framework to guide provisioning of medicines for 
the district health services countrywide to promote efficiency and availability of essential 
medicines.  
 
5.4.11 Approaches used in the medicine provisioning 
 
The Pharmaceutical Management Framework adopted by the World Health Organization 
as developed by the Management Sciences for Health, provide broader components to 
promote smooth medicine provisioning. The Framework propose that medicine 
provisioning should be guided by selection, procurement, distribution and use 
components supported by the legal framework and management support across the 
value chain (MSH 2012:2). 
  
 
 
Table 5.12: Provinces order handling process 
 
SITE A  SITE B   SITE C  SITE D  SITE E   SITE F  SITE G  SITE I 
Order 
originate 
from the end 
user and 
submitted to 
the depot for 
processing. 
Order 
originate 
from the end 
user and 
subjected to 
checking 
and approval 
by the 
District 
Pharmacist 
before 
submission 
for 
processing 
at the depot. 
Order 
originate 
from the end 
user and 
subjected to 
checking 
and approval 
by the 
Pharmacist 
before 
submission 
for 
processing 
at the depot. 
Order 
originate 
from the end 
user and 
subjected to 
checking 
and approval 
by the 
Pharmacist 
before 
submission 
for 
processing 
at the depot. 
Order 
originate from 
the end user 
and routed 
through the 
hospital 
complexes for 
checking and 
approval by 
the Hospital 
Pharmacist 
before 
submission for 
processing at 
the depot. 
Order originate 
from the end user 
and subjected to 
checking and 
approval by the 
Hospital or District 
Pharmacist before 
submission for 
processing at the 
depot. 
We have an order 
list that has items 
at their level. So it 
doesn’t allow them 
to order anything 
that is outside their 
level. It’s 
standardised list. 
Order originate from the 
end user and subjected to 
checking and approval by 
the District Pharmacist 
before submission for 
processing at the depot. 
 
 
 
 
 
 
 
 
 
 
1
2
1
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5.4.11.1 Different order handling processes  
 
Provinces depending on the available human resources handle the orders differently with 
majority requiring a pharmacist signature of approval before the depots could process 
and issue the ordered medicines. This was done in order to minimise losses and 
inaccurate quantities as the nurses in the clinics were seen as being overstretched 
handling medicine ordering as additional function.  
 
5.4.11.2 Thematic action area in approaches for medicine provisioning  
 
The review of orders via a hospital pharmacist increases the turnaround times for 
medicine provisioning although the process does assist with the promotion of rational 
medicine use and prevent excess ordering. The order handling process need to be 
reviewed such that the order can be processed by the depots without a pharmacist 
analysis as long as the order is within the maximum stock level previously approved for 
that particular clinic. 
 
5.4.12 Adequacy of the provision of medicines 
 
MSF (2013:13) reported that lack of access to medicines has complex underlying factors 
ranging from health programme implementation to medicine supply system challenges. 
A study conducted on Pharmaceutical Management of Tuberculosis in seven of the nine 
provinces in the Republic of South Africa (RSA) found that the provision of essential 
medicines including Anti-Retroviral and Tuberculosis medication was not optimal at less 
than 95 percent in five of the provinces, namely the Free State, Eastern Cape, Gauteng, 
Limpopo, and Mpumalanga. The factors contributing to poor provisioning of medicines 
were especially in clinic settings poor stock control and management in nurse-led primary 
health clinics and a lack of pharmacist’s assistants to take charge of drug supply 
management. Further a lack of electronic stock management systems also played a role 
as manual stock cards were found not to be updated at most facilities (Pure Health 
Consulting 2012:97). The participants generally confirmed the view that provision of 
medicines is better in the hospital setting than the primary health context.  
  
 
Table 5.13: Adequacy of medicine provisioning 
 
SITE A  SITE B   SITE C  SITE D  SITE E   SITE F  SITE G  SITE I 
Adequate 
with 
challenges 
in the PHC 
level due to 
limited 
pharmacy 
personnel, 
infrastructure 
and IT 
systems. 
Adequate 
with 
challenges 
in the PHC 
level due to 
budget and 
space. 
Adequate in the 
hospitals due to 
the whole unit that 
is focused on 
following up with 
suppliers.  Also we 
have been 
penalising 
suppliers for late 
deliveries. 
 
Adequate with 
challenges at 
PHC level due to 
the fact that the 
clinics battle 
because the 
sisters are busy 
with patients.  
 
They do not 
have the time to 
give adequate 
attention to the 
ordering of 
medicines. 
Adequate 
though 
deliveries were 
delayed due to 
backlog and 
challenges 
with the 
suppliers. 
Inadequate with 
challenges in 
hospitals, 
Community Health 
Centres and Primary 
Health Care settings 
due to supplies 
challenges, depot 
and facilities 
inefficiencies as well 
as manufacturing 
challenges 
Adequate as 
the 
provisioning is 
outsourced 
and managed 
through a 
Service Level 
Agreement.  
Adequate due to 
tight controls, 
good 
management, 
dealing with 
problems as 
they arise, and, 
from the depot’s 
side, we see 
ourselves here 
as the key to the 
success of 
medicine 
availability at the 
district level. 
  
 
 
 
 
 
1
2
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5.4.12.1 Adequacy of the provisioning of essential medicines  
 
Provinces reported that provisioning of medicines for the hospitals was generally 
adequate due to availability of pharmacists and assistants to manage ordering and stock 
control as well as the adequate space to store issued stock however there was 
unanimous presentation that primary health clinics were having inadequate medicine 
provisioning management as not all health districts have district pharmacists as well as 
Pharmacist Assistants in the primary health care facilities and poor distribution 
mechanism to reach the clinics. The participants highlighted the following: 
 
“I think, ideally, we would have loved to service all the primary health care facilities 
that they must order through the depots because what we have looked at, the 
process of them ordering through sub-depots is time-consuming and, if there is a 
shortage of a particular item, it takes forever to resolve of that particular item unlike 
if they were ordering directly from the depots” also “appointment of dedicated 
pharmacist assistants for PHC facilities is key if the stock outs are to be minimised”. 
 
5.4.12.2 Thematic area for action to improve adequacy of medicine provisioning  
 
The medical depot responsible for provisioning of medicines were generally under 
resourced with Managers responsible in acting positions except for two provinces as such 
there is an urgent need to appoint permanent managers to run the medical depots. 
Further the vacancy rate was high with one depot operating with general workers and one 
pharmacist assistant. There is need to fill vacant posts with pharmacist assistants to 
improve efficiencies within the primary health clinics.  
 
  
5.4.13 Special considerations 
 
Table 5.14: Proposals for improving medicine provisioning 
 
SITE A  SITE B  SITE C   SITE D  SITE E  SITE F  SITE G  SITE I   
Appointment of 
Pharmacist 
Assistants for 
PHC level. 
 
Electronic 
Stock 
Management 
System. 
 
Adequate 
network and 
technology. 
 
Stock 
Management 
group. 
 
Transport to 
shift stock 
around. 
 
Cooperative 
relations 
between 
districts. 
 
Electronic 
Stock 
Management 
System. 
 
Centralisation 
of medicine 
budget. 
Appointment of 
Post Basic 
Pharmacist 
Assistants for 
primary health 
care clinics for 
effective 
medicine stock 
management. 
 
Direct 
deliveries for 
the hospitals. 
Medicine 
supply 
Management 
training for the 
health facility 
staff. 
 
Focal nurses 
responsible for 
stock in PHC. 
 
Electronic 
stock 
management 
 
Weekly 
reporting for 
medicine 
availability. 
Hospital 
allowed to 
order weekly. 
Invest in IT 
systems to 
support 
pharmaceutical 
procurement 
and 
distribution for 
visibility better 
stock manage 
stock as well 
as manage 
supply 
performance. 
Pharmacist Assistant 
deployment to PHC 
level and Pharmacist 
in the hospitals to 
control orders. 
 
Needs forecasting to 
ensure consistent 
stock availability. 
Promotion of 
order 
replenishment 
dependent on 
the IT system 
with minimum 
and maximum 
stock levels 
instead of 
awaiting orders 
from the health 
facilities 
enabling both 
stock control and 
relieve facility 
staff for order 
placement and 
follow up time. 
 
1
2
5
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5.4.13.1 Participants views on special considerations  
 
The provinces manage the medicine budget differently either as a centralised budget 
enabling all facilities to have medicines as required without condition to prove financial 
resources or facilities have to prove budget availability with each order placed which if 
not produced medicine supply would be withheld with potential resultant medicine stock 
out in a health facility. The ideal would be central budget management with medicine 
provisioning based on need and budget savings shared across to fund high volume areas. 
Investing in electronic stock management system for medicine supply management was 
highly recommended to facilitate stock sharing as well as promote stock visibility and 
avoid excess ordering from health facilities. The participants shared good ideas on 
possible measures that could be implemented to enhance the provisioning of medicines. 
Some of the suggestions would be incorporated in the development of the proposed 
framework.  
 
5.4.13.2 Thematic action area for special considerations  
 
Whilst the employment of dedicated pharmaceutical personnel for all the primary health 
facilities is planned The clinics should have focal nurses responsible for medicine stock 
management in the facilities on condition that these nurses are exposed to medicine 
supply management courses in order to promote rational ordering and stock 
management. 
 
  
 
 
5.4.14 Different strategies utilised to ensure optimum provisioning of essential medicines  
 
Table 5.15: Best practices in medicine provisioning 
 
SITE A  SITE B   SITE C   SITE D  SITE E  SITE F  SITE G  SITE I 
Payment of 
suppliers 
within thirty 
days. 
 
Ordering 
schedule  
Direct 
Deliveries.  
 
Maintain 
three 
months’ 
buffer stock 
depot and 
hospital 
level six-
week buffer 
stock at 
PHC level.  
Ordering 
schedule  
Direct 
Deliveries. 
 
 
 
 
 
 
Maintain 
three 
months’ 
buffer stock 
depot and 
hospital 
level six-
week buffer 
stock at 
PHC level. 
Promote Direct 
Deliveries for 
the hospitals 
and 
Community 
Health 
Centres.  
Medicine 
Availability 
reporting. 
 
 
 
 
 
 
 
Depot has in-
house finance 
unit to facilitate 
payment of 
suppliers.  
 
Dedicated 
medicine stock 
for each district 
within the depot 
warehouse.  
Handle 
orders 
through 
hospital 
complexes 
due to 
limited 
human 
resources 
and 
capacity.  
Direct Deliveries for 
Hospitals to improve 
medicine availability 
and direct 
procurement for PHC 
facilities. 
Weekly 
medicines 
reporting. 
 
 
 
 
 
 
 
Appointment of 
pharmacy 
personnel. 
 
Medicine Supply 
Management. 
Weekly physical stock 
and order review 
meeting between the 
depot, pharmaceutical 
services focal person, 
hospital and district 
pharmacists. 
 
 
 
Dedicated Pharmacist 
Assistant who review 
orders from the facilities 
to identify discrepancies 
and irrational ordering. 
1
2
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5.4.14.1 Best practices identified  
 
The participants emphasised the need for payment of suppliers within 30 days and 
maintenance of buffer stock as critical strategies to ensure consistent provisioning and 
minimise stock out. Depot demand management by dedicated staff was also highlighted 
as key to ensure that orders are checked and the companies deliver in line with the 
standard contract terms.  
 
“I would say something that stands out from our depot is having our own finance 
unit because I hear a lot of provinces complaining that they send the payments to 
provincial office, to the CFO’s office, and it’s not prioritised.” 
 
5.4.14.2 Action area for strategies utilised to enhance medicine provisioning  
 
Medical depots should have dedicated finance and supply chain management units for 
efficient procurement and payment of suppliers.  
 
  
 
5.4.15 Role of the National Department of Health 
 
Table 5.16: Role of the National Department of Health 
 
SITE A  SITE B   SITE C   SITE D  SITE E   SITE F  SITE G  SITE I 
Approve policies 
and 
standardised 
indicators. 
 
 
 
Standardise 
Medicine Supply 
Management 
Systems. 
 
 
 
 
 
 
Standardise 
Human 
Resource 
Standards for 
PHC. 
 
Develop 
Stock 
Monitoring 
Systems. 
 
 
 
Provide 
country wide 
depot stock 
management 
system for 
global view. 
 
 
 
 
Contract 
Management 
for the 
medicine 
suppliers. 
 
Ensure timeous 
award of medicine 
supply contracts. 
 
 
 
 
Review and 
finalise outdate 
policies. 
 
 
 
 
 
 
 
Introduce uniform 
information and 
human resources 
management 
systems. 
Provide uniform 
information 
management 
systems 
 
 
 
Finalise policies 
and norms 
relating to 
pharmaceutical 
management 
and human 
resources for 
PHC. 
 
 
Continue with 
supplier 
performance 
contract 
management. 
National 
Tenders. 
  
 
 
 
 
Monitor 
supplier 
performance. 
 
 
 
 
 
 
 
Set 
Standards 
and policies 
for provision 
of medicines. 
 
Drive implementation 
of improved 
pharmaceutical 
procurement models to 
ensure supply of 
medicine supplies. 
Promote all 
stakeholders’ 
involvement in 
medicine 
procurement. 
 
 
Improve 
monitoring 
systems. 
  
 
 
 
 
 
 
Develop 
information 
management 
systems linked 
at all levels. 
 
Arrange 
contract 
timeously. 
 
 
 
 
Develop and 
Finalise 
human 
resources 
standards 
especially for 
the primary 
health 
setting. 
 
Formalise 
stock transfer 
process 
across 
provinces. 
 
1
2
9
 
  
SITE A  SITE B   SITE C   SITE D  SITE E   SITE F  SITE G  SITE I 
Ensure that all 
essential 
medicines are 
on national 
tenders to 
minimise buy 
outs. 
Review and 
finalise policy 
framework. 
Standardise 
reporting on 
medicine 
availability. 
Develop and 
formalise 
norms for 
human 
resources and 
clinical 
practices. 
Development 
and roll out 
of a national 
electronic 
stock 
management 
system. 
 
Standardise 
medicine 
reporting 
indicators. 
 
 
1
3
0
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5.4.15.1 Multiple inputs into the role of National Department of Health  
 
The participants had mixed views on the role of the National Department of Health that 
could be categorised into human resources standards, systems, policy development and 
contract management.  
 
“I think they need to come up with the proper information management systems 
because obviously it’s the way to go. Also primary health services are the ones 
that are providing majority of services and that’s where we’ve got most of the 
challenges. If you hear about stock-outs it will always be at clinics. Providing the 
tenders, definitely. They currently assist with contract management because we 
just don’t have the capacity to. So that is assisting a lot. I know they are working 
on several policies but also, I think at National level, they are also understaffed. If 
I look at the amount of tenders they need to secure with the small people they’ve 
got, I think they also hugely understaffed.” 
 
5.4.15.2 Thematic action area for the National Department of Health role 
 
Medicine provisioning practices should be standardised in the country as such National 
Department of Health was expected to ensure the following:  
 
 Review, development and finalisation of the national medicine policies. 
 Identification and management of reporting based on common indicators for 
medicine availability. 
 Finalisation of human resource norms for each level of care. 
 Development and roll out of the national electronic stock management system with 
visibility from the depot to the health facilities. 
 
  
5.4.16 Specific proposals 
 
Table 5.17: Specific proposals  
 
SITE A  SITE B  SITE C  SITE D  SITE E   SITE F  SITE G  SITE I 
Recruit and appoint 
more mid-level 
workers rather than 
professional 
pharmacist staff as 
they are difficult to 
retain for rural areas. 
 
 
 
 
 
 
 
Stock Visibility System 
roll out. 
 
 
 
 
Push system 
implementation to 
ensure consistent 
medicine supply. 
Standardise policy 
documents. 
 
 
 
 
 
 
 
 
 
 
 
 
Promote 
Pharmaceutical 
Committees 
functionality and 
provide feedback. 
 
Appoint 
Pharmacists and 
Assistants for PHC 
clinics for better 
Review of the 
National Drug 
Policy to suit 
current 
challenges  
Improve rational 
medicine use  
Introduce 
efficient 
operations 
management to 
do more with 
less.  
 
Capacitate 
depots to ensure 
uninterrupted 
medicine supply.  
Depot need more 
HR and IT 
support to deliver 
on the mandate 
for provision of 
medicine.  
Review 
issue based 
on pack size 
rather 
patient 
condition. 
 
Improve 
patient 
education to 
understand 
brand 
versus 
generic 
medicines. 
None  Stock 
management 
system for real 
time stock 
management 
view. 
 
 
 
 
 
 
 
 
Uniformity.  
Medicine 
provisioning 
should be linked 
with supply of the 
critical medical 
consumables. 
1
3
2
 
  
SITE A  SITE B  SITE C  SITE D  SITE E   SITE F  SITE G  SITE I 
medicine 
provisioning. 
 
Medicine supply 
Management 
training. 
 
Push medicine 
procurement 
strategies rather 
than waiting for 
orders from health 
facilities. 
 
1
3
3
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5.4.16.1 Thematic action for specific recommendations on specific proposals for 
improving medicine provisioning   
 
The importance of development and roll out of a stock visibility system and capacitation 
of the medical depots in terms of human resources and information management system 
for efficient essential medicine provisioning was mentioned by the participants as an area 
requiring urgent intervention. The model of pushing rather than awaiting orders from the 
health facilities was also recommended as a long-term strategy.   
 
5.5 SUMMARY OF ACTION AREAS ARISING FROM THE STUDY  
 
The following areas were identified as requiring action and intervention to improve 
essential medicine provisioning:  
 
 There is a need of a nationally agreed standard against which to measure the 
availability of essential medicines as all times is not achievable across all provinces 
as evidenced by reported stock outs within the health facilities. 
 The required action is to ensure that any framework developed should encompass 
all key processes required for effective medicine supply management  
 There must be mechanism and systems to ensure that the pharmaceutical 
therapeutic committees are functional and chaired by clinicians at all times to 
ensure that selection of medicines address the needs of the communities. Clear 
terms of reference should be available to guide provinces on how to formulate and 
sustain functionality of the PTCs. 
 The procurement processes of medicines should allow for direct delivery to 
hospitals and community health centres to allow the depots to focus and improve 
procurement and supply turnaround times for the primary health clinics thus 
increasing the medicine availability at the lowest level.  
 The distribution of medicines should be direct to health facilities instead of being 
from the depots to the hospitals or district warehouses before being sent to primary 
health clinic to ensure timeous availability at the health facility level. There also 
should be standard distribution contract specifications across provinces to ensure 
preservation of medicine quality and timeous delivery to the health facilities. 
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 Improvement through development of provincial and district training schedules and 
programmes targeting the health professionals in order to promote cost effective 
and efficient medicine provision and availability. 
 There is a need to review and develop new frameworks and policies to respond to 
the current health sector reforms including new Nursing Act 33 of 2005 and the 
shortage of pharmacy personnel to manage medicine supply in the district health 
services in particular the primary health setting as well as the rural areas.   
 The development and standardisation of the job description of district pharmacist 
positions through collaboration between the heads of pharmaceutical services and 
district managers.  
 The development and implementation of a common medicine information 
management system in all provinces to ensure stock visibility to all decision 
makers to be able to maintain minimum and maximum stock levels as well as stock 
movement between facilities to avoid essential medicine stock outs. 
 There is a need to develop a framework to guide provisioning of medicines for the 
district health services countrywide to promote efficiency and availability of 
essential medicines.  
 The order handling process need to be reviewed such that the order can be 
processed by the depots without a pharmacist analysis as long as the order is 
within the maximum stock level previously approved for that particular clinic.  
 Developing standard norms for medicine management staffing in the PHC setting 
as well as improve the distribution mechanisms and storage areas. 
 Central budget management with medicine provisioning based on need and 
budget savings shared across to fund high volume areas. 
 Invest in electronic stock management system for medicine supply management 
was highly recommended to facilitate stock sharing as well as promote stock 
visibility and avoid excess ordering from health facilities. 
 The clinics should have focal nurses responsible for medicine stock management 
in the facilities on condition that these nurses are exposed to medicine supply 
management courses in order to promote rational ordering and stock 
management.  
 Medical depots should have dedicated finance and supply chain management 
units for efficient procurement and payment of suppliers.  
 National depot should fast track:  
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I. Review, development and finalisation of the national medicine policies. 
II. Identification and management of reporting based on common indicators for 
medicine availability 
III. Finalisation of human resource norms for each level of care. 
IV. Development and roll out of the national electronic stock management system 
with visibility from the depot to the health facilities. 
 
5.6 CONCLUSION OF THE RESEARCH FINDINGS PHASE  
 
The above data concludes the study findings phase, in the following paragraphs the 
implemented action areas to improve provisioning of essential medicines will be 
discussed.  
 
5.7 DISCUSSION OF IMPLEMENTED ACTION AREAS AND EFFECTS 
 
Action research promotes reflection by the practitioners on their practice environment and 
makes suggestions for improvement. Coghlan and Brannick (2010:24) defined reflection 
as a continuous process of identifying the problem aspects of practice, review the practice 
and find constructive ways to deal with the practice problem identified. Action researchers 
are judged on whether they reflected on what was researched, testing own judgement 
against the critical feedback of others thus enabling self-learning from the participants 
(McNiff & Whitehead 2011:14). For this study the researcher and the participants worked 
together to identify practice challenges through joint discussion and review of the 
collected data towards developing new ways of providing essential medicines for the 
district health services. 
 
In the course of the study, there was engagement with various role players who could 
assist with the implementation of the proposed action areas. The interventions that 
emerged during the engagement with the participants will be discussed under the 
following sub headings: 
 
5.7.1 Nationally agreed essential medicine availability standard 
 
Based on review of the South African Department of Health strategic documents and 
engagement of the department of health officials there was no standard document or 
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guideline which provided a national benchmark standard against which to compare 
essential medicine availability across all the nine provinces.  
 
The proposed intervention is for the department to consider adopting the thirty-nine items 
listed in the National Core Standard document for the district and community health 
centres measurement and the ideal clinic standard document items as basis for primary 
health clinic availability measurement standards. 
 
5.7.1.1 Implemented action  
 
The national department is currently working on the essential availability standards 
however; in the meantime, the department encouraged all provinces to adjust their 
catalogues to provide for both the national core standards and ideal clinic essential 
medicine standards requirements. 
 
5.7.1.2 Implemented action effect 
 
There is now an interim guideline against which different level of health facilities are 
measured against for the availability of essential medicines namely ideal clinic and 
national core standard lists are applicable to primary health clinics and community health 
centres.  
 
5.7.2 Functionality of pharmaceutical therapeutic committees and presided by 
clinicians  
 
During site visits majority of the committees were chaired and hosted by pharmacists with 
little involvement of clinical staff who are the prescribers of medicines in the clinical 
settings. 
 
The PTC are the highest clinical governance and decision making committees in terms 
of provisioning of medicines as such should be functional to enhance provisioning of 
medicines There should be policy guidelines and terms of reference for the committees 
with clearly delineated mechanism and systems to ensure that the pharmaceutical 
therapeutic committees are functional and chaired by clinicians at all times to ensure that 
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selection of medicines address the needs of the communities and pharmaceutical  
services offices providing secretariat services and hosting function. 
 
5.7.2.1 Implemented action  
 
The participant provinces have committed to correct the structuring and functionality of 
the PTC by reviewing their committees’ terms of reference against the draft national policy 
for PTC establishment. 
 
5.7.2.2 Implemented action effect   
 
There has been little progress in the structuring of the PTC as provinces had vacant posts 
of district pharmacists to drive the process. 
 
5.7.3 Strengthen medical depots capacity to service primary health care clinics  
 
The medical depots  medicine distribution models differed  across provinces with some 
depots delivering directly to all health facilities including primary health clinics and some 
depots delivering to the district hospitals, community health centres the sub-depots or 
regional depots where they exists  which would then supply their catchment clinics and  
community health centres .This practice exposed the primary health clinics to medicine 
stock outs due to long route and increased turnaround times for the deliveries.   
 
The supply system therefore has to be reviewed and human resource capacity of the 
depots enhanced to promote direct deliveries to the primary health clinics through 
activation of the demander codes to ensure that the middle man is eliminated for PHC 
thus increasing the medicine availability at the lowest level. Medical Depots should have 
dedicated finance and supply chain management units for efficient procurement and 
payment of suppliers. 
 
5.7.3.1 Implemented action  
 
In the course of the study three provinces were able to fill critical posts including the depot 
managers, finance managements and commenced with the operations review to promote 
better service delivery for PHC clinics. 
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5.7.3.2 Implemented action effect   
 
There has been improvement in the provisioning of essential medicines as evidenced by 
reduced reports of medicine stock out across the nine provinces. 
 
5.7.4 Standardise the distribution services specifications across the country  
 
The site visits revealed that the vehicle and system used for distribution of medicines 
were varied across the eight provinces with few provinces utilising outsourced services 
with temperature control systems to maintain medicine quality standard of less than 25 
degrees Celsius and prevent theft whilst others utilised standard vehicles state vehicles 
not custom made for distribution medicines and protection against theft. The best practice 
standards as stated in the good warehousing practices should be standard distribution 
contract specifications which ensure protection of medicines in transit against excessive 
temperatures, theft across provinces to ensure preservation of medicine quality and 
timeous delivery to the health facilities. 
 
5.7.4.1 Implemented action 
 
There are emerging trends for improvement as during the study period three provinces 
called for proposals for a standard distribution contract with an intention to improve the 
distribution of medicines as expensive and fragile health commodities. The best practice 
noted is that in many provinces, there is a move from using state vehicles not compliant 
with good warehouse management practices (GWMP) and temperature-cold chain 
maintenance to an outsourced approach which is generally compliant with GWMP taking 
into account that the department of health core strength is service delivery not necessarily 
the logistic management. 
 
5.7.4.2 Implemented action effect 
 
The provinces with outsourced distribution services had lesser prevalence of stock losses 
and delivery to health facilities generally consistent as when stock loss are reported they 
are recoverable and replacement of out of service vehicles becomes the responsibility of 
the contracted supplier. 
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5.7.5 Standardised medicine supply management capacity building programme  
 
The participants also indicated varied approach to capacity building programmes to 
enable frontline health professionals to efficiently order and manage medicines in order 
to reduce wastage and irrational use of medicines.  
 
There is an urgent need to ensure consistency through development of provincial and 
district training schedules and programmes targeting the health professionals in order to 
promote cost effective and efficient medicine provision and availability. 
 
In order to promote rational ordering and stock management, the clinics should have focal 
nurses responsible for medicine stock management in the facilities and systems and 
support mechanisms should be in place to ensure that all nurses responsible for stock 
management are exposed to medicine supply management courses.  
 
5.7.5.1 Implemented action 
 
To realise this proposal, provinces were advised and accepted to solicit from the non-
government organisation operating within the districts as they are funded for health 
system strengthening activities including capacity building on medicine supply 
management. All provinces have secured medicine supply management training 
sessions with the support of the NGOs although these training and capacity building 
sessions remain varied depending on the particular district challenges and resources. 
 
5.7.5.2 Implemented action effect  
 
In the course of the study nursing prescribing and medicine stock management policy 
was developed and approved by the National Department of Health to guide nurses 
prescribing and managing medicine supply as well as necessary authorisation forms 
circulated for completion after successful completion of the prescribed training. There was 
increased training for professional nurses in particular for improved stock management 
using the stock visibility monitoring programme and conduct of in service training by the 
pharmaceutical supplies organisation on the processes involved in sourcing medicines 
for priority condition including Tuberculosis and Vaccines.  
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5.7.6 Improve availability of pharmacist and pharmacist assistants at PHC level  
 
There is a need to review and develop new frameworks and policies to respond to the 
current health sector reforms including new Nursing Act 33 of 2005 with revised scope of 
the nurses and the shortage of pharmacy personnel to manage medicine supply in the 
district health services in particular the primary health setting as well as the rural areas. 
 
The participants recommended that to improve provisioning of essential medicines and 
good medicine stock management in the health facilities, the practice of nurses being 
responsible for medicine supply management as an additional function should be 
reviewed and concerted effort made to employ the pharmacist to coordinate medicine 
supply at district, sub-district and community health centres and pharmacist assistants at 
the primary health clinic level.  
 
5.7.6.1 Implemented action 
 
To address the shortage of pharmacists and assistants within the district health system, 
provinces reviewed their allocation of community service pharmacists from tertiary 
hospitals to the district health services as roving pharmacist checking and supporting the 
PHC facilities to manage the medicine supplies better as well as supervision of the 
pharmacist assistants. Further the National Department of Health has deployed an 
increased number of pharmacist assistants to the eleven National Health Insurance 
districts to enhance quality of medicine provisioning within the districts.  
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5.7.6.2 Implemented action effect 
 
There are an increased number of primary health clinics within the NHI sites in the 
provinces with at least one pharmacist assistant contributing to better medicine stock 
management. 
 
5.7.7 Standardised job description of district pharmacists  
 
The participants during the site visits highlighted the varied understanding of the role of 
the district pharmacists and their reporting lines within the districts and their relationships 
with the pharmaceutical services at provincial levels. 
 
Poor understanding of the role of a district pharmacist has serious consequence for 
service delivery as district managers are generic managers who may not necessarily have 
expert knowledge on managing a pharmaceutical expert in the interest of better service 
delivery. 
 
5.7.7.1 Implemented action 
 
The development and standardisation of the job description of district pharmacist 
positions through collaboration between the heads of pharmaceutical services and district 
managers was advocated for and following key result areas were recommended as 
performance agreement standard:  
 
 Facilitate procurement of essential medicines for all health facilities within the 
District. 
 Promote rational medicine utilisation for all the health facilities and health workers. 
 Facilitate and institute mechanisms for continuous monitoring for consistent 
availability of essential medicines. 
 Providing training in rational drug use and drug supply management. 
 Supervise and mentor the mid-level workers responsible for medicine stock 
management. 
 Conduct research on essential medicine provisioning. 
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 Providing professional services and advice to district management and health 
programmes on pharmaceutical standards and compliance.  
 
5.7.7.2 Implemented action effect 
 
The job descriptions remain varied as majority of the district pharmacists where they exist 
report to district management with limited input of the heads of pharmaceutical on their 
performance management. 
 
5.7.8 Electronic stock management system  
 
The participants suggested that an electronic stock management system with capability 
of displaying real time stock levels, able to submit orders electronically to the depots for 
supply and promote sharing and movement of stock across the facilities where there are 
stock excesses and shortages. The intention was also to ensure that ultimately health 
facilities would be enabled to place orders electronically thus reducing the paperwork and 
turnaround time for handling orders as well as improve stock management. 
 
5.7.8.1 Implemented action 
 
In order to address the recommendation, all the provinces had a stock visibility system 
operationalised in all the South African primary health clinics by the National Department 
of Health in order to promote visibility of medicine stock availability status to key role 
players including pharmaceutical services. However, the uptake for utilisation has been 
low due to limited availability of pharmacist assistants at PHC levels.  
 
There is a further project currently in progress for the development and implementation 
of a common medicine information management system which is intended to link all 
provinces and medical depots to ensure real time medicine stock data visibility to be able 
to maintain minimum and maximum stock levels as well as stock movement between 
facilities to avoid essential medicine stock outs. Once fully implemented the system for 
medicine supply management would facilitate stock sharing as well as promote stock 
visibility and avoid excess ordering from health facilities. 
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5.7.8.2 Implemented action effect 
 
There is now medicine stock visibility in the primary health clinic for the role players to 
view and activate remedial plans including follow up on order placing, delivery as well as 
identification of common items out of stock which could be due to poor supplier 
performance requiring escalation to national level. The stock visibility electronic 
programme is affected by network and clinic staff multiple work functions resulting in the 
neglect of updating the medicine availability data timeously. 
 
5.7.9 Revised gatekeeping and processing of orders from the PHC facilities  
 
The processing of orders from the primary health clinics was delayed by the steps 
involved from the clinic manager submission to the district or hospital pharmacists before 
the order is sent to the medical depot for processing. The orders once processed in some 
provinces is then returned to the hospital to deliver to the clinic which is time consuming 
and has potential to cause stock out at clinic level. 
 
The proposal made was that the order handling process needs to be reviewed such that 
the order can be processed by the depots without having to be submitted via the district 
or hospital pharmacist analysis as long as the order is within the maximum stock level 
previously approved for that particular clinic.  
 
5.7.9.1 Implemented action 
 
The provinces had appointed pharmacist assistants and installed remote demander 
module for some clinics within the National Health Insurance (NHI) districts to improve 
medicine management, order processing and turnaround times. In the facilities where 
there are post basic pharmacist assistants in the clinics orders are generally submitted 
directly to the depots for processing using the remote demander module.  
 
5.7.9.2 Implemented action effect  
 
There is improved availability of essential medicines within the NHI districts due to 
increased availability of dedicated pharmacist assistants for medicine stock management 
and reporting.  
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Because the pharmacist assistants are dedicated and fully trained in medicine stock 
management and have capacity to move stock amongst the catchment health facilities 
there is reduction in surplus stock and expiry of medicines.  
 
5.7.10 Standard staffing norms for district health services  
 
The provinces had varied situation in their staffing norms for pharmaceutical staff 
composition some districts had district pharmacist and posts of Pharmacist assistants 
either at basic or post basic levels. Developing standard norms for medicine management 
staffing in the PHC setting was mentioned as a key improvement strategy. 
 
5.7.10.1 Implemented action 
 
The pharmacists were capacitated to engage with the human resource units utilising the 
South African Pharmacy Council good pharmacy practice standards to negotiate for 
minimum human resources requirement for effective pharmaceutical (medicine 
provisioning).  
 
Organogram reviews are currently in process through a workload indicator staffing norms 
(WISN) project spearheaded by the National Department of Health including availability 
of at least one pharmacist assistant depending on the health facility size and patient 
volumes as well as national district health services structure review proposal which has 
made provision for district pharmacists’ posts for all nine provinces. 
 
5.7.10.2 Implemented action effect  
  
In some provinces posts of the pharmacist assistants and district pharmacist have been 
created on the revised structure due to pharmaceutical services and programme 
managers lobbying human resources units for the posts creation. 
 
5.7.11 Central budget management with medicine provisioning  
 
The allocation and management of medicine budget was raised as a major concern as in 
some provinces facilities who did not have budget available could not be issued with 
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medicines thus resulting in the stock out owing to lack of resources and opportunity 
provided the pharmacist as medicine management experts manage the budget.  
 
The participants believed that if the budget is centralised and controlled by 
Pharmaceutical Services there is possibility of stock movements and control of placed 
orders to promote efficiency through review and reduction of quantities in line with 
essential medicine approved lists based on need and budget savings shared across to 
fund high volume areas. 
 
5.7.11.1 Implemented action 
 
The provincial budget offices had not all agreed on budget centralisation owing to health 
system development and decentralisation of delegations depending on supply chain and 
finance management capacity of the various provinces. The compromise was that the 
essential medicine budget availability was officially regarded as a non-negotiable item 
meaning all facilities should have budget available for medicines, where shortfalls are 
experiences budgets adjustments are implemented. 
 
5.7.11.2 Implemented action effect  
 
South Africa medicine situation is improved as provinces are monitored for their capacity 
to meet financial obligations by settling the medicine supplier’s account within 30 days. 
Where there are challenges fund shifts and budget adjustments are implemented.  
 
5.7.12 Finalisation of national policies and guidelines related to essential 
medicine provisioning 
 
The National Department as the policy development structure in the South African Health 
System had been engaged on the progress to develop the following key policies and 
guidelines to guide provisioning of essential medicines:  
 
 Review, development and finalisation of the new national (drug) medicine policies 
taking into account the current environment and service platform changes.  
 Identification and management of reporting based on common indicators for 
medicine availability.  
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 Finalisation of Human Resource norms for each level of care.  
 Development and roll out of the national electronic stock management system with 
visibility from the depot to the health facilities.  
 
5.7.12.1 Implemented action 
 
The affordable medicines directorate in the course of the study was still busy with policy 
and guideline drafts and conceptual notes which would be consulted and shared with the 
relevant stakeholders before approval and implementation.  
 
5.7.12.2 Implemented action effect  
 
The revised draft policies and produced concept notes are awaiting discussion and 
clearance by the National Health Council for public comments and discussions.  
 
5.8 CONCLUSION  
 
The participants were encouraged to continue engaging relevant stakeholders towards 
realisation of the proposed interventions envisaged to promote improved provisioning of 
essential medicines. The next chapter will present the proposed framework for provision 
of essential medicines for the District Health Services. 
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CHAPTER 6  
 
PROPOSED FRAMEWORK FOR PROVISION OF ESSENTIAL 
MEDICINES FOR THE DISTRICT HEALTH SERVICES  
 
6.1  INTRODUCTION 
 
The South African District Health Services is defined in line with the World Health 
Organization understanding of DHS as a district health system based on primary care is 
a more or less self-contained segment of the national health system. It comprises first 
and foremost a well-defined population living within a clearly delineated administrative 
and geographical area. It includes all the relevant health care activities in the area 
whether governmental or otherwise It therefore consist of a large variety of interrelated 
elements that contribute to health in homes, schools, workplaces, communities, the health 
sector and related social and economic sectors. It includes self-care and all health care 
personnel and facilities whether government or non-governmental up to and including the 
hospital at the first referral level and the appropriate support services such as diagnostic, 
laboratory and logistic support. It will be most effective if coordinated by an appropriately 
trained health officer working to ensure as comprehensive a range as possible of 
promotive, preventive, curative and rehabilitative health activities (NDOH 2013:12). 
 
The proposed framework was developed based on the input of the participants as well as 
adjusted based on the feedback obtained from the experts covering National Affordable 
Medicine(Pharmaceutical Services) Directorate and provincial district health services 
managers as well as Republic of South African Department of Health District Health 
Services Cluster in order to enhance its usefulness in practice and promote its utilization 
as well as possible adoption as a government framework for provision of essential 
medicines.  
 
The proposed framework would cover the medicine supply management cycle 
components as reflected below: 
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Figure 6.1  The pharmaceutical management framework 
(Management Sciences for Health [MSH] 2012) 
 
According to MSH (2012:1.10), pharmaceutical management framework comprises four 
basic functions: selection, procurement, distribution, and use. Selection involves 
reviewing the prevalent health problems, identifying treatments of choice, choosing 
individual medicines and dosage forms and deciding which medicines will be available at 
each level of the health system. Procurement Includes quantifying medicine 
requirements, selecting procurement methods, managing tenders, establishing contract 
terms, and ensuring pharmaceutical quality adherence to contract terms. Distribution 
includes clearing customs, stock control, store management, and delivery to depots, 
pharmacies, and health facilities. Use includes diagnosing, prescribing, dispensing, and 
proper consumption by the patient. In the pharmaceutical management cycle, each major 
function builds on the previous function and leads logically to the next. Selection should 
be based on actual experience with health needs and medicine use; procurement 
requirements follow from selection decisions, and so forth.  
 
At the centre of the pharmaceutical management cycle is the core of related management 
support systems, including the planning and organisation of services, financing and 
financial management, information management, and human resource management. 
These management support systems hold the pharmaceutical management framework 
together. Although individual parts of the framework may function independently for a 
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short time, the cycle as a whole will soon cease to operate and patient care will suffer 
without effective leadership, a functional organisational structure, adequate and 
sustainable financing, reliable management information, and motivated staff. The entire 
framework rests on a policy and legal components that establishes and supports the 
public commitment to essential medicine supply.  
 
The WHO member states subscribe to the above framework to manage provision of 
essential medicines .The paragraphs below will discuss each component and reflect key 
requirements for consistent provision of essential medicines.  
 
6.2 REPUBLIC OF SOUTH AFRICAN DISTRICT HEALTH SERVICES CONTEXT  
 
The Republic of South Africa has nine provinces made up of 52 districts with no less than 
3475 primary health clinics managed by professional nurses with limited midlevel worker 
staffing for the management of the medicine rooms and dispensing of medicines. The 
result has been long waiting times, high rate of expired medicines as well as medicine 
stock outs related to delayed placement of orders and follow up with the medical depots 
for outstanding items. 
 
There has been attempt to improve the availability and provisioning of essential medicines 
through employment of Pharmacist Assistants in particular for the National health 
insurance districts, implementation and roll out of the stock visibility system for the 
reporting and monitoring of the stock levels within the primary health care platform as well 
as implementing other various interventions including direct delivery by suppliers to health 
facilities  as part of service delivery improvements to ensure that the full range of essential 
medicines and other medical supplies are available in all public health facilities.  
 
6.3 LEGISLATIVE AND POLICY FRAMEWORK 
 
The following Legislative and Policy Framework have been used as basis in the 
formulation of the proposed framework: 
 
 National Health Act 61 of 2003  
 Pharmacy Act 50 of 1974, as amended  
 Nursing Act 33 of 2005, as amended  
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 Medicine and Related Substances Act 101 of 1965  
 National Core Standards for Health Establishments 2011 
 National Drug Policy of 1996 
 National Pharmaceutical and Therapeutic Committee Policy 2015 
 Good Pharmacy Practice Standards 2010  
 Good Warehousing Practices 2010 
 Policy on Nurse Prescribing 2016 
 
6.4 SCOPE OF THE PROPOSED FRAMEWORK  
 
The framework will be applicable to the first level of care district health services which 
cover the primary health clinics up to the district office.  
 
6.5 FRAMEWORK MISSION 
 
Consistent availability of essential medicines.  
 
6.6 FRAMEWORK VISION 
 
To ensure the effective and efficient procurement, distribution, storage and use of 
essential medicines in order to improve health outcomes of the service users across the 
district health service platform.  
 
6.7 UNDERPINNING VALUES  
 
 Access  
 Efficiency  
 Quality  
 Professionalism  
 Collaboration 
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6.8 INTENDED GOALS  
 
 Promote uninterrupted supply and provisioning of essential medicines within the 
district health services platform.  
 Promote positive practice environment for the health professionals within the 
district health service.  
 Promote savings and cost effective management of medicines. 
 
6.9 STRUCTURE OF THE POLICY FRAMEWORK ON PROVISION OF 
ESSENTIAL MEDICINES FOR THE DISTRICT HEALTH SERVICES  
 
The framework will be presented under the following headings:  
 
 The selection process  
 Procurement model  
 Warehousing  
 Distribution   
 Rational medicine use  
 Management support in terms of human resource development and management, 
information management systems 
 
The framework will be presented in the format providing details about the component, 
proposed approach and the monitoring standard which could be used to assess the 
degree of implementation and facilitate evaluation of the framework implementation.   
 
6.9.1 Essential medicines selection process component  
 
The selection of medicines to be used within the district will be based on the National 
Essential Medicine Lists, Provincial Pharmaceutical and Therapeutic Committee 
Approved catalogue as well as the Ideal Clinic and National Core Standards requirements 
relating to provision of essential medicines.  
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6.9.1.1 Selection process governance  
 
Each district shall have a district pharmaceutical therapeutic committee chaired by a 
senior district medical officer and comprising the minimum of the following professional 
members: 
 
 Head of primary health care programmes  
 Chief medical officers of the district hospitals  
 District clinical specialists both medical and nursing practitioners  
 Chief pharmacists of sub-districts, district hospitals and community health centres 
 District pharmacist shall serve as secretariat  
 Head of the health programmes within the districts  
 Finance manager 
 Supply chain manager 
 Pharmaceutical Services Policy Specialist  
 
The district manager shall be an ex officio member and the appointing authority for the 
members for period not exceeding three years which is renewable based on the 
participation of the particular member. 
 
The committee shall consider requests and submissions of items to be added or removed 
from the platform using the prescribed analysis procedures including high cost drivers 
(using ABC analysis) and (VEN) vital, essential and not important category analysis. 
 
The outcome of the committee decision on whether the items are to be added or not 
added in the basket of available medicines within the district health services shall be 
communicated to the Provincial PTC for ratification as either a provincial or a particular 
district item with the specific authorised prescriber level.  
 
6.9.1.2 Framework selection monitoring standards  
 
Number of districts with PTC meetings held at least once quarterly chaired by a senior 
clinician.   
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6.9.2 Procurement component   
 
The medicines appearing on the essential medicine lists are generally on the national 
contracts arranged nationally for cost effectiveness and affordability as well as ensuring 
the quality of the products.  
 
6.9.2.1 Procurement process  
 
The district shall procure essential medicines through the medical depots using the 
prescribed forms and approved catalogues which are updated at least quarterly. The 
orders should be approved by the pharmacy manager for the district hospital, pharmacy 
supervisor for the community health centre and the district pharmacist for the primary 
health clinics. Orders placed in a particular financial year but not delivered by the 30th 
April of the new financial year shall be cancelled by the 31st May of the new year and if 
the items are still needed the facility shall place a new order.  
 
6.9.2.2 Framework procurement monitoring standards  
 
 At least 90 percent of items required for the ideal clinic and national core standards 
appearing in the approved catalogue items and available on national contracts.  
 District has order cut-off date schedule for placement of orders at the depots.  
 There should be service level agreement between the district and medical depot 
on the expected turnaround times and parties’ responsibilities for smooth 
procurement and provisioning.  
 
6.9.3 Good warehousing practice component  
 
As far as possible there should be one medical depot per province warehousing medicine 
stock for the whole province instead of all Districts having district warehouses as the 
multiple depots or warehousing points increase the handling process, turnaround times 
for orders and the stock holding values for provinces which could lead to medicine stock 
out in other parts of the country. The bulk medicines shall be stored in temperature 
controlled rooms which should be monitored daily to ensure cold chain maintenance. 
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6.9.3.1 Good warehousing practice in the health facilities  
 
The health facilities should have at least two rooms designated for medicine warehousing 
and handling, one to serve as medicine store room and the other as the dispensing room. 
These rooms should have temperature control mechanism to maintain the temperature 
below 25 degree Celsius, proper steel shelving to store the medicines and the pallets for 
protection of the medicines from being located directly on the floor space. The rooms 
should have refrigerators to store vaccine and cold chain items requiring storage between 
2 and 8 degree Celsius to preserve the medicine usability.  
 
6.9.3.2 Good warehousing practice monitoring standard  
 
The number of health facilities with the medicine store room and the dispensing room with 
temperature control mechanism and proper steel shelving within the district.  
 
6.9.4 Distribution component   
 
The medicines shall be distributed by the medical depot directly to the ordering health 
facilities including the primary health clinics using the vehicles that are capable of 
maintaining the cold chain temperature at less than 25 degrees Celsius, closed design 
protecting the medicines from exposure to elements including sunlight and adverse 
weather conditions. 
 
6.9.4.1 Distribution approach  
 
The distribution of essential medicines shall be outsourced as the department of health 
competency is service delivery more than the logistics management. Best Practices also 
demonstrate that when the distribution is outsourced there is reduced risk for theft as well 
as losses due to inappropriate transportation of goods in the case of adverse weather 
conditions as well as industrial action protests which may increase turnaround times and 
possible state vehicles breakdown. 
 
Distribution shall occur once a month in accordance with the delivery schedule agreed 
with the service users. Emergency deliveries can be considered for life threatening 
conditions and vaccines.  
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6.9.4.2 Distribution standard monitoring  
 
 Number of districts with a delivery schedule with at least one delivery within the 21 
working days.  
 Number of districts with an outsourced distribution services for the distribution of 
medicines from the depot directly to the health facility.  
 
6.9.5 Rational medicine use component  
 
Due to limited availability of pharmacists and medical officers within the District Health 
System there is deviation from clinical management guidelines, limited evidence based 
prescriptions of antibiotics. Further the shortage of nurse clinicians as well as cold chain 
maintenance equipment for the vaccines and insulin and pharmacist assistants to 
manage stock at PHC level there is avoidable wastage of expensive medicines. 
 
6.9.5.1 Rational medicine 
 
Rational medicine use can be promoted through the following interventions:   
 
 Medicine supply management induction for all professional nurses within the 
primary health setting focusing on EML and guideline compliance, ordering and 
stock management in line with the good pharmacy practice. 
 Newly qualified professional nurses’ prescription to be countersigned by the 
experienced primary health care nurse clinician until they are certified competent 
to prescribe and issue medicines after undergoing Primary Care 101 modules as 
required by the authorised nurse prescribing policy issued by National Department 
of Health. 
 Conduct of prescription monthly audits for the doctors and nurses’ scripts 
dispensed using the National Core Standards checklist tools for pharmaceutical 
standards and provide feedback to the clinicians.  
 Promote mandatory stock count and rotation of medicines every quarter. The 
report should be shared with the district pharmacists and excess stock distributed 
to the catchment facilities to minimise expiry and excess ordering.  
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6.9.5.2 Rational medicines use monitoring standards  
 
 District based medicine supply management induction for professional nurses 
working in PHC setting.  
 Number of professional nurses who have completed Primary Care 101 and issued 
with Authorised Nurse Prescriber Certificate in terms of section 56 of the Nursing 
Act 33 of 2005. 
 Number of health facilities conducting monthly prescription clinical audits using the 
National Core Standards tools.  
 Number of health facilities within the district conducting quarterly stock count and 
rotation.  
 Value of excess stock movement across the facilities within the catchment area.  
 
6.9.6 Management support component  
 
Management support comprise of activities in the areas of the planning and organisation 
of services, financing and financial management, information management, and human 
resource management (including training and capacity building). 
 
6.9.6.1 Planning and organisation of health services  
 
As medicines are utilised across the health services chain the planning and organisation 
of health services should be such that at all levels there are well trained officials charged 
with the responsibility of ensuring continuous provisioning and availability of essential 
medicines. 
 
6.9.6.1.1 Planning and organisational requirements  
 
The organisational structure should consist of pharmaceutical services functions and 
incumbents as proposed under the human resource component. The strategic plan 
documents and annual performance plan should include indicators measuring whether 
the consistent provisioning is ensured, the proposed strategic objective and indicator is 
the following:  
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Table 6.1: Proposed formula for monitoring medicine availability 
 
Strategic objective  Indicator  Formula  
Ensure consistent availability 
of essential medicines  
Percentage availability of 
essential medicines as per 
the national core standard list 
for the level of care  
Number of items available  
Number of items on the 
national core standards list  
 
6.9.6.1.2 Planning and organisation monitoring standard  
 
The above strategic objective should appear and be monitored in all district health plans. 
 
6.9.6.2 Finance and financial planning   
 
The budget for provision of essential medicines has been identified as non-negotiable 
items for the Republic of South Africa which means that there are no financial challenges 
to procure medicines. The problems are mainly in payment of suppliers, excess stock and 
expiry of medicines due to non-execution of stock rotation and stock taking in the facilities.  
 
6.9.6.2.1 Key financial considerations  
 
The important areas that need to be strengthen are:  
 
 The facilitation of timeous payment of suppliers by the districts submitting proof of 
deliveries to the medical depots to ensure that there is no interruption of supplies.  
 Received stock orders reconciliation to be verified to ensure that medicines items 
and quantities ordered correspond with the received items. 
 Quarterly stock rotation and redistribution to other health facilities within the district. 
 
6.9.6.2.2 Financial monitoring standards  
 
 Number of proof of delivery vouchers certified correct and returned to the medical 
depot by the health facilities.  
 Number of health facilities with quarterly stock taking and rotation reports.  
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6.9.6.3 Human resource component  
 
The human resource component plays a critical role in ensuring that the medicines reach 
the end user for better health outcomes. In practices there are different categories and 
varied job functions of the officers put in charge of medicine provisioning.  
 
It is therefore important that standardised systems are put in place to ensure that the 
human resources are well qualified, in sufficient numbers and well developed to render 
cost effective provisioning of essential medicines. 
 
6.9.6.3.1 Human resources categories and job functions for improved provisioning of 
essential medicines  
 
For smooth provisioning of essential medicines, the following human resources 
categories with clear and standard job descriptions for consistent service delivery should 
be in place within a district level of care: 
 
Table 6.2: Human resource minimum staffing for DHS   
 
HR category  Number  Job functions  Work station  
District 
Pharmacist – 
Manager  
1  Facilitate Procurement of 
essential medicines for all health 
facilities within the  
 Promote rational medicine 
utilisation for all the health 
facilities and health workers  
 Facilitate and institute 
mechanisms for continuous 
monitoring for consistent 
availability of essential 
medicines  
 Providing training in rational 
drug use and drug supply 
management  
 Supervise and mentor the mid-
level workers responsible for 
medicine stock management  
 Liase with the key stakeholders 
including the medical depots 
and pharmaceutical services 
District Office  
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HR category  Number  Job functions  Work station  
 Promote conduct research on 
essential medicine provisioning  
 Providing professional services 
and advice to District 
Management and health 
programmes on pharmaceutical 
standards and compliance 
Sub-district 
Pharmacist -
Assistant 
Manager  
1  Facilitate Procurement of 
essential medicines for all health 
facilities within the Sub-district  
 Promote rational medicine 
utilisation for all the health 
facilities and health workers 
within the sub-district  
 Facilitate and institute 
mechanisms for continuous 
monitoring for consistent 
availability of essential 
medicines within the sub-district  
 Providing training in rational 
medicine use and medicine 
supply management 
 Supervise and mentor the mid-
level workers responsible for 
medicine stock management in 
the catchment health facilities  
 Promote conduct research on 
essential medicine provisioning  
 Providing professional services 
and advice to Sub-district 
Management and health 
programmes on pharmaceutical 
standards and compliance 
Sub-district Office  
Pharmacy -
Assistant 
Manager  
1  Manage the Pharmacy and 
Pharmacy Store  
 Supervise and mentor the 
pharmacy personnel  
 Monitor ordering patterns and 
stock management practices 
within the hospital units 
 Participate in rational medicine 
capacity building programmes  
 Participate in the management 
meetings providing expert 
advice in relation to 
Pharmaceutical related matters  
District Hospital 
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HR category  Number  Job functions  Work station  
Pharmacy 
Supervisor  
1  Manage the Pharmacy and 
Pharmacy Store  
 Supervise and mentor the 
pharmacy personnel  
 Authorise medicine orders  
 Monitor ordering patterns and 
stock management practices 
within the community health 
centre  
 Participate in rational medicine 
capacity building programmes  
 Participate in the management 
meetings providing expert 
advice in relation to 
Pharmaceutical related matters 
 Liase with the stakeholders 
including the medical depots 
and pharmaceutical services  
Community Health 
Centre  
Post Basic 
Pharmacist 
Assistants 
2  Manage the medicine stock 
room within the clinic  
 Dispense medicine scripts from 
the prescribers in the clinic  
 Prepare, submit and follow up 
approved orders for facility 
managers with the medical 
depot  
 Participate in the Sub-district 
Pharmacy forum  
Primary Health 
Clinic-The 
Pharmacist 
Assistants shall 
report to the 
Operational 
Manager PHC.  
 
6.9.6.3.2 Human resource monitoring standards 
 
 Number of districts with the appointed district pharmacist at a manager level. 
 Number of sub-districts with the appointed sub-district assistant manager 
pharmacy. 
 Number of district hospital with the hospital pharmacy assistant manager. 
 Number of community health centres with appointed pharmacy supervisor. 
 Number of primary clinics with at least 2 post basic pharmacist assistants. 
 
6.9.6.4 Training and capacity building  
  
The modalities and treatment protocols are updated continuously as well as new 
employees enter the health system which necessitate orientation and induction 
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programmes in the health sector to promote good and safe practices in relation to 
medicine provisioning and supply management. 
 
6.9.6.4.1 Annual capacity building plan 
 
There should be an annual plan of capacity building programmes within the district to 
promote effective and efficient management of medicine stock covering at least the 
following topics and subjects:  
 
 Rational medicine use covering essential medicine Lists, cost effective 
prescriptions.  
 Medicine supply management covering selection, procurement, legal prescripts 
and warehousing components.   
 Basic pharmacist and post-basic pharmacist assistant training to increase 
primary health clinic coverage with dedicated medicine room and dispensing 
services. 
 
6.9.6.4.2. Training and capacity building monitoring standards  
 
Existence of a comprehensive annual plan of capacity building programmes covering at 
least rational medicine use, medicine supply management and pharmacist assistant 
training. 
 
6.9.6.5 Information management   
 
The strategies used for information management include monitoring and evaluations, use 
of pharmaceutical management information systems and computer technology. The 
information systems are necessary for the reporting of medicine availability, quicker 
placement of orders as well as communication amongst the health professionals. 
 
6.9.6.5.1 Required information management systems  
 
The following systems coupled with computer hardware should be available for improved 
information management: 
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Table 6.3: Information management system options 
 
Level  Required System  Purpose  
District Remote Demander module  
 
Stock Visibility System  
To enable the district to 
review and approve orders 
electronically thus reducing 
turnaround times. 
 
SVS will be used to monitor 
stock availability within the 
district facilities. 
Sub-district  Order management system 
and Remote Demander 
module  
 
Stock Visibility System 
To assist with placement of 
the catchment clinic orders 
electronically.  
 
SVS will be used to monitor 
stock availability within the 
Sub-district facilities. 
District Hospital Order management system 
and Remote Demander 
module  
To assist with placement, 
stock management and 
dispensing of medicines 
within the hospitals.  
 
Community Health Centre  Order management system 
and Remote Demander 
module  
 
 
Stock Visibility System 
To assist with placement, 
stock management and 
dispensing of medicines 
within the unit. 
 
SVS will be used to report 
stock availability within the 
CHC.  
Primary health care clinic  Order management system 
and Stock Visibility System  
To assist with placement, 
stock management and 
dispensing of medicines 
within the clinic. 
 
SVS will be used to report 
stock availability within the 
CHC. 
 
6.9.6.5.2 Information management monitoring standard  
 
Number of health facilities with the identified functional information system for recording, 
management and monitoring medicine stock.  
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6.10 MONITORING AND EVALUATION OF THE FRAMEWORK  
 
The proposed framework was developed based on the input of the participants and 
subjected to the review of the experts covering National Affordable Medicine 
(Pharmaceutical Services) Directorate and provincial district health services managers 
as well as Republic of South African Department of Health District Health Services Cluster 
in order to enhance its usefulness in practice and promote its utilisation as well as 
possible adoption as a government framework for provision of essential medicines.  
 
The feedback obtained from the experts’ review was that the framework is useful for 
practice with few adjustments which were incorporated into the final proposed framework 
as presented in this chapter. 
 
In practice, the framework could be monitored and evaluated by assessing the number of 
facilities within the district which are able to meet the proposed monitoring standards. The 
monitoring could be done monthly by reporting on the monitoring standards and 
evaluation conducted annually by reviewing the progress made in the achievement of the 
consistent availability and provisioning of essential medicines.  
 
6.11 CONCLUSION  
 
The researcher believes that if the proposed framework is implemented and supported 
with the necessary financial, system and human resources there will be improved 
provisioning and availability of essential medicines with the resultant better treatment 
outcomes and a long healthy life for all South Africans.  
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CHAPTER 7  
 
CONCLUSION AND RECOMMENDATIONS FROM THE STUDY 
 
7.1 INTRODUCTION  
 
The study has been undertaken across the eight provinces of the Republic of South Africa 
which is a developing country with limited resources to provide for the health services 
coverage of all the people living in the country. The information and experiences shared 
have contributed towards the development of the proposed framework for improved 
provision of essential medicines presented in the preceding chapter.  
 
7.2 THE RESEARCH DESIGN AND METHOD  
 
The research design and methodology followed was qualitative research design and 
action research approach driven with an intention to improve clinical practice environment 
through:  
 
 Exploration and description of the different provinces approaches in the provision 
of essential medicines. 
 Proposing recommendations on a corrective measure to be implemented in order 
to improve the provisioning of essential medicine in the various provinces.  
 Identification and sharing best practices to be incorporated into the framework for 
the provision of essential medicines for the district health services. 
 Formulation of a framework for the provision of essential medicines for the district 
health services. 
 
7.2.1 Research approach action research  
 
This study was executed with the involvement of the participants in reviewing and 
improving their practice environment with an intention to promote development and 
consideration of new strategies to ensure consistent medicine provisioning for the health 
facilities.  
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Action research was found to be useful for this study as when participants input is sought 
in a collaborative manner, they share their expertise freely in an environment which utilise 
participatory, democratic processes to develop practical knowledge and promotion of 
flourishing of individuals and their communities. 
 
7.3 SUMMARY AND INTERPRETATION OF THE RESEARCH FINDINGS  
 
During the course of the study the following findings came across as key areas to be 
considered in order to promote improvements in essential medicine provisioning:  
 
7.3.1 Need for national standards for essential medicines availability  
 
There is a need of a nationally agreed standard against which to measure the availability 
of essential medicines as the principle that essential medicines should be available at all 
times is not achievable across all provinces as evidenced by reported stock outs within 
the health facilities. The list comprised of limited basket of items to be measured and 
available in all health facilities taking into account the level of care should be developed 
and consulted towards a national standard for essential medicines availability. 
  
7.3.2 Need for common framework for provision of essential medicines for the 
district health services  
 
There was no province that indicated existence of a comprehensive district health 
services framework for provision of essential medicines. The participants expressed a 
need to ensure that any framework developed should encompass all key processes 
required for effective medicine supply management namely selection, procurement, 
warehousing, distribution, rational medicine use, legal framework and management 
support to be effective otherwise. 
 
7.3.3 Varied functionality and composition of the pharmaceutical therapeutic 
committees 
 
The study revealed that not all PTCs were functioning in the standardised approach with 
majority being chaired and hosted by pharmaceutical services with limited participation of 
clinicians as the prescribers of the medicines at the health facility level.  
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There must be mechanism and systems to ensure that the pharmaceutical therapeutic 
committees are functional and chaired by clinicians at all times to ensure that selection of 
medicines address the needs of the communities. Clear terms of reference should be 
available to guide provinces on how to formulate and sustain functionality of the PTCs. 
 
7.3.4 The medical depots should consider the option of increasing direct 
deliveries for the hospitals and community health centres 
  
In order to ensure that the medical depots capacity to service the primary health care 
clinics better, the participants suggested that the procurement processes of medicines 
should allow for direct delivery to hospitals and Community Health Centres to allow the 
depots to focus and improve procurement and supply turnaround times for the primary 
health clinics thus improving the provisioning of essential medicines at the lowest level.  
 
7.3.5 The sub-depots are part of the bottleneck in the provisioning of medicines 
for the primary health clinics  
 
The distribution of medicines should be direct to health facilities instead of being from the 
depots to the hospitals or district warehouses before being sent to Primary Health Clinic 
to ensure timeous availability at the health facility level.  
 
7.3.6 Outsourced medicine distribution approach is better than the internal 
distribution 
 
The utilisation of state vehicles which do not meet the good distribution practices and 
expose medicines to unsuitable temperatures, adverse weather and possible theft as well 
as possible irreplaceable vehicle breakdown was highlighted as a key challenge that need 
to be addressed to ensure consistent delivery to the health facilities. 
 
The participants proposed that there should be standard distribution contract 
specifications across provinces to ensure preservation of medicine quality and timeous 
delivery to the health facilities and move towards outsourced distribution rather than 
dependency on state vehicles which are generally not capacitated to maintain and 
monitor cold chain in transit. 
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7.3.7 Standard job description for the district pharmacists  
 
The district pharmacists were identified as a group that could strengthen implementation 
of the key components of the medicine supply management cycle, however, the job 
descriptions were generally not clear and not encompassing all the components.  
 
The proposed framework has suggested key job functions which could be further refined 
with the collaboration between the heads of pharmaceutical services and district 
managers.  
 
7.3.8 National Department of Health role in strengthening essential medicine 
provisioning 
  
The policies governing pharmaceutical services provisioning were found to be old and 
outdated especially the National Drug Policy of 1996, a lot of policy changes have 
occurred including primary health care re-engineering and National Health Insurance 
which require new approaches in management of medicine supply.  
 
The study participants highlighted a need for the National Department of Health as a 
policy development and coordinating unit to fast track:  
 
 Review, development and finalisation of the national medicine policies. 
 Identification and management of reporting based on common indicators for 
medicine availability. 
 Finalisation of human resource norms for each level of care. 
 Development and roll out of the national electronic stock management system with 
visibility from the depot to the health facilities. 
 
7.4 STUDY RECOMMENDATIONS  
 
The study has produced a proposed framework for the provision of essential medicines 
for the district health services, the recommendations will be categorised under the 
following headings:  
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7.4.1 Recommendations for National Department of Health  
 
The National Department should consider adopting the proposed framework for the 
provision of essential medicines within the district health services as it has been 
developed with the participation of the majority of provinces (eight of the nine provinces). 
 
The department should also facilitate the development, review and approval of policy 
documents and standards for the provisioning of essential medicines including the 
National Drug Medicine Policy as well as the standard benchmark against which 
provinces will be measured in terms of the availability of medicines.  
 
7.4.2 Recommendations for Provinces  
 
The provinces should, taking into account that the proposed framework was developed 
with the involvement of the pharmaceutical services managers from the majority of the 
provinces, consider adopting the framework as mechanism to manage medicine supply 
and provisioning within the first level of care. 
 
7.4.3 Recommendations for pharmaceutical services  
 
As the units responsible for the medicine supply management services, pharmaceutical 
services should work towards standardisation of human resource practices and training 
materials for medicine supply management across the districts within their provinces. 
 
The harmonisation of job descriptions for the pharmaceutical management staff in 
collaboration with the managers responsible for district health services should be 
prioritised to ensure that all the key components of the medicine supply management 
cycle are reflected and contracted across the districts.  
 
Further In order to promote total coverage of the primary health clinics with the 
deployment of pharmacist assistants, pharmaceutical services should prepare a business 
case highlighting the wastage of financial resources through expiry of medicines , 
irrational prescribing and poor storage and handling of medicine stock and strengthen 
relationships with programme managers especially HIV and Aids units, human resource 
management and chief financial officers to mobilise resources for training and eventual 
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appointment of the pharmacist assistants for quality medicine supply management at 
primary health level.  
 
7.4.4 Recommendations for future research 
 
Medicine provisioning is critical for the service delivery in all countries as such need to be 
based on proper frameworks and guidelines to promote cost effectiveness and quality 
health services, it is therefore recommended that health researchers conduct further 
studies in their own countries on the provisioning of essential medicines for district health 
services taking into account the pharmaceutical medicine supply management 
framework. 
 
 Further studies can be conducted in the Republic of South Africa to assess level of 
implementation of the proposed framework in provinces as well as the resource 
investment requirements to ensure that the framework is fully implemented in practice 
environment. 
 
7.5 CONTRIBUTION OF THE STUDY 
 
The study has reviewed and consolidated the various provinces approach in the 
provisioning of essential medicines and considered the best practices for incorporation 
into the proposed framework to guide future practice. The possibility of a standardised 
approach across the country’s district health services platform in terms of human resource 
development, management and functions has potential to introduce improved 
management of the pharmaceutical services personnel within the district health services, 
cost savings and efficiency in the provision of essential medicines which is expensive 
health commodities. 
 
7.6 LIMITATION OF THE STUDY  
 
The study was conducted in eight of the nine provinces of the Republic of South Africa 
due to one province non willingness to participate despite numerous requests for 
participation.  
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7.8 CONCLUDING REMARKS  
 
Consistent supply and provisioning of essential medicines which is an expensive health 
commodity is key in the treatment and management of prevailing diseases and require to 
be managed efficiently to promote uninterrupted supply to the health facilities and rational 
use in particular the district health services as the first level of care with limited human 
resource coverage. 
 
It is believed that the experiences and proposed framework developed will go a long way 
in ensuring that the service users have improved access to essential medicines for control 
of their diseases thus increasing the life expectancy of the service users.  
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ANNEXURE C: EXCEPT FROM THE TRANSCRIPTION RECORDS 
 
I Now, we doing the responsible pharmacist for Free State medical depot.  So we’re 
starting.  Thank you for seeing me.   in summary, just tell me what is your job position, qualification, 
number of experience. 
P4 I am presently a responsible pharmacist at the provincial medical depot.  I’ve been 
appointed since first of February two thousand and fifteen.  I’ve been appointed in that position.  
I’m a pharmacist qualified in end of nineteen eighty-seven so I’ve got roughly about twenty-five 
years’ experience in pharmacy, B Pharm, in various fields of pharmacy, primarily in…eighty 
percent of that would be in hospital pharmacy and then about roughly six years’ experience in 
warehousing or distribution pharmacy. 
I What has been your experience in terms of district health services? 
P4 District health services, I spent a year in the Northern Cape as a district pharmacist and 
then, like I say, the six years’ experience in warehousing  
I Which includes? 
P4 That includes supporting the district health system in terms of availability of medicines and 
so on. 
I Now, what’s your understanding of your role in the provision of medicine in district health 
services in the province, you’ve got thirty-one hospitals.  Then you’ve got two thirty-two PHC.  So 
what role do you play in the provision of medicines for the DHS?   
P4 For the district health.  Obviously, within the medical depot setup, because the medical depot 
in the Province provides a service of making medicines available on order to a number of 
institutions at various levels of care.  Now, as you mentioned, primarily district hospitals, 
community health centres, and clinics.  So where there is a need identified by patients attending 
those institutions, that need is then consolidated into an order, an order for medication, and that 
order for medication is then presented to the depot for picking, packing, and delivery.  So that’s 
where my role primarily comes in to ensure that the pipeline in terms of availability at depot level 
and also the distribution of medication from the depot to the facility level happens within a 
timeframe so that the five Rs are met: right quantity, right place, right time, and all the right.  So 
that’s a big part of my role and I play an additional role also in terms of procurement from suppliers 
where we’ve got a procurement unit at the depot, we’ll then procure medicines on contract or 
sometimes on quotation basis to fill up the pipeline of available medicines at the depot.  Obviously, 
as responsible pharmacist, I have to authorise all those purchases to ensure that the amounts 
being ordered are not excessive and also not too little so that we can maximise availability.  So 
in rough, that’s my role. 
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ANNEXURE D: INTERVIEW GUIDE AND CONSENT FORM 
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Thank you for agreeing to be the participant in this study. 
The study intends to explore and produce a framework for the provision of essential 
medicines for the District Health Services using action research approach. 
You have been selected as a participant for this study on the basis of your expertize and 
involvement in the provision of medicines within the district health services. 
The data collected during the site visits and interview will form the basis for the Thesis of 
the Doctor of Philosophy and Literature Health Studies Degree with UNISA. 
 
PROCEEDINGS DETAILS  
 
The site visits and the interview sessions will not exceed 10 days for the whole study 
period per site with a view to learn and share best practices for sustained improvements. 
The site visits and interview will be conducted by the researcher with the proceedings 
being audio recorded. 
Participants will be allowed to ask any questions if there is any point you would like to be 
clarified during this process. 
The results will be shared with yourselves once completed for verification purposes. 
There shall not be any reference to your personal information, and each informant is free 
to withdraw or not comment if not comfortable. 
You are requested to sign the attached consent form if you are voluntarily willing to be a 
participant for the study. 
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CONSENT FORM TO BE A PARTICIPANT IN THE RESEARCH FOR THE 
FRAMEWORK FOR PROVISION OF ESSENTIAL MEDICINES FOR DISTRICT 
HEALTH SERVICES   
 
 
 
I …………………………………………    hereby voluntarily consent to participate in the 
study for the framework for provision of essential medicines for the District Health 
Services  
 
PARTICIPANT’S SIGNATURE ………………………. 
 
FULL NAMES …………………………………………… 
 
CONTACT NUMBERS ………………………………. 
 
DATE …………………………………………………….    
 
 
 
SIGNATURE OF THE RESEARCHER …………………………. 
MR SM ZUMA  
DATE  
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 We would like to know a bit more about you as a person 
 
 Please introduce yourself in terms of job position, qualifications and number 
of years’ experience in the provision of essential medicines for district health 
services.   
 
 
 Please explain your role in the provision of medicines in relation to the district 
health services. 
  
 Describe your understanding of the concept essential medicines  
o What is essential medicines 
o Taking into account the WHO Framework of Provision for 
Pharmaceutical Services as depicted below  
 
 
 
 
 
 
 
SECTION B:  BACKGROUND OF PARTICIPANTS  
SECTION C: ASPECTS REGARDING PROVISION OF ESSENTIAL 
MEDICINES SSAVAILABILITY (60 MINUTES) 
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o What are the key processes involved in the provision of essential 
medicines in terms of  
Component  Regional 
Hospitals  
District 
Hospitals  
Community 
Health Centre  
Primary 
Health 
Clinic  
Selection      
Procurement      
Distribution      
Use      
Legal 
Framework 
    
Management 
Support  
    
 
 Please explain if there is a documented framework for provisioning of 
essential medicines for the district health services in (i) South Africa or (ii) 
within your province.  
 
 Does all component stated above follow the key processes mentioned 
 
 How does your province approach the provision of essential medicines in 
general as well as specifically for the district health services ((i) Hospitals, (ii) 
Community Health Centres and (iii) Primary Health Clinics)? 
 Has there been adequate provision of essential medicines for district health 
services ((i) Hospitals, (ii) Community Health Centres and (iii) Primary Health 
Clinics)? if yes why or no why not.  
Level of Care  Narrative Content  
Regional 
Hospitals  
 
District Hospitals   
Community 
Health Centre  
 
Primary Health 
Care  
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 Should there be any special considerations for the provision of essential 
medicine for district health services ((i) Hospitals, (ii) Community Health 
Centres and (iii) Primary Health Clinics)? in terms of selection, procurement, 
use and distribution? 
o What special considerations? 
o Why do you think these special considerations are necessary? 
o What resources are required and why necessary  
 What strategies should be or have been used to provide essential medicines 
for the district health services (Hospitals, Community Health Centres and 
Primary Health Clinics)? 
 
Level of Care  Narrative Content  
Regional 
Hospitals  
 
District Hospitals   
Community 
Health Centre  
 
Primary Health 
Care  
 
 
 What role should National Department of Health play in the provision of 
essential medicines for the District Health Services in South Africa? 
 
 
 
 Do you have any other proposals for the framework for provision of essential 
medicines? 
 
CONCLUSION  
 
The draft report will be sent to you after analysis by the researcher for your review and 
comments before submission for examination. 
 
I would like to thank you for your time and participation in this process. 
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